TW201100387A - Microcapsule composition containing imidazole compound, curable composition and master batch curing agent using the same - Google Patents

Microcapsule composition containing imidazole compound, curable composition and master batch curing agent using the same Download PDF

Info

Publication number
TW201100387A
TW201100387A TW099112659A TW99112659A TW201100387A TW 201100387 A TW201100387 A TW 201100387A TW 099112659 A TW099112659 A TW 099112659A TW 99112659 A TW99112659 A TW 99112659A TW 201100387 A TW201100387 A TW 201100387A
Authority
TW
Taiwan
Prior art keywords
group
composition
compound
imidazole compound
patent application
Prior art date
Application number
TW099112659A
Other languages
Chinese (zh)
Inventor
Nobuhiro Ito
Teruyoshi Shimoda
Hisanao Yamamoto
Original Assignee
Asahi Kasei E Materials Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei E Materials Corp filed Critical Asahi Kasei E Materials Corp
Publication of TW201100387A publication Critical patent/TW201100387A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K9/00Use of pretreated ingredients
    • C08K9/10Encapsulated ingredients
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G59/00Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
    • C08G59/18Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
    • C08G59/40Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the curing agents used
    • C08G59/4007Curing agents not provided for by the groups C08G59/42 - C08G59/66
    • C08G59/4014Nitrogen containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00Compositions of epoxy resins; Compositions of derivatives of epoxy resins
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00Inks
    • C09D11/52Electrically conductive inks
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D5/00Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
    • C09D5/24Electrically-conducting paints
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere
    • C09K3/10Materials in mouldable or extrudable form for sealing or packing joints or covers
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2200/00Chemical nature of materials in mouldable or extrudable form for sealing or packing joints or covers
    • C09K2200/02Inorganic compounds
    • C09K2200/0243Silica-rich compounds, e.g. silicates, cement, glass
    • C09K2200/0247Silica
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2200/00Chemical nature of materials in mouldable or extrudable form for sealing or packing joints or covers
    • C09K2200/06Macromolecular organic compounds, e.g. prepolymers
    • C09K2200/0645Macromolecular organic compounds, e.g. prepolymers obtained otherwise than by reactions involving carbon-to-carbon unsaturated bonds
    • C09K2200/0647Polyepoxides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Epoxy Resins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paints Or Removers (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Provided is a composition having excellent curing abilities at a low temperature, high storage stability, and high solvent stability as being used as epoxy resin curing agent or the like, an epoxy resin curing agent using the same, and an epoxy resin composition. A microcapsule composition containing imidazole compound of the present invention contains a core containing an imidazole compound represented by the following formula (1), and a shell containing an organic high polymer, an inorganic compound or both of them, and covering a surface of the core. (wherein R1, R2, R3 respectively independently represents a hydrogen atom, a halogen group, a C1-20 alkyl group which may contains a substituent, an aromatic group which may contains a substituent, a C1-20 alkoxy group which may contains a substituent, or a phenoxy group which may contains a substituent; Q represents a C1-20 divalent hydrocarbon group which may contains a substituent; m represents an integer of 1 to 100, Z represents an organic group having a valence of m; Y represents a urea bond, a thiourea bond, an amide bond or a thioamide bond represented by the following formula (G).)

Description

201100387 t 六、發明說明: 【發明所屬之技術領域】 本發明係有關—種具有經微料化之特定 化合物、使用該化合物之硬化性說成物及母^的味唾 batch)型硬化劑。 明' (master 【先前技術】 環氧樹脂係由於其硬化物在機械特性 ο 特藥性以及接著性等為優異,_ === 氣電子用絕緣材料以及接著劑等之廣泛用途上金枓、電 般所使用之環氧樹脂組成物係於使用時 目前,- 劑之二液混合而使用的_ # μ π $ # 衣氧樹月日與硬化 氧樹一成物在室温氧液性環 脂與硬化劑分別保存,且在使用前-刻才依晨氧樹 配物進行計量並混合使用, 而將各調 合後立即硬化,因而每成 ’、。更且,由於會在混 〇 調配頻率增多、使作可使㈣__彳。因此, 用量有其限度。業效率降低’進而使組成物之有效使 而提决上述二液性環氧樹脂組成物之問題為目的 樹脂組成物係例如在产^成物岐案的早液性之環氧 師^删制、^=中調配有雙氰胺 性硬化劑者。 恥錯5物、胺鹽等硬化劑作為潛在 專利文獻1係提幸 定構造的咪唑化合物作、^有/刀子内含脲鍵或醯胺鍵之特 ’ ’、、環氧樹脂用之早期硬化劑或硬化 321995 5 201100387 *促進劑者。專利文獻2係提案使胺基己 ==酸基之化合物在乙腈中反應,:將沉澱後 所付之3有脲鍵的咪唾化合物之白色固體作 硬化劑使用者。專利文獻3係提案一種表面經異氛酸醋曰化 合物之反應物所包覆的環氧樹脂用硬化劑。 [先前技術文獻] [專利文獻] ο [專利文獻1]日本特開昭64_66172號公報 [專利文獻2]日本特開2〇〇〇_29〇26〇號公報 [專利文獻3]曰本特開平〇1_7〇523號公報 【發明内容】 [發明所欲解決之課題] Ο :而,使用該等硬化劑的環氧樹脂 -性與硬化性之平衡不足。例如,貯藏安定性優異= =生低,故為使其硬化而需設為高溫或需•二= 藏。例如使用專利文獻卜2所揭示之硬化中貯 ==:::差’故從生產性二= *,其在溶劑存在===-成 存在下之保存安定性不足。\特別疋在甲基乙基酮 之高=或之=’為7應付電路 的材料以達成行動機器輕量化:或是 321995 6 201100387 要求低溫中的快硬化性 定性(溶劑安定性)傷藏文疋性以及溶劑存在下之安 成單液性環氣樹環氧樹脂組成物、以及達 充分滿m4成 在性硬化劑。然而,事實上, 劑尚不為1所^性之單液性環氧樹月旨組成物及潛在性硬化 ,月係後鑑於上述情形而研創者,主要目的係提供 -^作為環氣樹脂用硬化劑等之時,低溫硬化性優異, 〇使用該組成物之举亦達成馬的溶劑安定性之組成物、 [用以解決課旨用硬化劑及環氧餘組成物。 本發明者等為 現,經由將具有特!!上述課題而專心致志研究’結果發 可達成上述之目的^造之味唾化合物進行微膠囊化,即 b 並依據該見解遂而完成本發明。 亦即,本發明係如下所述。 [1 ] 一種含有味啥彳卜人 0含有下述式⑴所之微膠⑽組Γ,係'包含: ^含有有機高分子、 *、、、機:化合物或該兩者且包覆上述芯的表 面之殼; R1 N ) R2(式中,R1、P、R3 久 ώ _ _ . 自獨立地表示氫原子、鹵基、可含取 代基之奴原子數 芝20之烷基、·^含取代基之芳香族基、201100387 t VI. Description of the Invention: [Technical Field of the Invention] The present invention relates to a specific compound having a micronized material, a curable composition using the compound, and a saponin type hardener. Ming' (previously) Epoxy resin is excellent in mechanical properties, special properties and adhesion, etc., _ === Insulating materials for gas and electronic materials and adhesives, etc. The epoxy resin composition used in the past is used at the time of use, and the two liquids of the agent are mixed and used _ # μ π $ #衣氧树月日与硬氧氧树一物 at room temperature oxygen liquid cycloaligen The hardeners are separately stored, and are metered and mixed according to the morning oxygen tree ligand before use, and each of them is hardened immediately after blending, so that each time is formed, and more, since the frequency of mixing is increased, Therefore, it is possible to make (4) __彳. Therefore, there is a limit to the amount of use. The industrial efficiency is lowered, and the composition is effective, and the problem of the above-mentioned two-component epoxy resin composition is determined. The early liquid epoxy chemist of the 岐 岐 ^ 删 删 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ Imidazole compound, ^ / / knife containing urea bond or guanamine Special '', early curing agent for epoxy resin or hardening 321995 5 201100387 * Promoter. Patent Document 2 proposes to react an amine group == acid group in acetonitrile: after precipitation The white solid of the urea-sodium compound having a urea bond is used as a hardener. Patent Document 3 proposes a hardener for epoxy resin coated with a reaction material of an isocyanate compound. [Prior Art Literature] [Patent Document 1] Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. [Brief Description of the Invention] [Problems to be Solved by the Invention] Ο: The balance between the epoxy resin-based property and the curability of the curing agent is insufficient. For example, the storage stability is excellent = = low, so It is hardened and needs to be set to a high temperature or to be required to be trapped. For example, using the hardening medium stored in the patent document 2, the ==::: difference is so from the productive two = *, which exists in the solvent ===- Insufficient preservation stability in the presence of \\Specially in the high of methyl ethyl ketone = or = '7 for the material of the circuit to achieve the weight of the mobile machine: or 321995 6 201100387 requires fast sclerosing in the low temperature qualitative (solvent stability) damage and the presence of solvent in the presence of a single liquid ring The resin composition of the resin and the fully cured m4 sclerosing agent. However, in fact, the agent is not a single-liquid epoxy resin composition and potential hardening, after the month In view of the above, the main objective of the researcher is to provide - as a curing agent for a cycloolefin resin, etc., which is excellent in low-temperature hardenability, and a composition for achieving solvent stability of horses by using the composition. The solution is to use a hardener and an epoxy residue. The inventors of the present invention have completed the present invention by microencapsulation of the taste-suppressing compound which achieves the above-mentioned purpose by focusing on the above-mentioned problems. That is, the present invention is as follows. [1] A microcapsule (10) group containing the following formula (1), which contains: an organic polymer, a *, a machine, a compound, or both, and coated with the above core R1 N ) R2 (wherein R1, P, R3 are long-lasting _ _ . . . independently from a hydrogen atom, a halogen group, a slave atom which may contain a substituent, a 20 alkyl group, Substituent aromatic group,

•Z (1) ΠΊ 321995 201100387 ΎΐΡ~ 可含取代基之碳原子數〗至20之烷氧基、或可含取代基之 苯氧基;Q表示可含取代基之碳原子數】至2〇之2價煙£基; m表示1至1〇〇之整數;z表示具有價數m之有機基;/表 示下述式(G)所示之脲鍵、硫脲鍵、醯胺鍵或硫醯胺鍵)• Z (1) ΠΊ 321995 201100387 ΎΐΡ~ may have a substituent of a carbon atom number to 20 alkoxy group, or a phenoxy group which may have a substituent; Q represents a carbon atom which may have a substituent] to 2〇 a valence of 1 to 1 ;; m represents an organic group having a valence of m; / represents a urea bond, a thiourea bond, a guanamine bond or a sulfur represented by the following formula (G) Amidoxime bond)

Η Ο ΗΗ Ο Η

»»

(G) m如[1]所記載之含有㈣化合物之微膠囊化組成物,其 中,R1、^2、!^係各自獨立地為氫原子、碳原子數i至仙 之燒基、或碳原子數1至10之燒氧基;Q係碳原子數1至 20之2價烴基;m係1至3之整數。(G) m The microencapsulated composition containing the compound of (4) as described in [1], wherein R1, ^2, ! ^ are each independently a hydrogen atom, a carbon atom number i to an immortal group, or an alkoxy group having a carbon number of 1 to 10; a Q-based carbon number of 1 to 20 divalent hydrocarbon group; m system 1 to 3 Integer.

[3] 如D],記載之含有咪唑化合物之微膠囊化組成物,其 中U、R3係各自獨立地為氫原子、碳原子數1至1〇 之烧基、或碳原子數1至Μ之絲基;Q係碳原子數3至 2 0之2價煙基;m係1至3之整數。 [4] 如[3]所e載之含有輕化合物之微膠囊化組成物,其 中,Y係脲鍵。 [5] 如[1]至[4]中任—項所記載之含有咪唾化合物之微膠 囊化組成物,其巾’上述輕化合物係在呢以上時為固 體,且為結晶性或非結晶性者。 [6] 如[1]至[5]中任一項所記載之含有咪唑化合物之微膠 囊化組成物,其中,料化合物係在251以上時為固體, 321995 8 201100387 、 且為在250°C以下具有融點的結晶性固體。 [7] 如[1]至[6]中任一項所記載之含有咪唑化合物之微膠 囊化組成物,其中,上述味唾化合物之最大粒徑係100/zm 以下,並且粒徑在0. 1 //m以上100/zm以下之粒子係在上 述咪唑化合物中之含量為90質量%以上。 [8] 如[1]至[7]中任一項所記載之含有咪唑化合物之微膠 囊化組成物,其中,上述芯含有上述咪唑化合物與低分子 胺化合物。 〇 [9]如[1]至[8]中任一項所記載之含有咪唑化合物之微膠 囊化組成物,其中,上述殼含有由異氰酸酯化合物所衍生 之有機高分子作為主成分,且表面至少具有吸收1630至 1680αη_1之紅外線的鍵結基與吸收1680至1725(:111_1之紅外 線的鍵結基。 [10] 如[1]至[9]中任一項所記載之含有咪唑化合物之微膠 囊化組成物,其中,上述殼含有由異氰酸酯化合物所衍生 q 之有機高分子作為主成分,且至少具有吸收1730至 1755CHT1之紅外線的鍵結基。 [11] 如[1]至[10]中任一項所記載之含有咪唑化合物之微 膠囊化組成物,其中,相對於上述芯100質量份,上述殼 為0. 01至100質量份。 [12] —種硬化性組成物,其中,相對於如[1]至[11]中任一 項所記載之含有咪唑化合物之微膠囊化組成物100質量 份,含有環氧樹脂10至50, 000質量份者。 [13] —種母料型硬化劑,其係含有如[12]所記載之硬化性 9 321995 201100387 * 組成物作為主成分者。 化性組成物之硬 ====所_硬化性組成物 ο 物或之硬化_ 用膜’其係含有如[12]所記載之硬化性組成 物或如[13]所記載之母料型硬化劑者。 士、从、種導電陡材料’其係含有如[12]所記載之硬化性組 或如[13]所記载之母料型硬化劑者。 [20] L " l種里方遺^蕾kit / . w; '、 蛋性(anis〇tropically conductive)材 ο 料其係含有如[12]所記載之硬化性組成物或如[I3]所記 載之母料型硬化劑者。 []種異方導電性膜’其係含有如[12]所記載之硬化性 、、且成物或如[13]所記载之母料型硬化劑者。 [22] 一種絕緣性材料,其係含有如[12]所記載之硬化性組 成物或如[13]所記载之母料型硬化劑者。 [23] 種密封材料’其係含有如[12]所記載之硬化性組成 物或如[13]所記載之母料型硬化劑者。 [24] —種塗佈用材料,其係含有如[a]所記載之硬化性組 成物或如[13]所記載之母料型硬化劑者。 10 321995 201100387 [25] -種塗料組成物,其係含有如[⑵所記載之硬化性組 成物或如[13]所記载之母料型硬化劑者。 [26] -種藏物(prepreg),其係含有如間所記載之硬化 性組成物或如[13]所記载之母料型硬化劑者。 ^一種導熱性材料’其係含有如[⑵所記載之硬化性組 成物或如[13]所記載之母料型硬化劑者。 [發明之效果] 如依本發明 〇 ❹ 現低溫硬化性優異,樹脂用硬化劑等時, 劑安定性之組成物、使安定性且亦達成綱 環氧樹脂組成物。用該組成物之環氧樹脂用硬化劑万 【實施方式】 [用以實施發明之型態] 以下,對用以實施本發 型態」)進行詳細說明 心(以下’稱為「本實施 實施型n者,在:^主t D_ 發8轉為限定在本發明之 本實施型態:含曰有=:内入可進行各種變化而實施。 含:含有特定構造物⑼膠囊化組成物係包 無機化合物或該兩者 σ之心’舆含有有機高分子、 態之含有㈣化合物之微表面之殼。本實施型 構造的咪哇化合物 / 料物#、將固體狀之特定 味唾化合物之微膠囊,並以殼包覆該表面者。含有 用,進-步可作為==物可作為環氧翻旨之硬化劑使 散在環氧樹菔中 而成的:料 微膠囊化組成物分 321995[3] The microencapsulated composition containing an imidazole compound, wherein each of U and R3 is independently a hydrogen atom, a carbon atom having 1 to 1 Å, or a carbon number of 1 to Μ, as described in D]. a silk base; a Q-based ketone having a carbon number of 3 to 20; m is an integer of 1 to 3. [4] A microencapsulated composition containing a light compound as contained in [3], wherein a Y-based urea bond. [5] The microencapsulated composition containing the imidazole compound according to any one of [1] to [4], wherein the light compound is solid or more crystalline and amorphous. Sex. [6] The microencapsulated composition containing an imidazole compound according to any one of [1] to [5] wherein the compound is solid at 251 or more, 321995 8 201100387, and is at 250 ° C. The following crystalline solid with a melting point. [7] The microencapsulated composition containing an imidazole compound according to any one of [1] to [6] wherein the maximum particle diameter of the above-mentioned flavor compound is 100/zm or less, and the particle diameter is 0. The content of 1 / m or more and 100 / zm or less is 90% by mass or more in the above imidazole compound. [8] The microencapsulated composition containing an imidazole compound according to any one of [1] to [7] wherein the core contains the imidazole compound and a low molecular amine compound. The microencapsulated composition containing an imidazole compound as described in any one of [1] to [8], wherein the shell contains an organic polymer derived from an isocyanate compound as a main component, and the surface is at least A bonding group having an infrared absorbing group of 1630 to 1680 αη_1 and a bonding group containing an infrared ray of 1680 to 1725 (the infrared ray of 111_1). [10] The microcapsule containing an imidazole compound according to any one of [1] to [9] And the above-mentioned shell contains an organic polymer derived from an isocyanate compound as a main component, and has at least a bonding group which absorbs infrared rays of 1730 to 1755 CHT1. [11] As in [1] to [10] The above-mentioned shell is 0.01 to 100 parts by mass with respect to 100 parts by mass of the above-mentioned core. [12] A hardenable composition, wherein 100 parts by mass of the microencapsulated composition containing an imidazole compound according to any one of [1] to [11], which contains 10 to 50,000 parts by mass of an epoxy resin. [13] A masterbatch type hardening Agent, which contains the hardening as described in [12] 9 321995 201100387 * The composition is the main component. The hard composition of the chemical composition ==== the hardening composition ο or the hardening _ the film 'containing the hardening composition as described in [12] Or the masterbatch type hardener as described in [13]. The conductive, steep material of the type, the type, the hardening group as described in [12] or the masterbatch type hardening as described in [13] [20] L " l kind of 遗 遗 蕾 蕾 kit / / kit kit 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 、 [I3] The master batch type hardener described in the above [I3] The heterogeneous conductive film 'containing the curable property as described in [12], and the product or the master batch as described in [13] [22] An insulating material which contains the curable composition as described in [12] or the masterbatch type hardener as described in [13]. [23] Sealing material' The curable composition according to [12] or the masterbatch type hardener according to [13]. [24] A coating material containing the hardening as described in [a] Sex composition Or a masterbatch type hardener as described in [13]. 10 321995 201100387 [25] A coating composition containing the curable composition as described in [(2) or the mother as described in [13] [26] - Prepreg, which contains a curable composition as described herein or a masterbatch type hardener as described in [13]. A thermally conductive material which contains a curable composition as described in [2] or a masterbatch type hardener as described in [13]. [Effects of the Invention] According to the present invention, it is excellent in low-temperature curability, a curing agent for a resin, etc., and a stabilizer composition, and an epoxy resin composition. The hardener for epoxy resin of this composition [Embodiment] [The mode for carrying out the invention] Hereinafter, the present embodiment is described in detail (hereinafter referred to as "this embodiment" In the case of the type n, the main body t D_ hair 8 is limited to the present embodiment of the present invention: the inclusion of 曰 =: the incorporation can be carried out with various changes. Contains: Contains a specific structure (9) Encapsulated composition system The inclusion of an inorganic compound or both of the σ cores 舆 contains an organic polymer, and contains a shell of the micro surface of the compound (IV). The mwa compound/material # of the structure of the present embodiment, the specific taste of the salic compound The microcapsules are coated on the surface with a shell. The inclusions can be used as a hardener for the epoxy resin to be dispersed in the epoxy tree stalk. 321995

II 201100387 以下,對於作為本實施型態之芯劑的咪唑化合物進行 說明。 本實施型態中使用之咪唑化合物係如下述式(1)所示II 201100387 Hereinafter, an imidazole compound as a core agent of the present embodiment will be described. The imidazole compound used in this embodiment is as shown in the following formula (1).

式中’ R1、R2、R3各自獨立地表示氫原子、羥基、齒基、 ^ 可含取代基之碳原子數1至20之统基、可含取代基之芳香 族基、可含取代基之碳原子數1至20之烷氧基、或可含取 代基之苯氧基。 上述鹵基表示氟、氯、溴或碘。 碳原子數1至20之烷基或烷氧基的烴構造可為直鏈構 造或分支構造進一步可為含有環己基等脂環基的構造。 該等fe部位在不影響硬化反應之範圍内可含有取代基,該 等之取代基可列舉如:經基、鹵基、腈基等。 芳香族基可列舉如:苯基、萘基、聯苯基等。芳香族 基以及苯氧基中之芳香環在不影響硬化反應之範圍内可含 有羥基、齒基、腈基、烷氧基等。 本實施型態所使用之咪唑化合物中,上述係以氫、 碳原子數1至20之烷基、碳原子數丨至2〇之烷氧基、芳 香族基或苯氧基為佳。特別是因氫、烷基以及苯氧基具有 供電子性,故會提高咪唑環之3位的三級氮之電荷密度, 使反應性提高,並使低溫中之硬化速度提高。並且,在碳 12 321995 201100387 原子數多於10之烷基或烷氧基中’例如在作為硬化劑使用 時,所得硬化物之接著性有變差之傾向。由上述觀點而言, R1係以氫、碳原子數1至10之烷基、或碳原子數1至10 之烧氧基更佳。 上述R2、R3係以氫、可具有取代基之碳原子數1至12 之烧基或碳原子數1至12之炫氧基為佳,以氫、碳原子數 1至10之烷基、或碳原子數1至1〇之烷氧基更佳。特別Wherein R 1 , R 2 and R 3 each independently represent a hydrogen atom, a hydroxyl group, a dentate group, a substituent having 1 to 20 carbon atoms which may have a substituent, an aromatic group which may have a substituent, and a substituent may be contained. An alkoxy group having 1 to 20 carbon atoms or a phenoxy group having a substituent. The above halogen group means fluorine, chlorine, bromine or iodine. The hydrocarbon structure of an alkyl group or alkoxy group having 1 to 20 carbon atoms may be a linear structure or a branched structure, and may further be a structure containing an alicyclic group such as a cyclohexyl group. These fe moieties may contain a substituent in the range which does not affect the hardening reaction, and examples of the substituent include a trans group, a halogen group, a nitrile group and the like. Examples of the aromatic group include a phenyl group, a naphthyl group, and a biphenyl group. The aromatic ring and the aromatic ring in the phenoxy group may contain a hydroxyl group, a dentate group, a nitrile group, an alkoxy group or the like within a range not affecting the hardening reaction. In the imidazole compound used in the present embodiment, the above is preferably hydrogen, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having a carbon number of 丨 to 2 Å, an aromatic group or a phenoxy group. In particular, since hydrogen, an alkyl group, and a phenoxy group have electron-donating properties, the charge density of the tertiary nitrogen at the 3-position of the imidazole ring is increased, the reactivity is improved, and the curing rate at a low temperature is improved. Further, in the case of carbon 12 321995 201100387, an alkyl group having more than 10 atoms or an alkoxy group, for example, when used as a curing agent, the adhesion of the obtained cured product tends to be deteriorated. From the above viewpoints, R1 is more preferably hydrogen, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms. The above R 2 and R 3 are preferably a hydrogen group, a carbon atom having 1 to 12 carbon atoms or a methoxy group having 1 to 12 carbon atoms which may have a substituent, and hydrogen, an alkyl group having 1 to 10 carbon atoms, or The alkoxy group having 1 to 1 carbon atom is more preferable. particular

疋因氫、燒基以及苯氧基具有供電子性,故會提高咪唾環 之3位的三級氮之電荷密度,使反應性提高,使低溫中之 硬化速度提高。並且,藉由作成碳原子數10以下之烷基或 烷氧基,例如在作為硬化劑使用時,會使所得硬化物之接 著性有更上一層之傾向。 上述式(1)中,Q係可含取代基之碳原子數1至20的2 二^基^烴基係飽和烴基、内部具有雙鍵之不飽和烴基、 ^具社芳㈣基。烴基可為直鏈構造或分支構 演等齒I具有脂環式構造。上述取代基可列舉如:氟、氯、 、土 ’酿基;胺基;腈基;羥基等。 至6又更*原子數係以3至2G為佳,以3至1G更佳,以3 時,會尤以3至4為特佳。Q之碳原子數為3以上 例如,在# —步提高1QrC以下之環氧樹脂的硬化速度。 為低溫要求14G°C左右之低溫硬化性時 ,由於雖稱 化合物的^熱溫度仍為較高,故即使本實卿態之料 逮度有多對環氧樹脂之溶解性不同,亦看不出硬化 、異。然而,在更低溫之硬化速度方面,若 321995 13 201100387 ‘咪峻化合物之融點低 度有加速之傾向。並且,衣巩樹脂之溶解性高時,硬化速 融點降低,同時亦繁為了達成更低溫中之硬化,除了 等由該觀點而魏,對%氧樹脂之轉性。本發明者 上時,除了提高d:一數… ㈣化合物的融點亦會降低。根據該見:時:=之 更低溫中之硬化性的觀點 之了更加提高 佳。並且,藉由使碳原子 原子數以3以上為 〇 于數在上述上限值以下,卽右祜把 溫硬化性優異,接著性亦進一步變佳之傾白 - -CH2Q^具有下述式⑵赫之任—構造者為特佳。 CH2_CH2_ ch2-ch- (2) ch3 —CH2"~CH2—ΌΗ2~* 〇 一CH2-CH2—CH2—CH2· 一CH2~CH—CH2一 CH3 並且’在上述中,從低溫硬化性更為優異之觀點 以具有下述式(2a)所示之任一構造者為特佳。 ’ 321995 14 201100387 —ch2-ch— ch3 一 ch2 - ch2-ch2— (2 a) 一CH2—CH2—CH2—CH2— 一CH2~~CH—CH2— ch3 ❹ 上述式(1)中,Y表示脲鍵、硫脲鍵、醯胺鍵或硫醯胺 鍵,各鍵結中所含之氮係與式中之Q結合。Y以脲鍵、硫 脲鍵為佳。該等之中,從低溫硬化性更優異之觀點來看, 以脲鍵為佳。 上述式(1)中之m表示1至100之整數。m以1至20 為佳,以1至10更佳,以1至3最佳。 上述式(1)中之Z為具有價數m之有機基。有機基可列 舉如烴基、芳香族基等,構造内可含有氧、氮、磷等雜原 〇 本實施型態所使用之咪唑化合物,一般可經由使下述 式(3)所示之含胺基的咪唑化合物、與下述式(4)所示之含 有異氰酸基或異硫氰酸基的化合物或是含有叛基或二硫代 叛酸基(carbodithioic acid group)的化合物進行反應而 得。上述式(1)中之Z的構造係與其所使用之原料的下述式 (4)中的Z相同。 R1Since hydrogen, an alkyl group, and a phenoxy group have electron donating properties, the charge density of the tertiary nitrogen at the 3-position of the sodium saliva ring is increased, the reactivity is improved, and the hardening rate at a low temperature is improved. Further, by forming an alkyl group or an alkoxy group having 10 or less carbon atoms, for example, when used as a curing agent, the adhesion of the obtained cured product tends to be higher. In the above formula (1), the Q system may contain a 2,2, 2 -hydrocarbyl-based saturated hydrocarbon group having 1 to 20 carbon atoms in the substituent, an unsaturated hydrocarbon group having a double bond in the inside, and a aryl group. The hydrocarbon group may have a linear structure or a branched structure, and the tooth I has an alicyclic structure. Examples of the above substituents include fluorine, chlorine, and a fluorinated group; an amine group; a nitrile group; and a hydroxyl group. To 6 and more * the number of atoms is preferably 3 to 2G, more preferably 3 to 1G, and especially 3 to 4, especially 3 to 4. The carbon number of Q is 3 or more. For example, in ## step, the curing rate of the epoxy resin of 1QrC or less is increased. When the low temperature hardening property of about 14G °C is required for low temperature, although the heat temperature of the compound is still high, even if the material capture degree of the actual state is different, the solubility of the epoxy resin is different. Hardened and different. However, in terms of the hardening rate of lower temperature, if 321995 13 201100387 ‘the melting point of the compound is prone to accelerate. Further, when the solubility of the coating resin is high, the melting point of the hardening is lowered, and at the same time, in order to achieve hardening at a lower temperature, in addition to the viewpoint, the conversion to the % oxygen resin is obtained. In the present inventors, in addition to increasing d: a number... (4) The melting point of the compound is also lowered. According to this view: Time: = The viewpoint of hardenability in lower temperatures is better. In addition, when the number of carbon atoms is 3 or more, the number is less than or equal to the above upper limit value, and the right side is excellent in warm hardenability, and the adhesion is further improved. -CH2Q^ has the following formula (2) The responsibility - the constructor is particularly good. CH2_CH2_ ch2-ch- (2) ch3 —CH2"~CH2—ΌΗ2~* 〇CH2-CH2—CH2—CH2· one CH2~CH—CH2—CH3 and 'in the above, it is more excellent from low temperature hardenability The viewpoint is particularly preferable as any one having the following formula (2a). ' 321995 14 201100387 —ch2-ch—ch3—ch2 — ch2-ch2—(2 a) a CH 2 —CH 2 —CH 2 —CH 2 — — CH 2 —~CH—CH 2 — ch 3 ❹ In the above formula (1), Y represents urea A bond, a thiourea bond, a guanamine bond or a thioguanamine bond, and the nitrogen contained in each bond is bonded to Q in the formula. Y is preferably a urea bond or a thiourea bond. Among these, a urea bond is preferred from the viewpoint of further excellent low-temperature curability. m in the above formula (1) represents an integer of 1 to 100. m is preferably from 1 to 20, more preferably from 1 to 10, most preferably from 1 to 3. Z in the above formula (1) is an organic group having a valence of m. The organic group may, for example, be a hydrocarbon group or an aromatic group, and may contain an imidazole compound such as oxygen, nitrogen or phosphorus in the present embodiment, and generally contains an amine compound represented by the following formula (3). a base imidazole compound, which reacts with a compound containing an isocyanato group or an isothiocyanate group represented by the following formula (4) or a compound containing a carbodithioic acid group. Got it. The structure of Z in the above formula (1) is the same as Z in the following formula (4) of the raw material used. R1

T N^N——Q—NH2 (3) R2 15 321995 (4) (4) (SCN^2 ΟT N^N——Q—NH2 (3) R2 15 321995 (4) (4) (SCN^2 Ο

G 201100387 (°°Ν^Ζ (H00C^Z . (HSSC^ 本實施型態之咪唑化合物係以在10t以上 結晶性或非結晶性者為佳。上述結晶性之 总 二 差熱分析(differential thermal analysi X 、日。丄由不 ^ ysis)# 10C/分鐘 升;’觀測到因融解所致之吸熱峰。 ''施型態之η中π全 化合物係上述吸熱峰之峰頂的融點為1〇亡以 本實施型態中,上述「1(rc以上為固體 者並且, 係指如在化合物面上設置直徑9. 55随 ? '"曰曰[生者」 球48小時後,該金屬球在化合物面上5g之金屬 m°r ^ 痕跡的溫度未 達i〇c。當^坐化合物在1(rc以上為 又禾 時,在與環氧樹脂調配之作#期間、或=動性之固體 形狀為止之期間(例如⑴,可有效地==« 因此,可維持作為潛在性硬化劑之高的$在=汁, 固體中所使用之,魏合物細在;5。。以上為 體且為非t日日性者為較佳’以融點在阶以上2啊以 下之結晶性固體為更佳告立為 固艚B# m 在阶以上之結晶性 化-二:般可維持固定的潛在性,而且,咪唑 點I 25S溫中亦容易維持形狀,操作性優異。當其為融 點在250 C以下之結晶性固體時,不 =性更為優異’而且25『c以下之溫度中的硬= 有更快速之傾向。 321995 16 201100387 * 本實施型態中,為粉末狀且作為芯之咪唑化合物中的 粒徑在0. 1 // m以上100 // m以下之粒子,係以在味β坐化合 物中為10質量%以上之構成者為佳。此處,所謂為粉末狀 者係指最大粒徑為2mm以下,例如已通過網眼2mm以下之 篩之狀態者。當其係粒徑為2mm以下之粒子時,例如在經 調配至環氧樹脂中而得到硬化物時,硬化物之成分有均勻 地硬化之傾向。 本實施型態中,以最大粒徑為1mm以下者為佳,以500 〇 /zm以下更佳,尤以100/zm以下最佳。 本實施型態中,粒徑在0. 1 // m以上100 /z m以下之粒 子係以於咪嗤化合物中之含量為30質量%以上為佳,以粒 徑在0. 1 # m以上100 // m以下之粒子的含量為90質量%以 上者更佳,以粒徑在0. l#m以上50#m以下之粒子的含量 為90質量%以上者最佳。並且,本實施型態中,亦可含有 0. 1/ζιη以下之超微粒子。 Q 上述粒形及全體之粒子分佈可使用市售之乾式的粒度 分佈測定裝置進行測定。例如:可使用日本雷射公司製造 之雷射繞射式粒徑分佈測定裝置(HELOS/BF-M),依乾式法 將咪唑化合物的粒徑分佈進行測定。 本實施型態中,以咪唑化合物之最大粒徑為500 // m以 下並且粒徑在0. 1 /z m以上100 # m以下之粒子於味σ坐化合 物中之含量為30質量%以上者為佳,以最大粒徑為100/zm 以下並且粒徑在0. 1 /zm以上100//m以下之粒子的含量為 90質量%以上者更佳,又以最大粒徑為100//m以下並且粒 17 321995 201100387 " 徑在〇. 1 /·πη以上μ , 者最佳。 ㈧从®以下之粒子的含量為90質量%以上 係以態之含有咪唑化合物的微膠囊化組成物之芯 ’、\ ’、匕合物與低分子胺化合物為佳。從 節低分子胺化合物夕h 組成物之融點調節成^而將含有味嗤化合物的微膠囊化 巧即成所期望之溫度的觀點、以及從可對含 有只Λ匕°物的微膠囊化組成物賦予更優異之低溫硬化性 ο 的觀點+而言’本實施型態之含有咪唾化合物的微膝囊化組 成物之芯係以含有味嗤化合物與低分子胺化合物為佳。 低分子胺化合物之含量係以在芯中為G1_以上 50,000ppm以下為佳,以0.lppm以上1〇 〇〇〇_以下(質 量分率)更佳。低分子胺化合物之含量在50,000_以下 時,可將與咪唑化合物之混合物的融點大幅降低 以抑制,在經微膠囊化後而調配環氧樹脂時,則有4更加 提高貯藏安定性之傾向。 〇 具體上,上述低分子胺化合物係指分子量2剛以下且 分子内具有1個以上-級胺基、二級胺基或三級胺基的有 機化合物,亦可在同-分子内同時具有2種以上該等相異 之胺基。 具有一級胺基之化合物之例可列舉如:曱胺、乙胺 丙胺、丁胺、乙二胺、丙二胺、六亞甲二胺、二伸乙三胺、 三伸乙四胺、乙醇胺、丙醇胺、環己胺、異佛爾_二胺、 苯胺、甲苯胺(toluidine)、二胺基二笨基甲烷、二胺基二 苯基颯等。 土一 321995 18 201100387 、 具有二級胺基之化合物之例可列舉如:二甲基胺、二 乙基胺、二丙基胺、二丁基胺、二戊基胺、二己基胺、二 甲醇胺、二乙醇胺、二丙醇胺、二環己基胺、哌啶、哌啶 酮(piperidone)、二苯基胺、苯基甲胺、苯基乙胺等。 具有三級胺基之化合物之例可列舉如:三甲基胺、= 乙基胺、苯甲基二f基胺、N,Ν’-二f基哌畊、三伸乙二胺、 1,8-二氮雜二環(5, 4,0)-十一碳-7-烯、i,5-二氮雜二環 (4, 3, 0)-壬-5-烯等三級胺類;2一二甲基胺基乙醇、卜甲基 _2-二甲基胺基乙醇、1-苯氧基甲基_2_二甲基胺基乙醇、 2-二乙基胺基乙醇、1一丁氧基甲基_2—二甲基胺基乙醇、甲 基二乙醇胺、三乙醇胺、N-石-羥乙基嗎福林等胺基醇類; 2-(二甲基胺基甲基)酚、2, 4, 6-三(二甲基胺基甲基)酚等 胺基酚類;2-甲基咪唑、2-乙基-4-甲基咪唑、2—十一烷基 咪唑(2-undecylimidazole)、2_十七烷基咪唑、2_苯基咪 唑、1-(2-羥基-3-苯氧基丙基)—2_甲基咪唑、丨_(2_羥基_3一 〇苯氧基丙基)-2-乙基甲基咪唑、1-(2-羥基-3-丁氧基丙 基)—2一?基咪唾、卜(2 一羥基-3-丁氧基丙基)-2-乙基一4 一 甲基咪吐等咪哇類;卜(2一經基_3_苯氧基丙基)一2_苯基味 唑啉、1-(2-羥基-3-丁氧基丙基)_2_甲基咪唑啉、2_甲基 味峻琳、2, 4-二甲基喃唾琳、2_乙基味唾琳、2_乙基—4一 甲㈣唾琳、2—苯甲基咪哇琳、2一苯基咪唾琳、2_(鄰甲苯 基)—味唾啉、四亞甲基-雙-味唑啉、1,1,3-三甲基一 i,4一 四亞甲基—雙'味唾琳、U,3-三甲基-1,4-四亞甲基-雙__ 米坐啉1’1’3~二甲基-i,4-四亞甲基一雙_4_甲基咪唑啉、 321995 19 201100387 " 1,3’ 3-二甲基-1,4-四亞曱基-雙-4-甲基ϋ米唾琳、;[,2-伸苯 基-雙_τΙ米嗤琳、1,3-伸苯基-雙-咪嗤琳、1,4-伸苯基-雙一 咪唑啉、1,4-伸苯基-雙-4-曱基咪唑啉等咪唑啉類;二甲 基胺基丙胺、二乙基胺基丙胺、二丙基胺基丙胺、二丁基 胺基丙fe·、一曱基胺基乙胺、二乙基胺基乙胺、二丙基胺 基乙胺、一 丁基胺基乙胺、N-甲基旅哄、N-胺基乙基派卩井、 二乙基胺基乙基哌Π井等三級胺基胺類;2-二甲基胺基乙硫 醇、2-巯基苯並咪唑、2-酼基苯並噻唑、2-巯基咣咬、ΐ-Ο 巯基吡啶等胺基硫醇類;Ν,Ν-二曱基胺基苯甲酸、Ν,Ν_: 甲基甘胺酸、於驗酸、異於鹼酸、π比咬甲酸(picoiinkaeid) 等胺基羧酸類;N,N-二甲基甘胺醯肼、菸鹼醯肼、異終驗 酿肼等胺基肼(amino hydrazine)類等。 又,同一分子内同時具有2種以上相異之胺基的化合 物之例可列舉如:作為本實施型態之原料使用的含胺基i 咪唑化合物、或1-胺基乙基-2-曱基咪唑啉、卜胺基=基 ❹ 2-甲基味唾琳等含有一級胺基的咪唾琳化合物等。 從調配在環氧樹脂時之組成物的保存安定性之觀點來 看,上述低分子胺化合物係以咪唑類、咪唑啉類以及含 胺基之°米°坐類為佳。 以下,對於作為本實施型態之含有味唾化合物之微膠 囊化組成物之芯的咪唾化合物之製造方法進行說明 本實施型態之咪唑化合物的製造方法至少具有·人成 咪唑化合物之步驟、與粉碎成所期望之粒徑的粉末 驟。更可依所需而再具有:該化合物之精製步驟、粒子的 321995 20 201100387 u 一牝含物 *分級步驟、各粒徑之粒子的再調配步驟。低分孑胺在, 可作為咪唑化合物之合成步驟中的未反應成分等而存 亦可另外調配至咪唑化合物中。 本實施型態中所使用之咪唑化合物的製造方法,印, 專利文獻1或專利文獻2所記載之習知方法製造。具有 可藉由使上述式(3)所示之含有胺基的咪唑化合物、與) 異氰酸基、異硫氣酸基、羧基或碳二硫基(cal"b〇di 〇 的化合物進行反應而製造。 Μ 對於本實施型態所適用之具有脲鍵的咪唑化合物ι 造方法進行說明。本實施型態所適用之具有脲鍵的冰'^化 合物可由上述式(3)所示之含胺基的味坐化合物與具有異 氰酸基的化合物(以下亦有通稱為異氰酸酯化合物之情形)G 201100387 (°°Ν^Ζ (H00C^Z . (HSSC^ The imidazole compound of this embodiment is preferably crystalline or amorphous at 10t or higher. The total thermal analysis of the above crystallinity (differential thermal) Analysi X, 日.丄由不^ ysis)# 10C/min liter; 'observed the endothermic peak due to melting. ''The π total compound in the η type is the melting point of the peak of the above endothermic peak is 1 In the present embodiment, the above "1 (the above is solid and the rc is the same as that, if the diameter of the compound is set to 9.55 with? '" The temperature of the metal m°r ^ trace of the ball on the surface of the compound is less than i〇c. When the compound is at 1 (r or more, the compound is blended with the epoxy resin, or = mobility) The period until the solid shape (for example, (1) can be effectively ==« Therefore, it is possible to maintain the high value of the latent curing agent, which is used in the juice, the solid, and the fine compound; 5 It is better for the body to be non-t day. The crystalline solid with the melting point above the order 2 is better. m crystallinity above the order - two: generally maintains the potential of fixation, and the imidazole point I 25S is also easy to maintain the shape in the temperature, excellent operability. When it is a crystalline solid with a melting point below 250 C , not = more excellent 'and harder than the temperature below 25 c = there is a tendency to be faster. 321995 16 201100387 * In this embodiment, the particle size in the imidazole compound as a powder and in the core is 0 1 / m or more and 100 / m or less of the particles are preferably composed of 10% by mass or more of the taste-based compound. Here, the powder is a maximum particle size of 2 mm or less. For example, when it has passed through a mesh having a mesh size of 2 mm or less, when it is a particle having a particle diameter of 2 mm or less, for example, when a cured product is obtained by blending into an epoxy resin, the component of the cured product tends to be uniformly hardened. In the present embodiment, the maximum particle size is preferably 1 mm or less, more preferably 500 Å/zm or less, and most preferably 100/zm or less. Particles of m or more and 100 / zm or less are used in the content of the ampicoid compound of 30 masses. The content of the particles having a particle diameter of 0.10 m or more and 100 / m or less is preferably 90% by mass or more, and the content of the particles having a particle diameter of 0. l#m or more and 50#m or less. It is preferably 90% by mass or more. Further, in the present embodiment, ultrafine particles of 0.1 or less may be contained. Q. For the above particle shape and the entire particle distribution, a commercially available dry type particle size distribution measuring device can be used. The measurement was carried out. For example, the particle size distribution of the imidazole compound can be measured by a dry method using a laser diffraction type particle size distribution measuring apparatus (HELOS/BF-M) manufactured by Japan Laser Co., Ltd. In the present embodiment, the content of the particles having a maximum particle diameter of the imidazole compound of 500 // m or less and having a particle diameter of 0.1 or more and 100 or less is 30% by mass or more. Preferably, the content of the particles having a maximum particle diameter of 100/zm or less and a particle diameter of 0.1/zm or more and 100//m or less is more preferably 90% by mass or more, and the maximum particle diameter is 100//m or less. And the grain 17 321995 201100387 " The diameter is in 〇. 1 /·πη above μ, the best. (8) The content of the particles of the following or less is 90% by mass or more. Preferably, the core of the microencapsulated composition containing the imidazole compound is a ', \', a chelate compound and a low molecular amine compound. From the viewpoint of adjusting the melting point of the low-molecular amine compound, and the microcapsule containing the miso compound, to the desired temperature, and from the microencapsulation of the material containing only the Λ匕In view of the fact that the composition imparts more excellent low-temperature curability ω, the core of the micro-knee-encapsulated composition containing the ipsi-salt compound of the present embodiment preferably contains a miso compound and a low molecular amine compound. The content of the low molecular weight amine compound is preferably G1_ or more and 50,000 ppm or less in the core, and more preferably 0.1 ppm or more (mass fraction). When the content of the low molecular amine compound is 50,000 Å or less, the melting point of the mixture with the imidazole compound can be greatly reduced to suppress, and when the epoxy resin is formulated after the microencapsulation, there is a tendency to further improve the storage stability. . Specifically, the above-mentioned low molecular weight amine compound means an organic compound having a molecular weight of 2 or less and having one or more -amino group, a secondary amino group or a tertiary amino group in the molecule, and may have 2 in the same molecule. The above various amino groups are mentioned above. Examples of the compound having a primary amino group include guanamine, ethamamine, butylamine, ethylenediamine, propylenediamine, hexamethylenediamine, diethylenetriamine, triethylenetetramine, ethanolamine, Propylamine, cyclohexylamine, isophorol-diamine, aniline, toluidine, diaminodiphenylmethane, diaminodiphenylphosphonium, and the like. Earth No. 321995 18 201100387 Examples of compounds having a secondary amine group include, for example, dimethylamine, diethylamine, dipropylamine, dibutylamine, dipentylamine, dihexylamine, dimethanol Amine, diethanolamine, dipropanolamine, dicyclohexylamine, piperidine, piperidone, diphenylamine, phenylmethylamine, phenylethylamine, and the like. Examples of the compound having a tertiary amino group include, for example, trimethylamine, =ethylamine, benzyldif-amine, N, Ν'-di-f-piperidin, tri-ethylenediamine, 1, Tertiary amines such as 8-diazabicyclo(5,4,0)-undec-7-ene, i,5-diazabicyclo(4,3,0)-non-5-ene ; 2 dimethylaminoethanol, benzyl 2 - dimethylaminoethanol, 1-phenoxymethyl 2 - dimethylaminoethanol, 2-diethylaminoethanol, 1 butyl Amino alcohols such as oxymethyl-2-dimethylaminoethanol, methyldiethanolamine, triethanolamine, N-stone-hydroxyethyl phofolin; 2-(dimethylaminomethyl)phenol Aminophenols such as 2,4,6-tris(dimethylaminomethyl)phenol; 2-methylimidazole, 2-ethyl-4-methylimidazole, 2-undecylimidazole (2 -undecylimidazole), 2_heptadecylimidazole, 2-phenylimidazole, 1-(2-hydroxy-3-phenoxypropyl)-2-methylimidazole, 丨_(2_hydroxy_3 〇 Phenoxypropyl)-2-ethylmethylimidazole, 1-(2-hydroxy-3-butoxypropyl)-2? Keimi saliva, di(2-hydroxy-3-butoxypropyl)-2-ethyl-4-methylmethymid, and other imines; di(2-amino)-3-phenyloxypropyl 2-phenyl benzoxazoline, 1-(2-hydroxy-3-butoxypropyl)_2-methylimidazoline, 2-methylphenanthrene, 2,4-dimethylpyrazine, 2 _Ethyl sulphate, 2_ethyl- 4-A (four) salicin, 2-benzylmethylimiline, 2-phenylimine, 2_(o-tolyl)-salt, tetramethylene Base-bis-isoxazoline, 1,1,3-trimethyl-i,4-tetramethylene-bis-sodium sulphate, U,3-trimethyl-1,4-tetramethylene- Double __ 米坐olin 1'1'3~ dimethyl-i,4-tetramethylene-double _4-methylimidazoline, 321995 19 201100387 " 1,3' 3-dimethyl-1 , 4-tetradecyl-bis-4-methylindolizine; [, 2-phenylene-bis-τΙ米嗤琳, 1,3-phenylene-bis-imiline, 1 , 4-phenylene-bis-imidazoline, 1,4-phenylene-bis-4-indolyl imidazoline, etc. imidazolines; dimethylaminopropylamine, diethylaminopropylamine, dipropyl Aminopropylamine, dibutylaminopropyl fe·, monodecylaminoethylamine, diethylaminoethylamine, two a tertiary amino amine such as arylamine, monobutylaminoethylamine, N-methyl oxime, N-aminoethylpyrazine, diethylaminoethylpyrazine well; -Aminomercaptan ethanethiol, 2-mercaptobenzimidazole, 2-mercaptobenzothiazole, 2-mercaptopurine, hydrazine-hydrazinopyridine, and the like; hydrazine, hydrazine-dihydrazino Aminobenzoic acid, hydrazine, hydrazine _: methylglycine, amino acid carboxylic acid such as acid test, alkali acid, π ratio picoiinkaeid; N,N-dimethylglycol oxime, tobacco Alkaline hydrazine, amino hydrazine, etc. Further, examples of the compound having two or more kinds of different amine groups in the same molecule include, for example, an amine group-containing imidazole compound or 1-aminoethyl-2-anthracene used as a raw material of the present embodiment. A pyridinium compound containing a primary amine group, such as a base imidazoline, a amide group, a hydrazine, a 2-methyl sage, or the like. From the viewpoint of the preservation stability of the composition when the epoxy resin is blended, the above-mentioned low molecular amine compound is preferably an imidazole, an imidazoline or an amine group. In the following, the method for producing the imidazole compound as the core of the microencapsulated composition containing the taste-salting compound of the present embodiment will be described. The method for producing the imidazole compound of the present embodiment has at least a step of forming an imidazole compound. And the powder is pulverized into a desired particle size. Further, it may further have a refining step of the compound, a step of refining the particles, a step of arranging the particles, a step of grading, and a step of re-dispensing the particles of each particle size. The low part decylamine may be present as an unreacted component or the like in the synthesis step of the imidazole compound, or may be additionally formulated into the imidazole compound. The method for producing an imidazole compound used in the present embodiment is produced by a conventional method described in Patent Document 1 or Patent Document 2. Having an imidazole compound containing an amine group represented by the above formula (3), reacting with an isocyanato group, an isothiocyanate group, a carboxyl group or a carbon disulfide group (cal"b〇di 〇 compound) Production method Μ The method for producing an imidazole compound having a urea bond to which the present embodiment is applied will be described. The ice compound having a urea bond to which the present embodiment is applied may be an amine represented by the above formula (3). a base-like compound and a compound having an isocyanate group (hereinafter also referred to as an isocyanate compound)

進行合成。並且,例如亦可藉由使含胺基的咪唑淋化合物 與異氰酸酯化合物反應,並在後步驟中經脫氫反應而將咪 唑啉部位作成咪唑構造,而合成具有脲鍵的咪唑化合物。 上述含胺基之咪唑化合物係以上述式(3)所示,式中之 Q為可含取代基之碳原子數1至2〇之2價烴基。烴基為飽 和fe基、内部具有雙鍵之不飽和烴基、玎具有芳香環之芳 =族基。而且,烴基可為直鏈構造或分支構造,亦可具有 =環式構造。並且’上述取代基可鱗如:氟、氯、漠等 土,酿基胺基、腈基、經基等。Q之破原子數以3至 If佳,以3至10更佳,以3至6又更佳,更以3至4 取圭。Q係以具有下述式⑵所示之任—構造者為特佳。 321995 21 201100387 • 一 ch2— 一 CH2—CHp""* 一CH2~CH— CHs (2) 一CH2—CH2.CH2— —ch2-ch2-ch2-ch2— —ch2-ch—ch2— CH3 ο 〇 關於上述含有胺基之咪唾化合物的具體例,在上述式 (3)中之Q為亞曱基時,可列舉如:1_胺基甲基_咪嗤、卜 胺基曱基-2-曱基咪唑、1-胺基曱基_2_乙基咪唑、i一胺基 曱基-2-丙基咪唑、1-胺基曱基_2_丁基咪唑、卜胺基曱基 ~2-己基咪唑、1-胺基曱基_2_戊基咪唑、丨_胺基曱基_2_ 庚基咪唑、1-胺基曱基-2-辛基咪唑、1—胺基甲基_2_壬基 咪唑、1-胺基曱基-2-癸基咪唑、卜胺基曱基_2_十一烷基 ❹咪唑、1 一胺基甲基-2-十七烷基咪唑、1-胺基曱基_2_苯基 咪唑、1-胺基曱基-2-曱基-4, 5—二羥基甲基咪唑、1一胺基 曱基-2-乙基-4, 5—二羥基甲基咪唑、卜胺基甲基_2_苯基 -4, 5 —二羥基甲基咪唑、卜胺基甲基_2_十一烷基_4, 5—二 羥基甲基咪唑、1-胺基甲基一2_十七烷基_4,5—二羥基甲基 米唾、1 —胺基甲基_2_甲基一4—甲基_5_經基甲基^米〇坐、卜 胺基甲基-2-乙基-4-甲基-5-羥基甲基咪唑、卜胺基甲基 -2-苯基-4-甲基-5-羥基甲基咪唑、卜胺基甲基_2_十一烷 基-4-甲基-5-羥基甲基咪唑、丨一胺基甲基_2_十七烷基—4_ 321995 22 201100387 ' 甲基羥基曱基咪唑、卜胺基甲基—4-曱基咪唑、i-胺基 甲基-2-曱基-4-甲基咪唑、1-胺基甲基_2一乙基_4一甲基咪 唑、1-胺基甲基-2-丙基-4-甲基咪唑、1-胺基曱基_2一丁基 -4-甲基咪唑、1-胺基甲基-2-己基-4-甲基咪唑、1-胺基甲 基-2-戊基-4-甲基咪唑、1-胺基曱基_2 一庚基_4_曱基咪 唑、1-胺基甲基-2-辛基-4-甲基咪唑、卜胺基甲基一2-壬基 -4-甲基咪唑、1-胺基甲基-2-癸基—4-曱基咪唑、1-胺基曱 基-2-十一烷基-4-曱基咪唑、1-胺基甲基_2_十七烷基_4_ 〇 甲基味嗤、1-胺基曱基-2-曱氧基咪唾、1一胺基曱基一2_曱 氧基-4-甲基咪唑、1-胺基甲基一2-甲氧基_4, 5_二羥基甲基 咪唑、1-胺基甲基-2-曱氧基-4-曱基-5-羥基曱基咪唑、1-胺基甲基-2-乙氧基咪唑、1—胺基曱基_2一乙氧基—4_甲基咪 嗤、1-胺基甲基-2-乙氧基-4, 5-二經基曱基咪唑、1-胺基 甲基-2-乙氧基-4-甲基-5-羥基甲基咪唑、丨_胺基曱基一2一 苯氧基咪唑、1-胺基甲基-2-苯氧基一4_曱基咪唑、j一胺基 〇甲基_2_苯氧基―4, 5一二羥基曱基咪唑、1-胺基曱基-2-苯氧 基-4-甲基-5-經基曱基咪唾等。 而且’Q為伸乙基時,可列舉例如:卜胺基乙基_咪唑、 1-胺基乙基-2-曱基咪唑、ι_胺基乙基_2_乙基咪唑、卜胺 基乙基-2-丙基咪唑、卜胺基乙基_2_丁基咪唑、卜胺基乙 基-2-己基咪唑、1—胺基乙基_2_戊基咪唑、丨_胺基乙基— 庚基咪唑、卜胺基乙基—2-辛基咪唑、卜胺基乙基_2_壬基 咪唑、1-胺基乙基-2-癸基咪唑、丨_胺基乙基_2_十一烷基 咪唑、1-胺基乙基-2-十七烷基咪唑、卜胺基乙基_2_笨基 321995 23 201100387 v 咪唑、1-胺基乙基-2-曱基-4, 5-二羥基曱基咪唑、1-胺基 乙基-2-乙基-4, 5-二羥基甲基咪唑、卜胺基乙基-2-苯基 -4, 5-二經基曱基。米〇坐、1-胺基乙基-2-H 烧基_4, 5-二經 基甲基咪0坐、1-胺基乙基-2-十七烧基-4, 5-二經基甲基味 唑、1-胺基乙基-2-曱基-4-曱基-5-羥基甲基咪唑、1-胺基 乙基-2-乙基-4-甲基-5-經基甲基味17坐、1-胺基乙基-2-苯 基-4-甲基-5-經基曱基11米峻、1-胺基乙基-2-十一烧基-4-曱基-5-羥基曱基咪唑、1-胺基乙基-2-十七烷基-4-甲基 ^ -5-羥基甲基咪唑、卜胺基乙基-4-甲基咪唑、1-胺基乙基 -2-甲基-4-甲基咪唑、1-胺基乙基-2-乙基-4-甲基咪唑、 1-胺基乙基-2-丙基-4-曱基咪唑、1-胺基乙基-2-丁基-4-曱基咪唑、1-胺基乙基-2-己基-4-曱基咪唑、1-胺基乙基 -2-戊基-4-甲基咪嗤、1-胺基乙基-2-庚基-4-曱基味°坐、 1-胺基乙基-2-辛基-4-甲基咪唑、1-胺基乙基-2-壬基-4-曱基咪唑、1-胺基乙基-2-癸基-4-曱基咪唑、1-胺基乙基 Q _2—十一烷基-4-曱基咪唑、1-胺基乙基-2-十七烷基-4-曱 基咪唑、1-胺基乙基-2-甲氧基咪唑、1-胺基乙基-2-甲氧 基-4-曱基咪唑、1-胺基乙基-2-甲氧基-4, 5-二羥基甲基咪 σ坐、1-胺基乙基-2-甲氧基-4-甲基-5-羥基甲基咪唑、1-胺基乙基-2-乙氧基咪唑、1-胺基乙基—2-乙氧基-4-甲基咪 唑、1-胺基乙基-2-乙氧基-4, 5-二羥基曱基咪唑、1-胺基 乙基-2-乙氧基-4-曱基-5-羥基曱基咪唑、卜胺基乙基_2一 苯氧基咪唑、1-胺基乙基-2-苯氧基-4-甲基咪唑、卜胺基 乙基-2-苯氧基-4, 5-二羥基曱基咪唑、卜胺基乙基_2一苯氧 24 321995 201100387 k基-4-甲基-5-羥基甲基咪唑等。 而且’ Q為碳原子數3之直鏈或分支構造的伸丙基時, 可列舉例如:1-胺基丙基_咪唑、卜胺基丙基_2—甲基咪唑、 1-胺基丙基-2-乙基咪唑、1_胺基丙基—2—丙基咪唑、卜胺 基丙基-2-丁基咪唑、卜胺基丙基_2_己基咪唑、卜胺基丙 基-2-戊基咪唑、丨-胺基丙基_2_庚基咪唑、卜胺基丙基_2一 辛基咪唑、1-胺基丙基-2-壬基咪唑、卜胺基丙基癸基 〇 咪嗤、1-胺基丙基_2—_j —烧基咪《坐、1-胺基丙基-2-十七 烷基咪唑、1-胺基丙基-2-苯基咪唑、1-胺基丙基_2_曱基 -4, 5-二羥基甲基咪唑、丨一胺基丙基_2_乙基_4, 5_二羥基甲 基味嗤、1-胺基丙基-2-苯基-4, 5-二經基甲基咪η坐、ι_胺 基丙基-2-十一烷基-4, 5-二羥基甲基咪唑、1-胺基丙基-2-十七烷基-4, 5-二羥基甲基咪唑、1-胺基丙基一2-甲基-4-曱基-5-羥基曱基咪唑、1-胺基丙基-2-乙基-4-甲基-5-羥 基曱基^米°坐、1-胺基丙基-2-苯基-4-曱..基-5-經基曱基味 〇 唑、卜胺基丙基-2-十一烷基-4-甲基-5-羥基甲基咪唑、1-胺基丙基-2-十七烧基-4-甲基-5-輕基曱基w米哇、1-胺基丙 基-4-甲基咪唑、1-胺基丙基-2-甲基-4-曱基咪唑、1-胺基 丙基-2-乙基-4-曱基咪唑、1-胺基丙基-2-丙基-4-甲基咪 唑、卜胺基丙基-2-丁基-4-甲基咪唑、1-胺基丙基-2-己基 -4-甲基p米嗤、1-胺基丙基-2-戊基-4-甲基咪峻、1-胺基丙 基_2-庚基-4-甲基味嗤、1-胺基丙基-2-辛基-4-曱基咪 β坐、1-胺基丙基-2-壬基-4-曱基σ米峻、1-胺基丙基-2-癸基 -4-曱基°米唾、1-胺基丙基-2-~)—烧基-4-甲基11 米嗤、1- 25 321995 201100387 ^ 胺基丙基一2—十七烷基-4-甲基咪唑、卜胺基丙基-2-甲氧基 咪嗤、1-胺基丙基-2-曱氧基-4-甲基味唾、1-胺基丙基—2_ 曱氧基-4, 5-二羥基甲基咪哇、1-胺基丙基一2-甲氧基一4一 甲基-5-羥基甲基咪唑、卜胺基丙基一2-乙氧基咪唑、卜胺 基丙基-2-乙氧基-4-曱基咪唑、1-胺基丙基一 2-乙氧基 -4, 5-二羥基甲基咪唑、卜胺基丙基—2-乙氧基—4-甲基_5_ 羥基甲基咪唑、1-胺基丙基—2-苯氧基咪唑、丨_胺基丙基一2__ 笨氧基-4-曱基咪唾、1-胺基丙基-2-苯氧基-4, 5-二經基甲 n - 基咪唑、1-胺基丙基-2-苯氧基-4-甲基-5-羥基甲基咪唑 等。 而且’ Q為碳原子數4之直鏈或分支構造的伸丁基時, 可列舉例如:1-胺基丁基-咪唑、1-胺基丁基_2_甲基咪唑、 1-胺基丁基-2-乙基咪唑、卜胺基丁基-2-丙基咪唑、1 一胺 基丁基-2-丁基咪唑、1-胺基丁基_2_己基咪唑、卜胺基丁 基-2-戊基咪唑、卜胺基丁基_2_庚基咪唑、卜胺基丁基 Ο 辛基咪唑、1-胺基丁基-2-壬基咪唑、1-胺基丁基-2-癸基 咪嗤、1-胺基丁基_2_十一烧基咪嗤、卜胺基丁基_2_十七 烷基咪唑、1-胺基丁基-2-苯基咪唑、1-胺基丁基-2-甲基 4,5 一輕·基曱基味°坐、1-胺基丁基-2-乙基-4,5-二經基甲 基1*米11坐、1-胺基丁基-2-苯基-4, 5-二羥基曱基咪唾、1-胺 基丁基-2-十一烷基-4, 5-二羥基曱基咪唑、1-胺基丁基_2一 十七烷基-4, 5-二羥基甲基咪唑、1-胺基丁基—2_曱基—4-甲基-5-經基甲基咪唑、卜胺基丁基一2一乙基_4一甲基_5_經 基甲基咪唑、1-胺基丁基-2-笨基-4-曱基-5-羥基曱基咪 321995 26 201100387 * 唑、1-胺基丁基-2-十一烷基-4-曱基-5-羥基甲基咪唑、卜 胺基丁基-2-十七烷基-4-甲基-5-羥基甲基咪唑、1-胺基丁 基-4-甲基咪唑、1-胺基丁基-2-甲基-4-甲基咪唑、1-胺基 丁基-2-乙基-4-甲基咪嗤、1-胺基丁基-2-丙基-4-甲基η米 唑、1-胺基丁基-2-丁基-4-曱基咪唑、1-胺基丁基-2-己基 -4-甲基味β坐、1 -胺基丁基-2-戍基-4-曱基咪β坐、1 -胺基丁 _ 基-2-庚基-4-曱基咪唑、1-胺基丁基-2-辛基-4-曱基味 哇、1-胺基丁基-2-壬基-4-曱基咪峻、1-胺基丁基-2-癸基 -4-甲基味峻、1-胺基丁基-2-( 烧基-4-甲基咪嗤、ι_ 胺基丁基-2-十七烷基-4-甲基咪嗤、1-胺基丁基一2一曱氧基 咪嗤、1-胺基丁基-2-曱氧基-4-甲基味唾、1-胺基丁基_2_ 甲氧基-4, 5-二羥基曱基咪唑、1-胺基丁基甲氧基_4_ 甲基-5-羥基甲基咪唑、1-胺基丁基_2_乙氧基咪唑、卜胺 基丁基-2-乙氧基-4-甲基咪唑、1-胺基丁基_2_乙氧基 一4, 5一二羥基甲基咪唑、卜胺基丁基-2-乙氧基-4-曱基_5一 Ο 羥基甲基咪唑、卜胺基丁基-2-苯氧基咪唑、卜胺基丁基_2_ 苯氧基-4-曱基咪唑、1-胺基丁基一2_苯氧基—4,5一二羥基甲 基咪唑、1-胺基丁基-2-苯氧基-4-甲基一羥基曱基$唾 等。 該等之中,咪唾部位之構造為2_甲基味唾型者係因有 加快硬化速度之傾向而為較佳,更且,以胺基所心之上 述式⑶中之Q係碳原子數2至4之2價烴殘基者為更佳, 尤以其係碳原子數3至4之2價烴殘基者為最佳。較佳之 含胺基的咪唑化合物之具體例係如下述式(5)所示。 321995 27 201100387Perform the synthesis. Further, for example, an imidazole compound having a urea bond can be synthesized by reacting an amino group-containing imidazole compound with an isocyanate compound and subjecting the imazoline moiety to an imidazole structure by a dehydrogenation reaction in a subsequent step. The above-mentioned amine group-containing imidazole compound is represented by the above formula (3), wherein Q is a divalent hydrocarbon group having 1 to 2 carbon atoms which may have a substituent. The hydrocarbon group is a saturated fe group, an unsaturated hydrocarbon group having a double bond in the inside, and a aryl group having an aromatic ring. Further, the hydrocarbon group may have a linear structure or a branched structure, and may have a = ring structure. Further, the above substituent may be of a scale such as fluorine, chlorine or molybdenum, a arylamino group, a nitrile group or a thiol group. The number of broken atoms of Q is preferably 3 to If, preferably 3 to 10, more preferably 3 to 6, and 3 to 4. It is particularly preferable that the Q is a structure having any of the following formulas (2). 321995 21 201100387 • A ch2—a CH2—CHp""* a CH2~CH—CHs (2) a CH2—CH2.CH2——ch2-ch2-ch2-ch2——ch2-ch—ch2—CH3 ο 〇 Specific examples of the above-mentioned amino group-containing stilbene compound, when Q in the above formula (3) is a fluorenylene group, for example, 1-aminomethyl oxime, acetoguanidino-2- Mercaptoimidazole, 1-aminomercapto-2-ethylimidazole, i-aminomercapto-2-propylimidazole, 1-aminomercapto-2-butylimidazole, amidinopurine~2 -hexyl imidazole, 1-aminoindenyl-2-pentylimidazole, hydrazine-aminoindenyl-2-heptyl imidazole, 1-aminomercapto-2-octyl imidazole, 1-aminomethyl-2 _ Mercaptoimidazole, 1-aminomercapto-2-mercaptoimidazole, amidinoindolyl-2-undecylimidazole, 1-aminomethyl-2-heptadecylimidazole, 1- Aminoguanidino-2-phenylimidazole, 1-aminomercapto-2-mercapto-4,5-dihydroxymethylimidazole, 1-aminomercapto-2-ethyl-4, 5-di Hydroxymethylimidazole, amidinomethyl-2-phenyl-4-is 5-dihydroxymethylimidazole, amidinomethyl-2-epynyl-4, 5-dihydroxymethylimidazole, 1 -aminomethyl- 2_10 Alkyl_4,5-dihydroxymethyl rice saliva, 1-aminomethyl-2-methyl-4-methyl-5-ylaminomethyl-methane, amidinomethyl-2- Ethyl-4-methyl-5-hydroxymethylimidazole, amidinomethyl-2-phenyl-4-methyl-5-hydroxymethylimidazole, amidinomethyl-2-epyndecyl -4-Methyl-5-hydroxymethylimidazole, indole-aminomethyl-2-phenylheptadecyl-4_ 321995 22 201100387 'Methylhydroxydecyl imidazole, amidinomethyl-4-pyrimidazole , i-Aminomethyl-2-mercapto-4-methylimidazole, 1-aminomethyl-2-ethylethyl-4-methylimidazole, 1-aminomethyl-2-propyl-4 -methylimidazole, 1-aminomercapto-2-butyl-4-methylimidazole, 1-aminomethyl-2-hexyl-4-methylimidazole, 1-aminomethyl-2-pentyl 4-methylimidazole, 1-aminoindenyl-2-monoheptyl-4-nonyl imidazole, 1-aminomethyl-2-octyl-4-methylimidazole, amidylmethyl 2-mercapto-4-methylimidazole, 1-aminomethyl-2-indolyl-4-mercaptoimidazole, 1-aminomercapto-2-undecyl-4-mercaptoimidazole, 1 -Aminomethyl_2_heptadecyl_4_ 〇methyl miso, 1-aminomercapto-2-oxooxypropargyl, 1-aminoindenyl- 2_曱4-methylimidazole, 1-aminomethyl- 2-methoxy-4, 5-dihydroxymethylimidazole, 1-aminomethyl-2-oxo-4-indolyl-5 -hydroxymercaptoimidazole, 1-aminomethyl-2-ethoxyimidazole, 1-aminomercapto-2-ethoxy-5-methylimidazole, 1-aminomethyl-2-ethyl Oxy-4,5-di-mercapto-imidazole, 1-aminomethyl-2-ethoxy-4-methyl-5-hydroxymethylimidazole, hydrazine-amino fluorenyl-2-oxophenoxy Imidazolyl, 1-aminomethyl-2-phenoxy-4-indolyl imidazole, j-amino hydrazine methyl-2-phenoxy- 4,5-dihydroxydecyl imidazole, 1-amino group Mercapto-2-phenoxy-4-methyl-5-methylpyridinium and the like. Further, when 'Q is an ethylidene group, for example, aminoethyl-imidazole, 1-aminoethyl-2-mercaptoimidazole, i-aminoethyl-2-ethylimidazole, and amidino group are mentioned. Ethyl-2-propylimidazole, amidinoethyl-2-butylimidazole, amidinoethyl-2-hexyl imidazole, 1-aminoethyl-2-pentyl imidazole, hydrazine-amino Base — heptyl imidazole, acetoethyl 2-octyl imidazole, acetoethyl 2-indenyl imidazole, 1-aminoethyl-2-mercaptoimidazole, hydrazine-aminoethyl _ 2_undecylimidazole, 1-aminoethyl-2-heptadecylimidazole, amidinoethyl-2-phenyl group 321995 23 201100387 v imidazole, 1-aminoethyl-2-indenyl -4,5-dihydroxydecyl imidazole, 1-aminoethyl-2-ethyl-4, 5-dihydroxymethylimidazole, amidinoethyl-2-phenyl-4, 5-dimen Base base. Rice bran, 1-aminoethyl-2-H alkyl _4, 5-dipyridylmethyl oxime, 1-aminoethyl-2-heptacene-4, 5-di Methyl myristazole, 1-aminoethyl-2-indolyl-4-mercapto-5-hydroxymethylimidazole, 1-aminoethyl-2-ethyl-4-methyl-5- Methyl sulphate 17-sodium, 1-aminoethyl-2-phenyl-4-methyl-5-ylhydrazinyl 11 m, 1-aminoethyl-2-undecyl-4- Mercapto-5-hydroxydecyl imidazole, 1-aminoethyl-2-heptadecyl-4-methyl^-5-hydroxymethylimidazole, amidinoethyl-4-methylimidazole, 1 -Aminoethyl-2-methyl-4-methylimidazole, 1-aminoethyl-2-ethyl-4-methylimidazole, 1-aminoethyl-2-propyl-4-oxime Imidazole, 1-aminoethyl-2-butyl-4-mercaptoimidazole, 1-aminoethyl-2-hexyl-4-mercaptoimidazole, 1-aminoethyl-2-pentyl- 4-methylimidazolium, 1-aminoethyl-2-heptyl-4-hydrazylamine, 1-aminoethyl-2-octyl-4-methylimidazole, 1-aminoethyl 2-mercapto-4-mercaptoimidazole, 1-aminoethyl-2-indolyl-4-mercaptoimidazole, 1-aminoethyl Q 2-1-undecyl-4-indolyl imidazole , 1-aminoethyl-2-heptadecyl-4-mercaptoimidazole, 1-aminoethyl-2-methyl Imidazole, 1-aminoethyl-2-methoxy-4-mercaptoimidazole, 1-aminoethyl-2-methoxy-4, 5-dihydroxymethyl oxime, 1-amine Base ethyl-2-methoxy-4-methyl-5-hydroxymethylimidazole, 1-aminoethyl-2-ethoxyimidazole, 1-aminoethyl-2-ethoxy-4 -methylimidazole, 1-aminoethyl-2-ethoxy-4, 5-dihydroxydecyl imidazole, 1-aminoethyl-2-ethoxy-4-indolyl-5-hydroxyindole Imidazole, etidylethyl-2-phenoxyimidazole, 1-aminoethyl-2-phenoxy-4-methylimidazole, amidinoethyl-2-phenoxy-4, 5 - Dihydroxy decyl imidazole, chloroethyl 2- phenoxy 24 321995 201100387 k-based 4-methyl-5-hydroxymethylimidazole and the like. Further, when 'Q is a propyl group having a linear or branched structure of 3 carbon atoms, for example, 1-aminopropyl-imidazole, amidinopropyl-2-methylimidazole, 1-aminopropyl 2-ethylimidazole, 1-aminopropyl-2-propylimidazole, amidinopropyl-2-butylimidazole, amidinopropyl-2-hexylimidazole, amidylpropyl- 2-pentylimidazole, fluorenyl-aminopropyl-2-heptyl imidazole, amidinopropyl-2-isoimidazole, 1-aminopropyl-2-mercaptoimidazole, amidylpropyl hydrazine Dimethoate, 1-aminopropyl _2-_j- succinyl "sit, 1-aminopropyl-2-heptadecylimidazole, 1-aminopropyl-2-phenylimidazole, 1-Aminopropyl 2-1-indolyl-4, 5-dihydroxymethylimidazole, indole-aminopropyl 2-ethyl- 4, 5-dihydroxymethyl miso, 1-aminopropyl Benzyl-2-phenyl-4, 5-di-methylmethyl η, 1, ι-aminopropyl-2-undecyl-4, 5-dihydroxymethylimidazole, 1-aminopropyl -2-heptadecyl-4, 5-dihydroxymethylimidazole, 1-aminopropyl- 2-methyl-4-indolyl-5-hydroxydecyl imidazole, 1-aminopropyl-2 -ethyl-4-methyl-5-hydroxyindolyl methane, 1-aminopropyl-2-phenyl-4- .. base-5-carbyl carbazole, amidinopropyl-2-undecyl-4-methyl-5-hydroxymethylimidazole, 1-aminopropyl-2-seven Pyridyl-4-methyl-5-light fluorenyl wmw, 1-aminopropyl-4-methylimidazole, 1-aminopropyl-2-methyl-4-mercaptoimidazole, 1 -Aminopropyl-2-ethyl-4-mercaptoimidazole, 1-aminopropyl-2-propyl-4-methylimidazole, amidinopropyl-2-butyl-4-methyl Imidazole, 1-aminopropyl-2-hexyl-4-methyl p-methane, 1-aminopropyl-2-pentyl-4-methylmithio, 1-aminopropyl-2-g 4-methyl miso, 1-aminopropyl-2-octyl-4-indolyl beta, 1-aminopropyl-2-indolyl-4-indenyl sigma, 1 -aminopropyl-2-mercapto-4-indolyl sulphate, 1-aminopropyl-2-~)-alkyl-4-methyl 11 m hydrazine, 1- 25 321995 201100387 ^ Amino Propyl-p-heptadecyl-4-methylimidazole, amidinopropyl-2-methoxyimidazole, 1-aminopropyl-2-oxime-4-methyl 1-aminopropyl-2-yloxy-4, 5-dihydroxymethylidene, 1-aminopropyl- 2-methoxy-4-methyl-5-hydroxymethylimidazole, aceamine Propyl 2-ethoxyimidazole, amidinopropyl -2-ethoxy-4-mercaptoimidazole, 1-aminopropyl 2-ethoxy-4, 5-dihydroxymethylimidazole, amidylpropyl-2-methoxy-4- Methyl _5_ hydroxymethylimidazole, 1-aminopropyl-2-phenoxyimidazole, hydrazine-aminopropyl-2__ phenyloxy-4-mercaptopurine, 1-aminopropyl-2 -phenoxy-4,5-di-dimethyl-imidazole, 1-aminopropyl-2-phenoxy-4-methyl-5-hydroxymethylimidazole, and the like. Further, when Q is a linear or branched butyl group having a carbon number of 4, examples thereof include 1-aminobutyl-imidazole, 1-aminobutyl-2-methylimidazole, and 1-amino group. Butyl-2-ethylimidazole, amidinobutyl-2-propylimidazole, 1-aminobutyl-2-butylimidazole, 1-aminobutyl-2-hexyl imidazole, amphetamine Benzyl-2-pentyl imidazole, acetobutyl-2-heptyl imidazole, butylaminobutyl octyl imidazole, 1-aminobutyl-2-mercaptoimidazole, 1-aminobutyl- 2-mercaptopurine, 1-aminobutyl-2-ep-oxime, acetobutyl-2-hexadecylimidazole, 1-aminobutyl-2-phenylimidazole, 1-aminobutyl-2-methyl 4,5-light ketone-based taste, 1-aminobutyl-2-ethyl-4,5-di-propylmethyl 1*m 11 , 1-aminobutyl-2-phenyl-4, 5-dihydroxyindolyl salicyl, 1-aminobutyl-2-undecyl-4, 5-dihydroxydecyl imidazole, 1- Aminobutyl-2-heptadecyl-4,5-dihydroxymethylimidazole, 1-aminobutyl-2-indolyl-4-methyl-5-tramethylimidazole, amidino Butyl-2-ethylethyl-4-methyl-5-transmethylimidazole, 1-aminobutyl-2-phenyl-4-yl -5-hydroxyindolyl 321995 26 201100387 * azole, 1-aminobutyl-2-undecyl-4-mercapto-5-hydroxymethylimidazole, amidinobutyl-2-heptadecane 4-methyl-5-hydroxymethylimidazole, 1-aminobutyl-4-methylimidazole, 1-aminobutyl-2-methyl-4-methylimidazole, 1-aminobutyl 2-ethyl-4-methylimidazolium, 1-aminobutyl-2-propyl-4-methyl η-mazole, 1-aminobutyl-2-butyl-4-fluorenyl Imidazole, 1-aminobutyl-2-hexyl-4-methyl-flavored β-sodium, 1-aminobutyl-2-mercapto-4-indolyl β-sodium, 1-aminobutyry-yl-2 -heptyl-4-mercaptoimidazole, 1-aminobutyl-2-octyl-4-mercapto-flavor, 1-aminobutyl-2-indenyl-4-mercapto-mi-jun, 1- Aminobutyl-2-mercapto-4-methyl succinyl, 1-aminobutyl-2-(alkyl-4-methyl oxime, ι-aminobutyl-2-heptadecyl- 4-methylimidazolium, 1-aminobutyl-2-oxooxypyridinium, 1-aminobutyl-2-oxo-4-methyl-salt, 1-aminobutyl-2- Methoxy-4, 5-dihydroxydecyl imidazole, 1-aminobutyl methoxy_4_methyl-5-hydroxymethylimidazole, 1-aminobutyl-2-epoxyimidazole, amidino Butyl-2-ethoxy-4-methylimidazole , 1-aminobutyl 2 -ethoxy- 4,5-dihydroxymethylimidazole, amidinobutyl-2-ethoxy-4-mercapto-5-hydroxymethylimidazole, Aminobutyl-2-phenoxyimidazole, amidinobutyl-2-phenoxy-4-mercaptoimidazole, 1-aminobutyl-2-phenyloxy-4,5-dihydroxymethyl Imidazole, 1-aminobutyl-2-phenoxy-4-methyl-hydroxyindenyl group, saliva, and the like. Among these, the structure of the sodium saliva site is preferably a 2-methyl-salt type because it tends to accelerate the rate of hardening, and further, the Q-based carbon atom in the above formula (3) which is based on an amine group. It is more preferable that the number of the two-valent hydrocarbon residues of 2 to 4 is particularly preferable, and it is particularly preferably a hydrocarbon residue having 3 to 4 carbon atoms. A specific example of the preferred amine group-containing imidazole compound is shown by the following formula (5). 321995 27 201100387

h2n*^n丄 NH2n*^n丄 N

WW

WW

丄 h2n,XSs^,^n^n \=y Η2Νν^-ν^\ΝΛΝ w Η2Ν<//χγ^Ν^Ν 該等之中,從使低溫硬化性更為優異之觀點來看,係 以下述式(5a)所示之任一種含胺基之咪唑化合物為特佳。 28 321995 201100387丄h2n, XSs^, ^n^n \=y Η2Νν^-ν^\ΝΛΝ w Η2Ν<//χγ^Ν^Ν Among these, from the viewpoint of further improving low-temperature hardenability, Any of the amine group-containing imidazole compounds represented by the formula (5a) is particularly preferred. 28 321995 201100387

N 丄N 丄

\=J\=J

N (5a)N (5a)

Η2Ν*^γ^Ν土N wΗ2Ν*^γ^Ν土N w

Q 上述異氰酸酯化合物可列舉如單異氰酸酯類、二異氰 酸酯類、三異氰酸酯類以及多異氰酸酯類。例如,單異氰 酸酯類可列舉如:異氰酸乙酯、異氰酸丙酯、異氰酸異丙 酯、異氰酸正丁酯、異氰酸正己酯、異氰酸環己酯、異氰 酸戊酯、異氰酸庚酯、異氰酸辛酯、異氰酸2-乙基己酯、 異氰酸壬酯、異氰酸癸酯、異氰酸十二烷酯、異氰酸十三 烧酯、異氰酸十四燒酯、異氰酸十六烧醋、異氰酸十八燒 〇 酯、曱基丙烯酸異氰酸基乙酯、丙烯酸異氰酸基乙酯等脂 肪族單異氰酸酯;異氰酸苯酯、異氰酸苯曱酯、異氰酸苯 乙酯、曱苯胺異氰酸酯、對氯苯基異氰酸酯、3, 4-二氯苯 基異氰酸酯、異氰酸萘酯等芳香族單異氰酸酯等。 而且,二異氰酸酯之例可列舉如:伸乙基二異氰酸酯、 六亞曱基二異氰酸酯、異佛爾酮二異氰酸酯、環己烷二異 氰酸酯、對伸苯基二異氰酸酯、間伸苯基二異氰酸酯、伸 苯二曱基(义717161^)二異氰酸酯、2,4-伸曱苯基二異氰酸 酯、2, 6-伸曱苯基二異氰酸酯、4, 4’-二苯基曱烷二異氰酸 29 321995 201100387 • 酯、聯茴香胺(dianisidine)二異氰酸酯、4, 4’ -二環己基 曱烷二異氰酸酯、氯伸苯基-2, 4-二異氰酸酯、1,5-萘二異 氰酸酯、二亞乙基二異氰酸酯、伸丙基-1, 2-二異氰酸酯、 伸環己基二異氰酸酯、3, 3’ -二甲基-4, 4’ -伸聯苯基二異氰 酸酯、3, 3’-二曱氧基-4, 4’-伸聯苯基二異氰酸酯、3, 3’-二苯基-4, 4’-二苯基-伸聯苯基二異氰酸酯、3, 3’-二氯 -4, 4’-伸聯苯基二異氰酸酯、降冰片烷二異氰酸酯、1,3-雙(異氰酸基甲基)-環己烷等。 ^ 而且,三異氰酸酯類之例可列舉如:六亞曱基二異氰 酸酯之縮二脲(biuret )、六亞甲基二異氰酸酯之異氰脲酸 酯、六亞曱基二異氰酸酯與脂肪族三元醇之加成體、異佛 爾酮二異氰酸酯之縮二脲、異佛爾酮二異氰酸酯之異氰脲 酸酯、異佛爾酮二異氰酸酯與脂肪族三元醇之加成體、三 苯基曱烷三異氰酸酯等。 多異氰酸酯之例可列舉如··聚合物狀之二苯基曱烷二 0 異氰酸醋等。 本實施型態所適用之具有脲鍵的咪唑化合物係藉由在 無溶媒或溶媒的存在下,使上述含胺基之咪唑化合物與異 氰酸酯化合物反應而得。溶媒只要為與所使用之原料的含 胺基之咪唑化合物或異氰酸酯化合物以及所生成之具有脲 鍵的咪唑化合物不反應者、或不形成鹽等者,則無特別限 制。如此溶媒之例可列舉如:二曱醚、二乙醚、二丙醚、 二丁醚、二苯醚、乙二醇二曱醚、二乙二醇、四氳吱喃等 醚類;乙酸曱酯、乙酸乙酯等酯類;苯、己烷、環己烷、 30 321995 201100387 .甲苯、二甲苯(xylene)、苯等烴類;乙腈、丙腈、苯甲腈 等腈類等。該等溶媒可為溶解所得料化合物之良溶媒 (good solvent)、亦可為不溶解之不良溶媒(p〇〇r solvent) 〇 反應溫度並無特別限定,一般係在〜2〇它至15〇1之範 圍下實施。以-lot至ioo°c為佳,以讪它至8(rc更佳。 反應溫度為15 0 C以下時,所得喃β坐化合物有高收率之傾 向。 〇 由上述反應所合成之咪唑化合物,當在反應中有使用 溶媒時,可經由以蒸發(evaporation)等去除溶媒而得之。 當使用對所期望之咪唑化合物不溶解的不良溶媒時,藉由 在反應結束後進行過濾即可容易地獲得所期望之咪唑化合 物。 經由適當地選擇上述反應時之溶媒’亦可設定使所期 望粒徑之咪唑化合物會析出的條件。並且,以更加提升咪 Q 唾化合物之純度的目的而言,可將所得咪°坐化合物以不良 溶媒進行清洗,或可使用與合成時所使用之溶媒為相同或 相異的溶媒進行晶析等精製。 本實施型態所使用之咪唑化合物的製造中,以進行上 述合成步驟、或歷經其接下來之精製步驟而進行粉碎步驟 者為佳。粉碎步驟中,可直接使用上述所得之粉末狀的咪 唑化合物,亦可使用將上述所得之咪唑化合物在融點以上 融解並冷卻而得之固體進行粗粉碎者。 粉碎步驟所進行之粉碎方法並無特別限定,其例可列 31 321995 201100387 • 舉如:以乳钵等進行粉碎之方法;使用球磨機(ball mill) 進行粉碎之方法;於溶媒中溶解後利用溫度所致之溶解度 差、或使用不良溶媒進行相分離而使之再沉澱的方法;於 溶媒中溶解後以喷霧乾燥法而得微粉末之方法;分散於不 良溶媒中並以濕式超高壓法而得微粉末之方法;以利用空 氣等之高壓喷射氣流的喷磨機(jet mi 11)進行粉碎之方法 等。 本實施型態中,可僅以上述各種方法中之1種而得到 ^ 所期望粒徑之咪唑化合物,亦可組合2種以上之各種粉碎 的方法。更且,亦能將以上述各種方法所得之微粉末分級 為各種粒徑,並藉由再調配而調整所期望粒徑者成為所期 望之含量。 在上述之粉碎方法中,較佳者係:於溶媒中溶解後以 噴霧乾燥法而得微粉末之方法;分散於不良溶媒中並以濕 式超高壓法而得微粉末之方法;以利用空氣等之高壓喷射 Q 氣流的喷磨機進行粉碎之方法。由於該等方法能以高收率 得到10 0 // m以下之粒徑的咪唾化合物,因而為佳。該等之 中,以利用空氣等之高壓喷射氣流的喷磨機進行粉碎之方 法更佳。如依此法,即能以高收率得到50/zm以下之粒徑 的咪唑化合物。在以喷磨機進行粉碎之方法中,可使用市 售之乾式喷磨機裝置,可適宜使用例如(股)Aishin Nano Technologies 公司製造之 Nano Jetmizer 等。 本實施型態中之低分子胺化合物,可作為在製造上述 p米峻化合物時的未反應成分而殘留在組成物中,亦可另外 32 321995 201100387 添加至σ米'1坐化合物中。 本實施型態中之㈣化合物,其形狀並無特別限定, 可為球狀、減狀之任H彳如,如為球狀,則在調配 至環氧樹脂中時’其組成物有低黏度化之傾❼此處之球 狀當然包含正球型,亦包含無規型之_ 止 <角帶有圓形感之形 調配時,其接觸 狀。並且,如為無規型,則在與環氧樹脂 面有增加之傾向。Q The above isocyanate compound may, for example, be a monoisocyanate, a diisocyanate, a triisocyanate or a polyisocyanate. For example, examples of the monoisocyanate include ethyl isocyanate, propyl isocyanate, isopropyl isocyanate, n-butyl isocyanate, n-hexyl isocyanate, cyclohexyl isocyanate, and isocyanide. Amyl oleate, heptyl isocyanate, octyl isocyanate, 2-ethylhexyl isocyanate, decyl isocyanate, decyl isocyanate, dodecyl isocyanate, isocyanate Fatty esters, tetradecyl isocyanate, hexadecyl isocyanate, octadecyl isocyanate, isocyanatoethyl methacrylate, isocyanatoethyl acrylate and other aliphatic monoisocyanates ; aromatic phenyl isocyanate, phenyl phthalate, isocyanate, aniline isocyanate, p-chlorophenyl isocyanate, 3, 4-dichlorophenyl isocyanate, naphthyl isocyanate Isocyanate, etc. Further, examples of the diisocyanate include, for example, ethyl diisocyanate, hexamethylene diisocyanate, isophorone diisocyanate, cyclohexane diisocyanate, p-phenylene diisocyanate, meta-phenylene diisocyanate, Diphenylene (I. 7171161) diisocyanate, 2,4-extended phenyl diisocyanate, 2,6-extended phenyl diisocyanate, 4,4'-diphenyldecane diisocyanate 29 321995 201100387 • Ester, dianisidine diisocyanate, 4, 4'-dicyclohexyldecane diisocyanate, chlorophenyl-2, 4-diisocyanate, 1,5-naphthalene diisocyanate, diethylene Diisocyanate, propyl-1,2-diisocyanate, cyclohexyl diisocyanate, 3,3'-dimethyl-4,4'-terphenyl diisocyanate, 3,3'-dioxane 4--4'-Exbiphenyl diisocyanate, 3,3'-diphenyl-4,4'-diphenyl-extended biphenyl diisocyanate, 3,3'-dichloro-4, 4 '-Extended biphenyl diisocyanate, norbornane diisocyanate, 1,3-bis(isocyanatomethyl)-cyclohexane, and the like. Further, examples of the triisocyanate include biuret of hexamethylene diisocyanate, isocyanurate of hexamethylene diisocyanate, hexamethylene diisocyanate and aliphatic ternary Addition of alcohol, biuret of isophorone diisocyanate, isocyanurate of isophorone diisocyanate, adduct of isophorone diisocyanate and aliphatic triol, triphenyl Decane triisocyanate and the like. Examples of the polyisocyanate include diphenyl decane dioxane acetonate such as a polymer. The imidazole compound having a urea bond to which this embodiment is applied is obtained by reacting the above-mentioned amine group-containing imidazole compound with an isocyanate compound in the absence of a solvent or a solvent. The solvent is not particularly limited as long as it does not react with the amine group-containing imidazole compound or the isocyanate compound of the raw material to be used and the formed imidazole compound having a urea bond, or does not form a salt or the like. Examples of such a solvent include dimethyl ether, diethyl ether, dipropyl ether, dibutyl ether, diphenyl ether, ethylene glycol dioxime ether, diethylene glycol, tetradecyl ether, and the like; Ester such as ethyl acetate; benzene, hexane, cyclohexane, 30 321995 201100387 . Hydrocarbons such as toluene, xylene, and benzene; nitriles such as acetonitrile, propionitrile, and benzonitrile. The solvent may be a good solvent for dissolving the obtained compound or a poor solvent (p〇〇r solvent). The reaction temperature is not particularly limited, and is generally from ~2〇 to 15〇. Implemented under the scope of 1. It is preferred to use -lot to ioo°c, and it is preferably 8 (rc is preferred.) When the reaction temperature is 15 0 C or less, the obtained compound has a tendency to have a high yield. 咪唑Imidazole compound synthesized by the above reaction When a solvent is used in the reaction, it can be obtained by removing a solvent by evaporation, etc. When a poor solvent which does not dissolve the desired imidazole compound is used, it is easy to perform filtration after the reaction is completed. The desired imidazole compound is obtained. The solvent of the desired particle size can also be set by appropriately selecting the solvent in the above reaction. Further, in order to further enhance the purity of the pyrimidine compound, The obtained imidazole compound may be washed with a poor solvent, or may be purified by crystallization or the like using a solvent which is the same as or different from the solvent used in the synthesis. In the production of the imidazole compound used in the present embodiment, It is preferred to carry out the above-mentioned synthesis step or to carry out the pulverization step through the subsequent purification step. In the pulverization step, the powder obtained as described above can be used as it is. The azole compound may be obtained by coarsely pulverizing the solid obtained by melting and cooling the imidazole compound obtained above above the melting point. The pulverization method carried out in the pulverization step is not particularly limited, and examples thereof may be listed as 31 321995 201100387. : a method of pulverizing with a mortar or the like; a method of pulverizing using a ball mill; a method of dissolving in a solvent, using a difference in solubility due to temperature, or reprecipitating by phase separation using a poor solvent; a method of obtaining a fine powder by a spray drying method after dissolving in a solvent; a method of dispersing in a poor solvent and obtaining a fine powder by a wet ultrahigh pressure method; and a jet mill using a high-pressure jet stream of air or the like (jet mi 11) A method of pulverizing, etc. In the present embodiment, an imidazole compound having a desired particle diameter can be obtained by only one of the above various methods, and two or more kinds of pulverization methods can be combined. It is also possible to classify the fine powder obtained by the above various methods into various particle diameters, and to adjust the desired particle diameter by re-adjusting to a desired content. In the pulverization method described above, a method of obtaining a fine powder by a spray drying method after dissolving in a solvent; a method of dispersing in a poor solvent and obtaining a fine powder by a wet ultrahigh pressure method; A method of pulverizing a high-pressure jet Q-flow jet mill, and it is preferable that these methods can obtain a sodium salium compound having a particle diameter of 100 μm or less in a high yield. The method of pulverizing the jet mill of the high-pressure jet stream is more preferable. According to this method, an imidazole compound having a particle diameter of 50/zm or less can be obtained in a high yield. In the method of pulverizing by a jet mill, A commercially available dry jet mill device can be used, and for example, a Nano Jetmizer manufactured by Aishin Nano Technologies, Inc., or the like can be suitably used. The low molecular weight amine compound in the present embodiment may remain in the composition as an unreacted component in the production of the above p-small compound, or may be added to the sigma-m'1 sitting compound in addition to 32 321995 201100387. The compound of the fourth embodiment in the present embodiment is not particularly limited in shape, and may be spherical or reduced. For example, if it is spherical, when it is formulated into an epoxy resin, its composition has a low viscosity. The spherical shape here of course includes a true spherical shape, and also includes a random type of _ stop < when the corner has a circular shape, the contact shape. Further, in the case of a random type, there is a tendency to increase the surface with the epoxy resin.

Ο 本實施型態中之咪i化合物係以. 狀 佳,以粉末狀為更佳。此處之粉末狀雖師職定,惟以 平均粒徑0.1至50/zm者為佳,以0·5至1〇#111者更佳。 粒徑係指以光散射法所測定之史脫克斯直徑( diameter)。並且,平均粒徑係指中值粒徑(如^抑 diameter) ° 本貫施型態中之含有咪唑化合物的微膠囊化組成物, 係具有如下述之構造:含有咪唑化合物之芯的表面係經含 有有機南分子、無機化合物或該兩者之殼所包覆的構造。 相對於芯,殼的含量雖無特別限定,惟相對於芯 質量份’殼的含量以0.01至100質量份為佳,以〇.丨至 80質量份更佳,又以1至6〇質量份又更佳,尤以5至50 質量份為最佳。 有機高分子可列舉如:纖維素、天然橡膠、澱粉、蛋 白質等天然高分子及合成樹脂等。該等之中,以貯藏安定 性、硬化時對殼的破壞容易度、以及硬化物之物性的均一 性之觀點而言,以合成樹脂為佳。 33 321995 201100387 . 合成樹脂可列舉如:環氧樹脂、兩烯酸系榭脂、聚西t =;_脂、聚乙稀樹脂、尼軸旨、聚苯乙烯樹脂: 脲樹月曰、胺醋(urethane)樹脂以及該等 物。該等之中,以酚樹脂,一元或多元醢& 物或 υ4夕疋醇與單或多里氰 酯的加成生成物之胺酯系樹脂,同時 /、 ^ 鍵、胺酯鍵以及縮二脲鍵的聚合物、種以上之脲 脂r應生成物,以及該等之混合物 〇化:物可為一般之具有一級胺基或二級按基的化合物,亦 可為將異氰酸酯化合物以水分解而改質為胺美者 無機化合物可列舉如:氧化爛1酸醋2化合物、 二氧=、氧化解。鮮之巾,叫的安定性與加熱時 之破壞谷易度之觀點而言’以氧化爛為佳。 本貫施型態中,當殼為-元或多元醇與單或多異氛酸 酯之加成生成物的胺酯系樹脂、或同時具 " J六'为Z種以上之脲 鍵、胺酿鍵以及縮二脲鍵的聚合物、或胺系化合物與環氧 〇樹脂之反應生成物、以及該等之混合物或共聚物時,從貯 藏安定性與反應性之平衡的觀點來看,在其表面至少具有 吸收波數1630至1680CHT1之紅外線的鍵結基(}〇與吸收波 數1680至1725cm之紅外線的鍵結基(y)者係較佳。 上述鍵結基(X)與鍵結基(y )之紅外線吸收係可使用傅 立葉轉換紅外線光譜儀(Fourier Transform Infrared化合物 The compound of the formula i in this embodiment is preferably in the form of a powder, more preferably in the form of a powder. The powder shape here is determined by the division, but the average particle size is 0.1 to 50/zm, and the 0.5 to 1〇#111 is better. The particle size refers to the strish diameter measured by the light scattering method. Further, the average particle diameter refers to a medium-sized particle diameter (e.g., diameter). The microencapsulated composition containing an imidazole compound in the present embodiment has a structure as follows: a surface system containing a core of an imidazole compound A structure covered with a shell containing an organic south molecule, an inorganic compound, or both. The content of the shell is not particularly limited with respect to the core, but is preferably 0.01 to 100 parts by mass, more preferably 〇. 丨 to 80 parts by mass, and 1 to 6 parts by mass, relative to the core part by weight. It is even better, especially 5 to 50 parts by mass. Examples of the organic polymer include natural polymers such as cellulose, natural rubber, starch, and protein, and synthetic resins. Among these, synthetic resin is preferred from the viewpoints of storage stability, ease of damage to the shell during hardening, and uniformity of physical properties of the cured product. 33 321995 201100387 . The synthetic resin may, for example, be an epoxy resin, a dienoic acid-based resin, a poly-t-t =; a fat, a polyethylene resin, a nylon resin, a polystyrene resin: a urea tree, an amine vinegar (urethane) resin and the like. Among these, a phenol resin, a mono- or poly-anthracene/amp; or an amine ester-based resin of an addition product of a hydrazine and a mono- or poly-cyano ester, and /, ^ bond, amine ester bond, and shrinkage a diurea-bonded polymer, a urate-containing urethane product, and a mixture of the above-mentioned compounds, which may be a compound having a primary amine group or a secondary group, or an isocyanate compound. The inorganic compound which is decomposed and modified to be an amine is exemplified by an oxidized rotten acid vinegar 2 compound, a dioxane =, and an oxidative solution. The fresh towel, called the stability and the point of view of the damage to the valley during heating, is preferably oxidized. In the present embodiment, the amine ester-based resin in which the shell is an addition product of a mono- or polyhydric alcohol and a mono- or poly-iso-acidic acid ester, or a urea bond having a Z-type of Z or more; From the viewpoint of a balance between storage stability and reactivity, a polymer of an amine-doped bond and a biuret bond, or a reaction product of an amine-based compound and an epoxy resin, and a mixture or copolymer thereof Preferably, the bonding group (y) having an infrared ray having an absorption wave number of 1630 to 1680 CHT1 and a bonding group (y) having an infrared ray having an absorption wave number of 1680 to 1725 cm are preferred. The above bonding group (X) and the bonding bond are preferred. The infrared absorption system of the base (y) can be a Fourier transform infrared spectrometer (Fourier Transform Infrared)

Spectrophotometer,以下稱為「FT-IR」)進行測定。又, 關於至少在含有咪唑化合物之微膠囊化組成物的表面(亦 即殼)具有鍵結基(X)及/或鍵結基(y)—事,係可使用顯微 321995 34 201100387 • FT-IR進行測定。鍵結基(x)中,特別適用者可列舉如:脲 鍵。鍵結基(y)中,特別適用者可列舉如:縮二脲鍵。具有 該脲鍵、縮二脲鍵者係由異氰酸酯化合物與活性氫化合物 之反應所生成的反應生成物。 用以生成上述代表鍵結基(X)之脲鍵及/或生成上述代 表鍵結基(y)之縮二脲鍵的異氰酸酯化合物,只要是1分子 中具有1個以上異氰酸基之化合物即可,以1分子中具有 2個以上異氰酸基之化合物為佳。較佳之異氰酸酯可列舉 ^ 如:脂肪族二異氰酸酯、脂環式二異氰酸酯、芳香族二異 氰酸酯、低分子三異氰酸酯、多異氰酸酯。 脂肪族二異氰酸酯之具體例可列舉如:伸乙基二異氰 酸酯、伸丙基二異氰酸酯、伸丁基二異氰酸酯、六亞甲基 二異氰酸酯、三甲基六亞曱基二異氰酸酯等。 脂環式二異氰酸酯之具體例可列舉如:異佛爾酮二異 氰酸酯、4, 4’ -二環己基曱烷二異氰酸酯、降冰片烷二異氰 q 酸酯、1,4-異氰酸基環己烷、1,3-雙(異氰酸基曱基)-環己 烧、1,3 -雙(2 -異氮酸基丙基-2基)-環己燒等。 芳香族二異氰酸酯之具體例可列舉如:伸曱苯基二異 氰酸酯、4, 4’-二苯基曱烷二異氰酸酯、伸苯二曱基二異氰 酸酯、1,5-萘二異氰酸酯等。低分子三異氰酸酯之具體例 可列舉如:1,6, 11-十一烷基三異氰酸酯、1,8-二異氰酸基 -4-異氰酸基甲基辛烷、1,3, 6-六亞甲基三異氰酸酯、2,6-二異氰酸基己酸-2-異氰酸基乙酯、2, 6-二異氰酸基己酸 -1-曱基-2-異氰酸基乙酯等脂肪族三異氰酸酯化合物;三 35 321995 201100387 * 環己基甲烷三異氰酸酯、二環庚烷三異氰酸酯等脂環式三 異氰酸酯化合物;三苯基曱烷三異氰酸酯、硫代磷酸三(異 氰酸基苯酯)等芳香族三異氰酸酯化合物等。 多異氰酸酯可列舉如:聚亞曱基聚苯基多異氰酸酯, 或由上述之二異氰酸醋、低分子三異氰酸醋所衍生之多異 氰酸酯。由上述之二異氰酸酯、三異氰酸酯所衍生之多異 氰酸酯係有例如異氰脲酸型多異氰酸酯、縮二脲型多異氰 酸酯、胺酯型多異氰酸酯、脲曱酸酯(al lophanate)型多異 ^ 氰酸酯、碳二亞胺型多異氰酸酯等。該等多異氰酸酯亦可 合併使用。 用以生成代表鍵結基(X)之脲鍵及代表鍵結基(y)之縮 二腺鍵的活性氫化合物可列舉如:水、1分子中具有1個 以上之一級及/或二級胺基的化合物、1分子中具有1個以 上之羥基的化合物。該等可合併使用。該等之中,以水及 1分子中具有1個以上之羥基的化合物為佳。 0 1分子中具有1個以上一級及/或二級胺基的化合物係 可使用脂肪族胺、脂環式胺、芳香族胺。 脂肪族胺之具體例可列舉如:曱胺、乙胺、丙胺、丁 胺、二丁胺等烷基胺;乙二胺、丙二胺、丁二胺、己二胺 等伸烷二胺;二伸乙三胺、三伸乙四胺、四伸乙五胺等聚 伸烷多胺;聚氧伸丙基二胺、聚氧伸乙基二胺等之聚氧伸 烷基多胺類等。 脂環式胺之具體例可列舉如:環丙胺、環丁胺、環戊 胺、環己胺、異佛爾酮二胺等。芳香族胺之具體例可列舉 36 321995 201100387 .如:苯胺、甲苯胺、苯甲胺、萘胺、二胺基二苯基甲烷、 一胺基一苯基諷等。 作為活性氫化合物使用的1分子中具有1個以上經基 的化合物可列舉如:醇化合物與酚化合物。醇化合物可列 舉如:曱醇、丙醇、丁醇、戊醇、己醇、庚醇、辛醇、壬 醇、癸醇、十一醇、月桂醇、十二醇、硬脂醇、二十醇、 烯丙醇、巴豆醇、炔丙醇、環戊醇、環己醇、苯甲醇、肉 〇 桂醇、乙二醇單甲醚、乙二醇單乙醚、乙二醇單乙醚、二 乙二醇單丁醚等一元醇類;乙二醇、聚乙二醇、丙二醇、 聚丙二醇、1,3-丁二醇、1,4~丁二醇、氫化雙酚A、新戊 二醇、丙三醇、三羥甲基丙烷、新戊四醇(pentaery thr i to 1) 等多元醇類。 並且,多元醇之例示亦可為1分子中具有2個以上二 級羥基的化合物,其中,該具有2個以上二級羥基的化合 物係藉由使1分子中具有1個以上環氧基的化合物、與1 〇 分子中具有1個以上羥基、羧基、一級或二級胺基、巯基 的化合物進行反應而得者。此等醇化合物可為一級、二級 或三級醇之任一者。酚化合物可列舉如:石碳酸(carbolic acid)、甲基酚(cresol)、二甲基酚(xylenol)、香芹酚 (carvacrol)、百里酚(thymol)、萘酚等一元酚類;兒茶酚、 間苯二酚(resorcin)、對苯二酚(hydroquinone)、雙酚 A、 雙紛F、焦掊酌'、間苯三齡(phloroglucinol)等多元齡類。 該等1分子中具有1個以上羥基的化合物係以多元醇類及 多元酚類等為佳。又以多元醇類更佳。 37 321995 201100387 . 殼中,鍵結基(x)之濃度以在1至1000meq/kg之範圍 為佳。並且,鍵結基(y)之濃·度以在1至l〇〇〇meq/kg之範 圍為佳。 此處,所謂的濃度係指相對於芯之單位質量,鍵結基 之濃度。鍵結基(X)之濃度設在lmeq/kg以上時,可得到對 機械剪切力具有高耐性之膠囊型硬化劑。並且,設在1000 meq/kg以下時,可得到高的硬化性。更佳之鍵結基(X)濃 度係在10至300meq/kg之範圍。 ^ 鍵結基(y)之濃度設在lmeq/kg以上時,可得到對機械 剪切力具有高耐性之膠囊型硬化劑。並且,設在l〇〇〇meq/kg 以下時,可得到高的硬化性。更佳之鍵結基(y)濃度係在 10 至 200meci/kg 之範圍。 又,殼係以另具有吸收波數1730至1755^11<之紅外線 的鍵結基(z)者為佳。關於鍵結基(z)之紅外線吸收,亦可 使用傅立葉轉換紅外線光譜儀(ΓΓ-IR)進行測定。並且, Q 關於至少在以味唆化合物為主成分之芯的表面具有鍵結基 (z)—事,可使用顯微FT-IR進行測定。 該鍵結基(z)中,特別適用者為胺醋鍵。該胺醋鍵係由 異氰酸酯化合物與1分子中具有1個以上羥基的化合物進 行反應所生成者。此處所使用之異氰酸酯化合物可使用用 以生成脲鍵、縮二脲鍵的異氰酸酯化合物。 用以生成代表鍵結基(z)之胺酯鍵的1分子中具有1個 以上經基的化合物,係可使用脂肪族飽和醇、脂肪族不飽 和醇、脂肪式醇、芳香族醇等醇化合物、酚化合物。 321995 38 201100387 • 脂肪族醇可列舉如:曱醇、丙醇、丁醇、戊醇、己醇、 庚醇、辛醇、壬醇、癸醇、十一醇、月桂醇、十二醇、硬 脂醇、二十醇等一元醇類;乙二醇單曱醚、乙二醇單乙醚、 乙二醇單丁醚、乙二醇單己醚等乙二醇單烷基醚類;乙二 醇、聚乙二醇、丙二醇、聚丙二醇、1,3-丁二醇、新戊二 醇等二元醇類;丙三醇、三羥曱基丙烷等三元醇類;新戊 四醇等四元醇類。脂肪族不飽和醇可列舉如:烯丙醇、巴 豆醇、炔丙醇等。脂環式醇可列舉如:環戊醇、環己醇、 ^ 環己烷二曱醇等。芳香族醇可列舉如:苯曱醇、肉桂醇等 一元醇類。該等醇可為一級、二級或三級醇之任一者。 1分子中具有1個以上環氧基的化合物與1分子中具 有1個以上羥基、羧基、一級或二級胺基、巯基的化合物 經反應而得之1分子中具有1個以上二級羥基的化合物亦 可作為醇化合物使用。 紛化合物可列舉如:石碳酸、曱基紛、二曱基紛、香 Q 芹酚、百里酚、萘酚等一元酚;兒茶酚、間苯二酚、對苯 二酚、雙酚A、雙酚F等二元酚;焦掊酚、間苯三酚等三 元酚。該等1分子中具有1個以上羥基的化合物係以具有 2價以上之經基的醇化合物或紛化合物為佳。 殼之鍵結基(z)之較佳濃度範圍為1至200meq/kg。此 處所謂之濃度係指相對於殼之單位質量,鍵結基之濃度。 當鍵結基(z)之濃度設在1 meq/kg以上時,可形成對機械 剪切力具有高耐性之殼。並且,設在200 meq/kg以下時, 可得到高的硬化性。更佳之鍵結基(z)的濃度範圍在5至 39 321995 201100387 100meq/kg。鍵結基(x)、鍵結基(y)、以及鍵結基(?)之濃 度的定量可依日本特開平01_70523號公報中所揭示之方 法進行。 殼之鍵結基(x)、鍵結基(y)、以及鍵結基(z)的存在區 域之總厚度係以平均層厚5至1〇〇〇nm為佳。若在5nm以上 則獲得貯藏安定性,而在1000mm以下時則得到實用之硬化 性。此處,所謂的層厚可藉由穿透型電子顯微鏡進行測定。 特佳之芯表面的鍵結基之總厚度,其平均層厚為1〇至 ^ lOOnm。 相對於殼,鍵結基的比率,就質量比而言係以100/1 至100/100者為佳。在該範圍内可兼具有貯藏安定性與硬 化性。以100/2至100/80為佳,以1〇〇/5至1〇〇/6〇更佳, 以100/10至100/50又更佳。 〇 使鍵結基存在於殼中之方法可列舉如:⑴在使鍵結基 之成分溶解並使殼分散之分散媒中,藉由降低鍵結基之成 分的溶解度,而使鍵絲析出妓之方法;⑵在使殼分散 之刀散媒中進行鍵結基的形成反應,使鍵結基析出於以味 二二物作為主D之殼的方法;(”將殼作為反應場所並 在其中使鍵結基生叙方法等。該等之中,由於⑵及⑶ 之方法可㈣進行反應與包覆,Μ較佳。 此處之分散媒可列舉如:溶媒、塑化劑、樹脂類等。 並且,亦可使用環氧樹脂作為分散媒。 物^媒之例可列舉如:苯、甲笨、、二甲苯、環己烧、鑛 物油積(mineral spirit)、ζ:、丄 石油腦(naphtha)等烴類;丙 321995 40 201100387 酮、曱基乙細、曱基異τ基㉚等酮類;6酸乙§旨、乙酸 正丁醋、丙二醇單甲基乙基峻乙_#g旨類;曱醇、里丙 醇、正丁醇、丁基溶纖劑(butyl cellQsQive)、丁基卡必 醇等醇類;水等。塑化劑可列舉如:鄰笨二甲酸二丁酉旨、 鄰苯二甲酸二(2-乙基己酯)等鄰苯二甲酸二醋系;己二酸 二(2-乙基己酯)等脂肪族二元酸酯系;磷酸三曱苯酯 (tricresyl ph〇Sphate)等磷酸三醋系;聚乙二醇醋等二醇 酉旨⑷yc。! ester)系等。樹脂類之例可列舉如:錢樹脂 (silicone resin)類、環氧樹脂類、酚樹脂類等。 以鍵結基包覆殼之方法中,可作為分散媒使用的環氧 樹脂之例可列舉如:將雙㈣、雙㈣、㈣ad、雙紛S、 〇 四甲基雙紛A、四甲基雙粉F、四甲基雙紛仙、四甲基錐 紛S、四錢驗A、四氯麵A、四氟雙紛a等雙紛類予= 縮水甘油化而成的雙紛型環氧樹脂;將聯紛(biPhenol)、 二羥基萘、二羥基苯、9,9_雙(4_羥基 賴予以縮水甘油化而成之環氧樹二 ^ = 基苯基)w、4,4-(W4介⑷M 卜 苯基)亞乙基)雙酚等二祕魅工 ^ ^ i τ基乙基) m 1 m ί 甘油化㈣之環氧樹 油化而成之環氧榭浐.妝、貝于以縮水甘 尹祕藤清漆、雙二二Γ清漆(ph_ _心)、 雙驗a祕清漆等 1曝=漆、漠化齡轉清漆、漠化 而成的祕清漆型/氧)類予以縮水甘油化 蚤!%氧樹脂等;將多元酚類 化而成之環她、將甘油或聚乙二醇等多元醇= 321995 42 201100387 甘油化而成的脂肪族醚型環氧樹脂;將 -殘基I甲酸等縣㈣:基本甲酸、万 氧樹脂;將如鄰苯二甲酸、對苯:甘曱:= 水甘油化而成之酯型環氧樹腊;4 4—二胺酸予以縮 間-胺基紛等胺化合物的縮水甘油化物及里土-本基Μ或 甘油醋等_縣樹料縮水甘油 ^職三縮水 環氧基環己基f基〜3 土歪衣氧樹脂、與3, 4〜 氧化物等。 乳基環己燒幾酸醋等赌環族環 點來看I以缩水曰組成物之高的貯藏安定性之觀 甘油化而成之環氧樹 /將多元齡類予以縮水 购氧樹腊、將雙㈣予以::紛A予以縮水甘油化 月曰、將二窥基萘予以縮水甘油 甘油化而成之環氧樹 在上述(3)以殼作為及靡媼纟之環氧樹脂又更佳。 之方法中,異象酸醋Γ合反物應與==其令使鍵结基生成 ::至_之溫度範圍下進二 應時間。 υ刀鐘至12小時的反 物中之活性氫的當量比為1:。、㈣基與活性氳化合 當使用由芯與環氧樹腊之反.1000之範圍中使用。 毂時’上述反應通常是在代至ς而得的反應生成物作為 佳之溫度範圍下,進行丨至 c ’以㈣至100 時,以2至72切為佳 321995 42 201100387 之反應時間,亦可在分散媒中進行。分散媒可列舉如溶媒、 塑化劑等。並見,環氧樹月旨本身亦可作為分散媒使用。此 時,母料型硬化劑中之環氧樹脂、與殼形成反應中所使用 之環氧樹脂,玎為相同的環氧樹脂。 溶媒之例=舉如:笨、甲苯、二甲苯、環己燒1 物油精、石油脑#類;丙_、曱基乙基綱、甲義異 綱等酮類;乙酸乙醋、乙酸正丁醋、丙二醇單甲^ : ο 乙酸酯等酯類;曱醇、異丙醇、正醇 ^ 土醚 基卡必醇等醇類;水等。丁知、丁基溶纖劑、丁 〇 塑化劑—鄰苯二甲酸二丁㈣ 一(2-乙基己醋)等鄰笨二甲酸二醋系塑化劑;己二酸夂 乙基己醋)等脂肪族二元酸酉旨系塑化劑;碟酸三甲一: 酸三醋系塑化劑;聚乙二醇醋等二醇醋系塑化劑等。專忪 在使芯與毅=形成反應中所使用的環氧樹 時之質量比並無特別限定,通常,相對於 :反應 質量(芯的質量/環氧樹脂之質量)如在刚〇/1至二, 之範圍即可,以100/1至1/100之範圍更佳。 00 當使用由怒與環氧樹脂之反應而得的反應生成 殼時’以殼包覆芯之方法可列舉如:(a)在使殼成分為 使芯分散之分散媒中’藉由降低殼成分的溶解度而使叔^ 出在芯'的表面之料;(b)錢料散之綠射^ :成反應’使殼析出於芯的表面之方法;或者是㈦::的 =面作為反應場所並於其巾生成殼之方法等。該等t‘r 於(b)及⑹之方法可同時進行反應與包覆,而為极隹 43 32l995 201100387 • 在採用後者之(b)及(c)時,本實施型態之環氧樹脂用硬化 劑可將芯中之低分子量胺化合物作為形成殼之成分使用, 亦可另行添加。 本實施型態中,包覆芯的表面之殼的厚度係以平均層 厚5至lOOOnm為佳。在5nm以上則得到貯藏安定性,而在 1000mm以下時則得到實用之硬化性。此處,所謂的層厚可 藉由穿透型電子顯微鏡觀察。特佳之芯的厚度,其平均層 厚為50至700nm。 ^ 關於殼之形成反應中所使用的環氧樹脂,在無損及本 實施型態之目的之效果之範圍内,並無特別限定。該環氧 樹脂之例可列舉如:將雙驗A、雙紛F、雙紛AD、雙盼S、 四曱基雙酚A、四曱基雙酚F、四曱基雙酚AD、四曱基雙 酚S、四溴雙酚A、四氯雙酚A、四氟雙酚A等雙紛類予以 縮水甘油化而成的雙酚型環氧樹脂;將聯酚、9, 9-雙(4-羥基苯基)苐等其它的二酚類予以縮水甘油化而成之環氧 Q 樹脂;將1,1,1-三(4-羥基苯基)曱烷、4, 4-(1-(4-(1-(4-羥基苯基)-1-曱基乙基)苯基)亞乙基)雙酚等三酚類予以 縮水甘油化而成之環氧樹脂;將1,1,2, 2-四(4-羥基苯基) 乙烷等四酚類予以縮水甘油化而成之環氧樹脂;將酚酚醛 清漆、曱酚酚醛清漆、雙酚A酚醛清漆、溴化酚酚醛清漆、 溴化雙酚A酚醛清漆等酚醛清漆類予以縮水甘油化而成的 酚醛清漆型環氧樹脂等;將多元酚類予以縮水甘油化而成 之環氧樹脂、將甘油或聚乙二醇等多元醇予以縮水甘油化 而成的脂肪族醚型環氧樹脂;將對-羥基苯曱酸、万-羥基 44 321995 201100387 '甲酸等&基㈣予㈣水甘油化而成 脂;將如鄰苯二甲酸、對 曰孓衣氣樹 油化而成之酯型環氧樹二7: 4夕70幾酸予以縮水甘 胺絲等職合物_水甘油化物❹ 或間- 酉旨,型環氧樹脂等縮水甘— =己基甲基-3’4’氧基環己烷·酸醋等脂環族環:化 ο 該等環氧樹脂可單獨使用,亦可將2種以上併用。 =形成反應中所❹的環氧樹脂之 ::下。以__以下為佳,— 以:=下又更佳,進一步以一 ^ 更50_以下為特佳。總氯量在25〇_以下即可得到 宁,定性之平衡性高_氧樹脂組成物。總氯 罝可依據以JISK-7243-3為基準之方法測定。 ο 從更易於控制殼之形成反應的觀點來看,殼之形成反 應中所使用的環氧樹脂之總氣量以〇 〇1議以上。以 〇. 02卯m以上為佳,以Q』5酬以上更佳以q. _以上 又更進一步以°.2_以上為佳,以G.5ppm以上更佳。 氯里在0-lppm以上即可使殼之形成反應在硬化劑表面 有效地進行,而可得到貯藏安定性優異之殼。 本實施型態中’可作成包含上述含有味峻化合物之微 膠囊化組成物與環氧樹脂的硬化性级成物。硬化性組成物 可因應用途直接使之硬化而使用。本實施型態之硬化性組 45 321995 201100387 成物可藉由加熱而硬化,以表現所期望的性能。 硬化性組成物中,相對於含有咪唑化合物之微膠囊化 組成物100質置份’以含有1〇至5〇, 〇〇〇質量份之環氧樹 脂^佳。環氧樹脂在50,_ f量份以下時,硬化反應性有 更k南之彳!向在1G質量份以上時,硬化性組成物之黏 度不致過冋’而有獲得更佳作業性之傾向。由此觀點而言, 硬化性組成物巾之環氧樹脂之調配量,相對於含有味嗤化 合物之微膠囊化組成物⑽f量份,以謂至5剛質量份 為佳以120至1〇〇〇質量份更佳尤以15〇至棚質量份 為特佳。 本實施^^之硬化性組成物係以含有味唾化合物之微 膠囊化組絲㈣氧樹料為域分者為佳。此處,所謂 7成分係指佔總成分之5G質量%以上之成分之意,以加 ,硬化性成分之60質她上者為佳。以70議以上更 〇填化性之成分可列舉例如:增量劑、強化材、充 =對=:Γ、有機溶劑、樹脂類等,然該等成 ^相對於組成物全體,以在0至90質量%之範圍内使用為 之母’可作成含有上述硬化性組成物 心甘枓型硬化劑。較佳者係以硬 母料型硬化劑。此處,主成分.為主成分之 以上者。 ,、才主成刀中含有50質量% 母料型硬化劑之總氣量,為了達成兼具高的硬化性舆 321995 46 201100387 貯藏女疋性’宜為25〇〇ρριη以下,以i5〇〇ppin以下為佳, 以800PPm以下更佳,進一步以4〇〇ppm以下為佳, 以 200ppm 以下更佳’以100PPm以下又更佳,以80ppm以下最佳,更 以50ppm以下為特佳。 ^母料型硬化劑中之環氧樹脂的總氯量’為了達成兼具 回的硬化性與貯藏安定性,宜為2500ppm以下,以1500ppm 以下為佳,以8〇〇ppm以下更佳,進一步以1〇〇ppm以下又 〇 更佳,又以5〇ppm以下為最佳。 田母料型硬化劑中之環氧樹脂與殼形成反應中所使用 之¥氧樹脂相同時,從更易於控制殼的形成反應之觀點來 看’母料型硬化劑中之環氧樹脂的總氯量宜為G.Glppm以 上以0· 〇2ppm以上為佳,以〇. 〇5ppm以上更佳,進一步 、〇. lppm以上為佳,尤以〇. 2ppm以上更佳,又以〇. 5卯瓜 以上為最佳。 本貫施型態中之母料型硬化劑的製造方法並無特別限 G 疋,可列舉如:例如使用三軸輥等,使含有咪唑化合物之 ,膠囊化組成物分散在環氧樹脂中的方法;在環氧樹脂中 藉由進行芯的包覆反應而進行微膠囊化,同時得到母料型 硬化劑之方法等。該等之中,後者係因生產性高而為佳。 在本實施型態之母料型硬化劑中可含有環狀硼酸酯化 合物等硼酸化合物。在含有硼酸化合物之情況下,可使組 成物之貯藏安定性,特別是使高溫中的貯藏安定性提高。 ^上述硼酸化合物係以由硼酸與脂肪族或芳香族二醇所 得之於環式構造中含有硼的化合物為佳。例如:三—鄰-伸 321995 47 201100387 .苯基雙硼酸酷、雙-二甲基三亞甲基焦硼酸醋、雙_二甲基 伸乙基焦爛酸酯、雙-二乙基伸乙基焦哪酸自旨、2,2,—氧基 雙(5, 5,-二甲基」,3, 2_二氧雜己蝴燒 等。該等之中,以2, 2,-氧基雙(5, 5,_二甲基气仏二氧 雜己硼烷)為佳。 上述環狀硼酸醋化合物之含量,相對於母料型硬化劑 中之環氧樹脂⑽質量份,以G. _至1G質量份為佳,以 〇如J至2質量份更佳,又以〇.〇5至〇.1質量份為特佳。 2該_内之含量’即可得到組成物在高溫時之貯藏 二::優異、且短時間硬化性、耐熱性、接著性以及連接 罪丨生不文損的優異硬化物。 本實施型態中之硬化性組成物在不使其機能降低 因應各種用途而含有其它成分。其它成分之含量 舞於全部㈣物,仙未達50質量%者為f 〇 本實施型態之硬化性組成物以及母料型硬化劑 印可T要是平均每分子具有2個以上環氧基者 ㈣將㈣w_AD、雙 土 四甲基雙齡F、四甲基細ad、四甲基 甘=雙:A、四氯雙W、四氣雙紛a等雙_予以 321995 48 1 9、: 的雙紛型環氧樹赌;將聯驗、二經基萘、 雙(4-象基本基)¾等其它的二酴類予以縮水甘 成之環氧樹脂;將】,;[卜三" ,,、'而 (“(4、'-n、, 基)甲燒、4,4_〇-(4~ _予=: 乙基)苯基)亞乙基)雙紛等三紛 4縮水甘油化而成之環氧樹赌;將1,ι,2, 2_四(4, 201100387 苯基)乙烧等赠類予以縮水甘油化而成之環氧樹脂;將紛 雜清漆、Μ賴清漆、㈣A喊清漆、演化紛祕 清漆、㈤b㈣A祕清料_料齡簡水甘油化 而成的祕清漆型環氧樹m多元縮水甘油 化而成之環氧樹脂;將如甘油或聚乙二醇等多元醇予以縮 水甘油化而成的脂肪族醚型環氧樹脂;將如對—羥基苯甲 酸、/9-經基萘甲酸等幾基練予以縮水甘油化而成之_The Spectrophotometer, hereinafter referred to as "FT-IR", was measured. Further, regarding at least a surface (i.e., a shell) of the microencapsulated composition containing an imidazole compound having a bonding group (X) and/or a bonding group (y), a microscopic 321995 34 201100387 • FT can be used. -IR was measured. Among the bond groups (x), for example, a urea bond can be cited. Among the bonding groups (y), for example, a biuret bond can be cited. The one having the urea bond or the biuret bond is a reaction product formed by the reaction of an isocyanate compound and an active hydrogen compound. The isocyanate compound for forming the above-mentioned urea bond representing the bond group (X) and/or the biuret bond forming the above-mentioned bond group (y), as long as it is a compound having one or more isocyanate groups in one molecule That is, a compound having two or more isocyanate groups in one molecule is preferred. Preferred examples of the isocyanate include aliphatic diisocyanate, alicyclic diisocyanate, aromatic diisocyanate, low molecular triisocyanate, and polyisocyanate. Specific examples of the aliphatic diisocyanate include ethyl diisocyanate, propyl diisocyanate, butyl diisocyanate, hexamethylene diisocyanate, and trimethyl hexamethylene diisocyanate. Specific examples of the alicyclic diisocyanate include isophorone diisocyanate, 4,4'-dicyclohexyldecane diisocyanate, norbornane diisocyanate, and 1,4-isocyanato group. Cyclohexane, 1,3-bis(isocyanatodecyl)-cyclohexane, 1,3-bis(2-isoxylpropyl-2-yl)-cyclohexane or the like. Specific examples of the aromatic diisocyanate include phenyl diisocyanate, 4, 4'-diphenyldecane diisocyanate, benzodiylidene diisocyanate, and 1,5-naphthalene diisocyanate. Specific examples of the low molecular weight triisocyanate include 1,6,11-undecyltriisocyanate, 1,8-diisocyanato-4-isocyanatomethyloctane, 1,3,6 - hexamethylene triisocyanate, 2,6-diisocyanatohexanoic acid-2-isocyanatoethyl ester, 2,6-diisocyanatohexanoic acid-1-indenyl-2-isocyano An aliphatic triisocyanate compound such as acid ethyl ester; 3 35 321995 201100387 * an alicyclic triisocyanate compound such as cyclohexylmethane triisocyanate or dicycloheptane triisocyanate; triphenyldecane triisocyanate or thiophosphoric acid tris(iso) An aromatic triisocyanate compound such as cyanatophenyl ester). The polyisocyanate may, for example, be a polyarylene polyphenyl polyisocyanate or a polyisocyanate derived from the above-mentioned diisocyanate or low molecular triisocyanate. The polyisocyanate derived from the above-mentioned diisocyanate or triisocyanate is, for example, an isocyanuric acid type polyisocyanate, a biuret type polyisocyanate, an amine ester type polyisocyanate, or an allophanate type polyisocyanate. An acid ester, a carbodiimide type polyisocyanate or the like. These polyisocyanates may also be used in combination. The active hydrogen compound for generating a urea bond representing a bonding group (X) and a dimeric bond representing a bonding group (y) may, for example, be water, have one or more primary and/or secondary in one molecule. An amine group compound or a compound having one or more hydroxyl groups in one molecule. These can be combined. Among these, a compound having one or more hydroxyl groups in one molecule of water is preferred. The compound having one or more primary and/or secondary amine groups in the molecule of 0 1 may be an aliphatic amine, an alicyclic amine or an aromatic amine. Specific examples of the aliphatic amine include alkylamines such as guanamine, ethylamine, propylamine, butylamine, and dibutylamine; and alkylenediamines such as ethylenediamine, propylenediamine, butanediamine, and hexamethylenediamine; a polyalkylene polyamine such as diethylenetriamine, triamethylenetetramine or tetraamethyleneamine; polyoxyalkylene polyamines such as polyoxypropylene propylene diamine and polyoxyethylene ethylamine . Specific examples of the alicyclic amine include cyclopropylamine, cyclobutylamine, cyclopentylamine, cyclohexylamine, and isophoronediamine. Specific examples of the aromatic amine include 36 321995 201100387. For example, aniline, toluidine, benzylamine, naphthylamine, diaminodiphenylmethane, monoamine-monophenyl, and the like. The compound having one or more trans groups in one molecule used as the active hydrogen compound may, for example, be an alcohol compound or a phenol compound. The alcohol compound may, for example, be decyl alcohol, propanol, butanol, pentanol, hexanol, heptanol, octanol, decyl alcohol, decyl alcohol, undecyl alcohol, lauryl alcohol, dodecanol, stearyl alcohol, twenty Alcohol, allyl alcohol, crotyl alcohol, propargyl alcohol, cyclopentanol, cyclohexanol, benzyl alcohol, fentanyl alcohol, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monoethyl ether, diethyl Monohydric alcohols such as diol monobutyl ether; ethylene glycol, polyethylene glycol, propylene glycol, polypropylene glycol, 1,3-butylene glycol, 1,4-butanediol, hydrogenated bisphenol A, neopentyl glycol, Polyols such as glycerol, trimethylolpropane, pentaerythrine thr i to 1 or the like. Further, the polyol may be a compound having two or more secondary hydroxyl groups in one molecule, and the compound having two or more secondary hydroxyl groups is a compound having one or more epoxy groups in one molecule. It is obtained by reacting a compound having one or more hydroxyl groups, carboxyl groups, primary or secondary amino groups, and fluorenyl groups in one molecule. These alcohol compounds may be any of the primary, secondary or tertiary alcohols. Examples of the phenol compound include monocarboxylic phenols such as carbolic acid, cresol, xylenol, carvacrol, thymol, and naphthol; Polyphenols, resorcin, hydroquinone, bisphenol A, double F, coke, and phloroglucinol. The compound having one or more hydroxyl groups in one molecule is preferably a polyhydric alcohol or a polyhydric phenol. It is better to use polyols. 37 321995 201100387 . In the shell, the concentration of the bonding group (x) is preferably in the range of 1 to 1000 meq/kg. Further, the concentration of the bonding group (y) is preferably in the range of 1 to 1 〇〇〇 meq/kg. Here, the concentration refers to the concentration of the bonding group with respect to the unit mass of the core. When the concentration of the bonding group (X) is set to lmeq/kg or more, a capsule-type curing agent having high resistance to mechanical shearing force can be obtained. Further, when it is 1000 meq/kg or less, high curability can be obtained. A more preferred bond group (X) concentration is in the range of 10 to 300 meq/kg. ^ When the concentration of the bonding group (y) is set to lmeq/kg or more, a capsule-type hardener having high resistance to mechanical shearing force can be obtained. Further, when it is set to l〇〇〇meq/kg or less, high hardenability can be obtained. A more preferred bond group (y) concentration is in the range of 10 to 200 meci/kg. Further, the shell is preferably a bonding group (z) having an infrared ray having an absorption wave number of 1730 to 1755^11 < The infrared absorption of the bonding group (z) can also be measured using a Fourier transform infrared spectrometer (ΓΓ-IR). Further, Q has a bonding group (z) at least on the surface of a core containing a miso compound as a main component, and can be measured by microscopic FT-IR. Among the bonding groups (z), an amine vinegar bond is particularly suitable. The amine vinegar bond is produced by reacting an isocyanate compound with a compound having one or more hydroxyl groups in one molecule. As the isocyanate compound used herein, an isocyanate compound for forming a urea bond or a biuret bond can be used. An alcohol having one or more kinds of a trans group in one molecule for forming an amine ester bond representing a bonding group (z), and an alcohol such as an aliphatic saturated alcohol, an aliphatic unsaturated alcohol, a fatty alcohol or an aromatic alcohol can be used. Compound, phenolic compound. 321995 38 201100387 • Examples of aliphatic alcohols include: decyl alcohol, propanol, butanol, pentanol, hexanol, heptanol, octanol, decyl alcohol, decyl alcohol, undecyl alcohol, lauryl alcohol, dodecanol, hard Monohydric alcohols such as aliphatic alcohols and pentaerythritol; ethylene glycol monoalkyl ethers such as ethylene glycol monoterpene ether, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, ethylene glycol monohexyl ether; ethylene glycol , glycols such as polyethylene glycol, propylene glycol, polypropylene glycol, 1,3-butylene glycol, neopentyl glycol; triols such as glycerol and trihydroxydecyl propane; and neopentyl alcohol Alcohols. The aliphatic unsaturated alcohol may, for example, be allyl alcohol, crotonol or propargyl alcohol. Examples of the alicyclic alcohol include cyclopentanol, cyclohexanol, and cyclohexanedimethanol. The aromatic alcohol may, for example, be a monohydric alcohol such as benzoquinone or cinnamyl alcohol. The alcohols can be any of the primary, secondary or tertiary alcohols. A compound having one or more epoxy groups in one molecule and one compound having one or more hydroxyl groups, carboxyl groups, primary or secondary amine groups, and fluorenyl groups in one molecule are reacted to obtain one or more secondary hydroxyl groups in one molecule. The compound can also be used as an alcohol compound. Examples of compounds include: stone carbonate, thiol sulfonate, diterpene quinone, fragrant Q celery, thymol, naphthol, etc.; catechol, resorcinol, hydroquinone, bisphenol A , diphenols such as bisphenol F; triols such as pyrogallol and phloroglucin. The compound having one or more hydroxyl groups in the above-mentioned one molecule is preferably an alcohol compound or a compound having a transvalent group of two or more. The preferred concentration of the bond group (z) of the shell ranges from 1 to 200 meq/kg. The concentration referred to herein means the concentration of the bonding group with respect to the unit mass of the shell. When the concentration of the bonding group (z) is set at 1 meq/kg or more, a shell having high resistance to mechanical shearing force can be formed. Further, when it is 200 meq/kg or less, high hardenability can be obtained. A more preferred bond group (z) concentration ranges from 5 to 39 321995 201100387 100 meq/kg. The quantification of the concentration of the bonding group (x), the bonding group (y), and the bonding group (?) can be carried out in accordance with the method disclosed in Japanese Laid-Open Patent Publication No. Hei 01-70523. The total thickness of the existence region of the bond group (x), the bond group (y), and the bond group (z) of the shell is preferably an average layer thickness of 5 to 1 Å. When it is 5 nm or more, storage stability is obtained, and when it is 1000 mm or less, practical hardenability is obtained. Here, the so-called layer thickness can be measured by a transmission electron microscope. The total thickness of the bonding groups on the surface of the superior core has an average layer thickness of from 1 Å to 10,000 nm. The ratio of the bonding groups with respect to the shell is preferably from 100/1 to 100/100 in terms of mass ratio. Within this range, both storage stability and hardenability can be achieved. It is preferably from 100/2 to 100/80, preferably from 1〇〇/5 to 1〇〇/6〇, and even better from 100/10 to 100/50. The method of causing the bonding group to be present in the shell may be, for example, (1) in the dispersion medium in which the components of the bonding group are dissolved and the shell is dispersed, and the bond filament is precipitated by lowering the solubility of the component of the bonding group. (2) performing a formation reaction of a bonding group in a slurry in which the shell is dispersed, and decomposing the bonding group into a shell having a taste of the second substance as a main D; ("using the shell as a reaction site and in which In the above, the method of (2) and (3) can be carried out by reacting and coating (4). Preferably, the dispersing medium herein is a solvent, a plasticizer, a resin, or the like. Further, an epoxy resin may be used as the dispersing medium. Examples of the material may be benzene, methyl benzene, xylene, cyclohexane, mineral spirit, hydrazine: hydrazine brain ( Naphtha) and other hydrocarbons; C 321995 40 201100387 Ketones such as ketone, mercapto-ethyl, decyl-iso-t-butyl 30; 6-acid acetyl acetate, n-butyl acetate, propylene glycol monomethyl ethyl urethane _#g Steroids, propylene glycol, n-butanol, butyl cellosolve (butyl cellQsQive), butyl carbitol, etc. Examples of plasticizers include: dibutyl phthalate, diphthalic acid di-(2-ethylhexyl) phthalate diacetate; adipic acid di(2-ethyl) Aliphatic dibasic acid esters such as hexyl hexyl ester; triacetate phosphates such as triplesyl ph〇Sphate; diols such as polyethylene glycol vinegar; (4) yc. Examples of the epoxy resin, epoxy resin, phenol resin, etc. Examples of the epoxy resin which can be used as a dispersion medium in the method of coating the shell with a bonding group include, for example: Will be double (four), double (four), (four) ad, double S, 〇 tetramethyl double A, tetramethyl double powder F, tetramethyl double dan, tetramethyl cone S, four money test A, tetrachloromethane A, PTFE, A, etc., double-type epoxy resin formed by glycidation; biPhenol, dihydroxynaphthalene, dihydroxybenzene, 9,9_bis (4-hydroxyl) The epoxy resin formed by the glycidylation of di-glycidyl 2 ^ = phenyl) w, 4, 4- (W 4 (4) M phenyl) ethylene) bisphenol, etc. ^ ^ i τ ethyl ) m 1 m ί glycerol (4) epoxy tree Made of epoxy enamel. Makeup, shell to shrink water Gan Yin secret vine varnish, double two bismuth varnish (ph_ _ heart), double test a secret varnish, etc. 1 exposure = paint, desertification age to varnish, desert The secret varnish type/oxygen type is obtained by glycidolization %!% oxygen resin, etc.; the polyphenols are formed into a ring, and the polyol such as glycerin or polyethylene glycol is glycerolized by 321995 42 201100387 An aliphatic ether type epoxy resin; a residue - residue I formic acid and the like (four): a basic formic acid, an oxy-oxygen resin; an ester type ring such as phthalic acid, p-benzene: kansin: = water glycerol Oxygen tree wax; 4 4 - diamine acid is a glycidyl compound of a di-amino-amine compound, and a soil-based base or glycerin vinegar, etc. _ county tree glycidol ^ job tri-condensed epoxy cyclohexyl F-based ~ 3 soil enamel, with 3, 4~ oxides, etc. Milk-based ring-fired sulphuric acid vinegar and other gambling ring family point of view point I look at the high storage stability of the shrinking hydrazine composition of the glycerol-formed epoxy tree / shrink the multi-age class to buy oxygen tree wax, The double (four) will be given:: A condensed glycidylated sulphate, and the oligo-glycine glycerol glycerol is formed in the above (3) and the epoxy resin is better as the shell. . In the method, the viscous acid vinegar compound should be combined with the == which causes the bond group to form a temperature range of :: to _. The equivalent ratio of active hydrogen in the counters of the sickle clock to 12 hours was 1:. (4) The combination of the base and the active oxime is used in the range of the core of the core and the epoxy resin. In the case of the hub, the above reaction is usually carried out in the temperature range of the reaction product, and the reaction time is as follows: (4) to 100, and the reaction time of 2 to 72 is preferably 321995 42 201100387. It is carried out in a dispersion medium. Examples of the dispersing medium include a solvent, a plasticizer, and the like. See also, the epoxy tree itself can also be used as a dispersing medium. At this time, the epoxy resin in the master batch type hardener and the epoxy resin used in the reaction with the shell form the same epoxy resin. Examples of solvent = such as: stupid, toluene, xylene, cyclohexane, 1 oil, petroleum brain #; C, 曱 乙基 ethyl, ketone and other ketones; acetic acid, vinegar, acetic acid Butane vinegar, propylene glycol monomethyl ^ : ο esters such as acetate; alcohols such as decyl alcohol, isopropanol, n-alcohol, earth ether carbitol, water, etc. Dingzhi, butyl cellosolve, butadiene plasticizer - dibutyl (tetra) phthalate (2-ethylhexyl vinegar) and other o-dicarboxylic acid diacetate plasticizer; adipic acid hexanoic acid vinegar) Such as aliphatic diacid acid is intended to be a plasticizer; trimethyl sulphate: acid triacetate plasticizer; polyethylene glycol vinegar and other glycol vinegar plasticizer. The mass ratio of the epoxy tree used in the reaction between the core and the y = is not particularly limited, and generally, relative to: the reaction mass (mass of the core / mass of the epoxy resin) as in 〇/1 To the second, the range is preferably in the range of 100/1 to 1/100. 00 When a shell is formed by a reaction obtained by the reaction of anger and epoxy resin, the method of coating the core with a shell may be exemplified by: (a) in the dispersion medium in which the shell component is dispersed in the core, by reducing the shell The solubility of the component causes the uncle to be on the surface of the core; (b) the green emission of the money material: the method of reacting to precipitate the shell out of the surface of the core; or (7):: = face as reaction The method of forming a shell in a towel, and the like. The methods of (b) and (6) can be carried out simultaneously with the reaction and coating, and are the electrode 43 32l995 201100387. • When the latter (b) and (c) are used, the epoxy resin of this embodiment The low molecular weight amine compound in the core may be used as a shell-forming component by a hardener, or may be added separately. In this embodiment, the thickness of the shell of the surface of the coated core is preferably from 5 to 100 nm. Storage stability is obtained at 5 nm or more, and practical hardenability is obtained at 1000 mm or less. Here, the so-called layer thickness can be observed by a transmission electron microscope. The thickness of the superior core has an average layer thickness of 50 to 700 nm. The epoxy resin used in the formation reaction of the shell is not particularly limited insofar as it does not impair the effects of the object of the present embodiment. Examples of the epoxy resin include, for example, double test A, double F, double AD, double expect S, tetradecyl bisphenol A, tetradecyl bisphenol F, tetradecyl bisphenol AD, tetraterpene a bisphenol type epoxy resin obtained by glycidylation of bisphenol S, tetrabromobisphenol A, tetrachlorobisphenol A, tetrafluorobisphenol A, etc.; biphenol, 9, 9-double ( Epoxy Q resin obtained by glycidylation of other diphenols such as 4-hydroxyphenyl) hydrazine; 1,1,1-tris(4-hydroxyphenyl)decane, 4, 4-(1- An epoxy resin obtained by glycidylation of a trisphenol such as 4-(1-(4-hydroxyphenyl)-1-indenylethyl)phenyl)ethylidene bisphenol; 1,1, An epoxy resin obtained by glycidylation of a tetraphenol such as 2,4-tetrakis(4-hydroxyphenyl)ethane; a phenol novolac, a nonylphenol novolac, a bisphenol A novolac, a brominated phenol novolac a novolak-type epoxy resin obtained by glycidylation of a phenolic varnish such as brominated bisphenol A phenol varnish; an epoxy resin obtained by glycidylating a polyhydric phenol, glycerin or polyethylene glycol, etc. Polyhydric alcohol obtained by glycidation Ether type epoxy resin; p-hydroxybenzoic acid, 10,000-hydroxy 44 321995 201100387 'formic acid, etc. & base (four) to (four) hydroglycerylation of fat; such as phthalic acid, 曰孓 曰孓 气 树Ester-type epoxy tree II 7: 4 70 70 acid to shrink glycine and other complexes _ hydroglyceride ❹ or between - 酉 ,, type epoxy resin and other shrinking sweet - = hexyl methyl - An alicyclic ring such as 3'4'-oxycyclohexane-acid vinegar: These epoxy resins may be used singly or in combination of two or more. = Formation of the epoxy resin in the reaction. It is better to use __ below, - to: = is better, and further to be more than 50%. The total chlorine content is 25 〇 _ or less to obtain Ning, and the qualitative balance is high _ oxy resin composition. Total chloranil can be determined according to the method based on JIS K-7243-3. ο From the viewpoint of easier control of the formation reaction of the shell, the total amount of the epoxy resin used in the formation reaction of the shell is 〇 〇 or more. It is better to use 〇. 02卯m or more, and it is better to use Q 』5 or more to q. _ or more. It is better to use °. 2_ or more, and more preferably G. 5ppm or more. When the chlorine content is 0-lppm or more, the formation reaction of the shell can be efficiently carried out on the surface of the hardener, and a shell excellent in storage stability can be obtained. In the present embodiment, a sclerosing grade comprising the above-described microencapsulated composition containing a taste compound and an epoxy resin can be prepared. The curable composition can be used by directly curing it according to the intended use. The curable group of this embodiment 45 321995 201100387 The article can be hardened by heating to exhibit desired properties. In the curable composition, the epoxy resin is contained in an amount of from 1 to 5 Å by mass based on 100 parts of the microencapsulated composition containing the imidazole compound. When the epoxy resin is below 50, _ f, the hardening reactivity is more k-south! When the amount is 1 g parts by mass or more, the viscosity of the curable composition is not excessively 冋, and there is a tendency to obtain better workability. From this point of view, the amount of the epoxy resin of the curable composition towel is preferably from 120 to 1 Å with respect to the amount of the microencapsulated composition (10) f containing the miso compound. 〇 The mass is better, especially from 15 〇 to shed. The curable composition of the present embodiment is preferably a microencapsulated silk (4) oxygen tree material containing a taste compound. Here, the term "7-component" means a component of 5 G% by mass or more of the total component, and it is preferable to add 60 or more of a curable component. For example, a filler, a reinforcing material, a charge = a pair of Γ, an organic solvent, a resin, etc., may be mentioned as a component of the composition of 70 or more. It is used as a mother to be used in the range of 90% by mass to form a hardening agent containing the above-mentioned curable composition. Preferably, a hard masterbatch type hardener is used. Here, the main component is the main component or more. , the main gas into the knife contains 50% by mass of the masterbatch type hardener total gas volume, in order to achieve a high degree of hardenability 1995321995 46 201100387 storage of female genital 'should be 25 〇〇ρριη below, to i5〇〇ppin The following is preferable, and it is preferably 800 ppm or less, further preferably 4 ppm or less, more preferably 200 ppm or less, and more preferably 100 ppm or less, and most preferably 80 ppm or less, and more preferably 50 ppm or less. The total chlorine content of the epoxy resin in the masterbatch type hardener is preferably 2,500 ppm or less, more preferably 1,500 ppm or less, even more preferably 8 〇〇 ppm or less, in order to achieve both the hardenability and the storage stability. It is preferably 1 〇〇ppm or less, and 5 〇ppm or less. When the epoxy resin in the masterbatch type hardener is the same as the foaming resin used in the shell formation reaction, the total amount of the epoxy resin in the masterbatch type hardener is from the viewpoint of easier control of the shell formation reaction. The amount of chlorine is preferably G.Glppm or more and 0. 〇2ppm or more, preferably 〇. 〇5ppm or more, further, 〇. lppm or more is preferable, especially 〇. 2ppm or more is better, and 〇. 5卯Melon is the best. The method for producing the master batch type hardener in the present embodiment is not particularly limited, and examples thereof include, for example, using a triaxial roll to disperse an encapsulated composition containing an imidazole compound in an epoxy resin. Method; a method of performing microencapsulation by a coating reaction of a core in an epoxy resin, a method of obtaining a masterbatch type hardener, and the like. Among the above, the latter is preferred because of its high productivity. The master batch type hardener of the present embodiment may contain a boric acid compound such as a cyclic borate ester compound. In the case of containing a boric acid compound, the stability of the composition can be improved, and in particular, the storage stability at high temperatures can be improved. The above boric acid compound is preferably a compound containing boron in a ring structure derived from boric acid and an aliphatic or aromatic diol. For example: Tri-Ning-Ext 321995 47 201100387 . Phenyl diborate, bis-dimethyltrimethylene co-borate, bis-dimethyl-ethyl co-earate, bis-diethyl exoethyl coke Which acid is intended, 2,2,-oxybis(5,5,-dimethyl), 3,2-dioxahexene, etc. Among these, 2, 2,-oxy double (5, 5, _ dimethyl hydrazine dioxahexyl borane) is preferred. The content of the above cyclic boronic acid vinegar compound is G. _ relative to the epoxy resin (10) by mass in the masterbatch type hardener. It is preferably 1 parts by mass, more preferably, for example, J to 2 parts by mass, and particularly preferably 〇.〇5 to 〇.1 parts by mass. 2 The content of the _ can be obtained at a high temperature. Storage 2: Excellent and short-term hardenability, heat resistance, adhesion, and excellent hardened materials that are linked to sin. The hardenable composition in this embodiment does not reduce its function to suit various uses. Contains other ingredients. The content of other ingredients is danced to all (four) substances, and the 50% by mass of the immortalization is f. The hardening composition of the present embodiment and the masterbatch type hardener T can be averaged per If the child has two or more epoxy groups (IV), (4) w_AD, double earth tetramethyl double age F, tetramethyl fine ad, tetramethyl gan=double: A, tetrachlorobis W, four gas double a, etc. Give 321995 48 1 9:: double-type epoxy tree gambling; combine the other two diterpenoids such as dimethine, di-carbazide, double (4-like basic group) 3⁄4, etc.; 】,;[卜三",,, and ("(4, '-n,, base), A, 4,4_〇-(4~ _pre=: ethyl)phenyl)ethylidene Epoxy tree gambling made by three different types of glycidol; epoxy resin obtained by glycidylation of 1,1,2,2_4 (4, 201100387 phenyl) Epoxy resin obtained by mixing varnish, varnish, (4) A varnish, evolutionary varnish, (5) b (four) A secret material _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ An aliphatic ether type epoxy resin obtained by glycidylation of a polyhydric alcohol such as glycerin or polyethylene glycol; and glycidylation of a group such as p-hydroxybenzoic acid or /9-pyridyl naphthoic acid _

型環氧樹脂;將如鄰苯二甲酸、對苯二甲酸等多元竣酸予 以縮水甘油化而成之酯型環氧樹脂;4,4_二胺基二苯基曱 烧或間-絲料職合物的縮水甘油化物及異氰腺ς三 縮水甘油酯等胺型環氧樹脂、與3,4_環氧基環己基甲基 一3, 4-環氧基環己烷羧酸酯等脂環族環氧化物等。 土Epoxy resin; an ester type epoxy resin obtained by glycidylating a polybasic phthalic acid such as phthalic acid or terephthalic acid; 4,4-diaminodiphenyl fluorene or inter-filament An amine type epoxy resin such as a glycidyl compound or an isocyanurin triglycidyl ester of a compound, and a 3,4-epoxycyclohexylmethyl-3,4-epoxycyclohexanecarboxylate, etc. An alicyclic epoxide or the like. earth

本實施型態之含㈣唾化合物之微膠囊化組成物盘環 氧樹脂之混合比並無特職定,可由硬化性、硬化性之觀 點來決定。相對於含有咪魏合物之微膠囊化組成物1{)〇 質篁份’環氧樹脂之含量以Q. ii咖質量份 0.5至500質量份更佳,以3至·質量份又更佳。將環 氧樹脂之含量設在1刚質量份以下時,可得到實用上可充 分滿足的硬化性能,設在1〇〇質量份以上時,各成分不會 分布不均,可得到平衡佳之硬化性能。 曰 本實施型態之母料型硬化劑中,可混合一種樹脂,其 係環氧樹脂之㊉分子聚體,且為具有自抒成膜性之一般稱 為苯氧樹脂(phenoxy resin)的樹脂。 本實施型態之含有咪唑化合物之微膠囊化組成物、硬 321995 49 201100387 • 化性組成物以及母料型硬化劑,可併用至少1種選自酸酐 類、酚類、肼(hydrazine)類以及胍(guanidine)類所成組 群中的硬化劑。 酸酐類之例可列舉如:鄰苯二甲酸酐、偏苯三甲酸酐、 均笨四甲酸酐、六氫鄰苯二甲酸酐、四氳鄰苯二曱酸酐、 3-氯鄰苯二甲酸酐、4-氯鄰苯二曱酸酐、二苯甲酮四羧酸 酐、丁一酸酐、甲基丁二酸酐、二甲基丁二酸酐、二氯丁 〇 —酉文野、甲基納迪克酸酐(methyl nadic anhydride)、十 一烧基丁一I酐、氯茵酸酐(chl〇rendic anhydride)、順 丁烯二酸酐等。 酚類之例可列舉如:酚酚醛清漆、甲酚酚醛清漆、雙 紛A祕清漆等;肼類之例可列舉如:丁二酸二酿肼、己 ^酸二醯肼、鄰苯二甲酸二醯肼、間苯二甲酸二醯肼、對 苯-甲酸二酿肼、對、經基苯曱醯肼、水揚醯肼、苯基胺基 丙醯肼、順丁烯二酸二醯肼等。 〇 脈類之例可列舉如:雙氰胺、甲基胍、乙基胍、丙基 胍、丁基胍、二甲基胍、三甲基胍、苯基胍、二苯基脈、 甲本基脈等。 較佳之硬化劑可列舉如胍類及酸酐類等,更佳者可列 舉如.雙氰胺、六氳鄰苯二曱酸酐、甲基四氫鄰苯二甲酸 酐、曱基納迪克酸酐等。 在使用硬化劑時,相對於含有咪唑化合物之微膠囊化 組成物G.G1至2GG質量份’所使用之硬化劑係以成為)至 2〇〇質量伤之量者為佳。在該範圍内使用時,可賦予硬化 321995 50 201100387 耐 .性與貯藏安定性更為優異之組成物,而可得到耐熱性、 水性更為優異之硬化物。 本實施型態之母料型硬化劑中,可依所望而添加増 劑、強化材、充填劑、導電微粒、顏料、有機溶劑、^ 性稀釋劑、非反應性稀釋劑、其它之樹脂類、結晶性醇μ 耦合劑等。 ^' 充填劑之例可列舉如:煤焦油(coal hr)、破螭纖 石棉纖維(asbestos fiber)、蝴纖維、碳纖維春、 聚乙稀粉、聚丙埽粉、石英粉、礦物性石夕酸鹽、〜奮、 棉粉、板岩(slate)粉等。 1 衣母、石 顏料之例可列舉如:高屬土、氧化銘三水合物、、 化鋁、白堊(chalk)粉、石膏、碳酸鈣、= 氧氧 醚(penton)、氧化矽(Siiica)、氣溶膠、立榨粉、氯化聚 (iithopone)、重晶石(baryte)、二氧化鈦等^ ” 導電微粒之例可列舉如:碳黑、石二 丄u不、木硬皆(carbon 〇 nanotube)、昌勒烯、氧化鐵、金、银 M 跟鋁粉、鐵粉、夺米 級之金屬結晶、金屬間化合物等。 有機溶劑之例可列舉如:甲苯、—田# 讲甘田个甘加 一7本、甲基乙基酮、 甲基異丁基輞、乙酸乙S旨、乙酸丁醋等。 反應性稀釋劑之例可列舉如:丁其始, 丞縮水甘油醚、ν,ν,- ,缩水甘油基-鄰-甲苯胺、苯基縮水甘油越、氧化苯 乙二醇二縮水甘油醚、丙二醇二縮水 ’ 冗/由醚、1,6-己二醇 二縮水甘油醚等。 ’ u # 非反應性稀釋劑之例可列舉如··翻 ¥本一甲酸二辛酯、 321995 51 201100387 鄰苯:甲酸一丁酯、己二酸二辛酯、石油系溶劑等。 其匕之樹脂類之例可列舉如:聚酯樹脂、聚胺酯樹脂、 丙1酸系樹月旨、聚鍵樹脂、三聚氰胺樹脂及胺s旨改質環氧 樹月曰橡膠改質環氧樹脂、醇酸改質環氧樹脂等改質環氧 樹月曰、'、〇曰曰性醇可列舉如:1,2-環己二醇、1, 3-環己二醇、 1,4-¾ 己二醇、報^^ 新戍四醇、山梨糖醇、蔗糖、三羥曱基丙 烷。 〇 〇 該等之任一者可因應用途而有效地使用。 匕1 .占中’可作成含有上述硬化性組成物或上述 用硬化劑之膏狀組成物、膜狀組成物、接著劑、接合 接α用膜、導電性材料、異方導電性材料、絕緣性 導熱性、塗佈用材料、塗料組成物、預浸物以及 劑、著:合:fd接r膜可有用於作為液狀接著 之製造方也 黏阳((1161:)011(11叩)材料等。膜狀接著劑 及日本特門半:列舉例如:日本特開03 62一14⑽3號公報 體而言號公報等所記载之方法等。更具 液狀環氣樹r、3〆合媒之全部成分’使固形環氧樹脂、 計==及因應需要之固形的胺輯樹脂以 液。於料散於u巾,而作成溶 溶-中使其二二硬化劑添加、分散於 50,m ί ;;rni^ 上’使甲苯乾燥後之厚度麵 二醋基材 -30# 藉由使甲苯乾燥, 321995 201100387 而可獲得在节/皿中為惰性,且會經由加熱而以潛在性 劑之作用來發揮接著㈣接合賴。 更化 導電性材料可列舉如:導電膜、導電膏等。 二方導電性材料可卿如:異方導電性膜、異方 ! 生膏等其衣造方法之例可列舉如:日本特開平〇卜山 號公報所記載之方法。更具體而言,例如在上述接合用腺 之裝&中’在調製漆時,將導電性材料及異方導電性材料 進行混合、分散並塗佈在剝離用之基材後,經由乾 π u 製得。 'Γ 導電#子了列舉如.焊料粒子(s〇lder即出。^) · 粒子;奈米級之金屬結晶;以其它金屬包覆金屬表面之叔 子,銅與銀之傾斜粒子等金屬粒子;以及例如將苯乙椒 脂、胺醋樹脂、三聚氰胺樹脂、環氧樹脂、丙烯酸系樹月,、 紛樹脂、苯乙埽-T二烯樹脂等的樹脂粒子以金、鍊、= 銅、焊料等之導電性薄膜施行包覆的粒子等。導電、 〇 常為1至20左右之球形微粒。 在作成膜時,例如有在作為基材之聚酯、聚乙婦 醯亞胺、聚四氟乙稀等基材上塗饰後,使溶劑乾燥之方法 專0 ^緣性材料可列舉如:絕緣接著膜、絕緣接著膏。藉 =使:上述接合用膜’可得到作為絕緣材料 “The microencapsulated composition containing the (iv) salic compound of the present embodiment has no specific duty ratio, and can be determined by the viewpoint of hardenability and hardenability. The content of the epoxy resin containing the microencapsulated composition 1{) enamel ' 'epoxy resin is preferably 0.5 to 500 parts by mass of the Q. ii coffee portion, more preferably 3 to · parts by mass. . When the content of the epoxy resin is set to 1 part by mass or less, a hardening property which can be sufficiently satisfactorily obtained can be obtained, and when it is set to 1 part by mass or more, the components are not unevenly distributed, and a well-balanced hardening property can be obtained. . In the masterbatch type hardener of the present embodiment, a resin which is a very heteropolymer of an epoxy resin and which is generally called a phenoxy resin having a self-filming property may be mixed. . The microencapsulated composition containing the imidazole compound of the present embodiment, the hard 321995 49 201100387 chemical composition and the masterbatch type hardener may be used in combination with at least one selected from the group consisting of an acid anhydride, a phenol, a hydrazine, and A hardener in a group of guanidines. Examples of the acid anhydrides include phthalic anhydride, trimellitic anhydride, tetrazoic anhydride, hexahydrophthalic anhydride, tetraphthalic acid anhydride, and 3-chlorophthalic anhydride. 4-chlorophthalic anhydride, benzophenone tetracarboxylic anhydride, butyric anhydride, methyl succinic anhydride, dimethyl succinic anhydride, dichlorobutyl hydrazine - 酉文野, methyl nadic anhydride (methyl nadic Anhydride), eleven-butanyl-I anhydride, chloric acid anhydride (chl〇rendic anhydride), maleic anhydride, and the like. Examples of the phenols include phenol novolacs, cresol novolacs, and bismuth A secret varnishes; examples of the terpenoids include, for example, succinic acid, bismuth, bismuth phthalate, phthalic acid Diterpenoids, dioxonium isophthalate, p-benzoic acid-dicarboxylic acid, p-benzoquinone, hydrazine, phenylaminopropionate, diammonium maleate Wait. Examples of the ruthenium include dicyandiamide, methyl hydrazine, ethyl hydrazine, propyl hydrazine, butyl hydrazine, dimethyl hydrazine, trimethyl hydrazine, phenyl hydrazine, diphenyl pulmonate, and abenzine. Base pulse and so on. Preferred examples of the curing agent include hydrazines and acid anhydrides, and more preferred examples include dicyandiamide, hexamethylene phthalic anhydride, methyltetrahydrophthalic anhydride, and fluorenamic acid anhydride. When the curing agent is used, it is preferred that the hardening agent used for the microencapsulated composition containing the imidazole compound G.G1 to 2GG parts by mass is used in an amount of up to 2% by mass. When it is used in this range, a composition which is more excellent in durability and storage stability can be imparted to the hardened 321995 50 201100387, and a cured product which is more excellent in heat resistance and water resistance can be obtained. In the masterbatch type hardener of this embodiment, an expectorant, a reinforcing material, a filler, a conductive fine particle, a pigment, an organic solvent, a diluent, a non-reactive diluent, and other resins may be added as desired. A crystalline alcohol μ coupling agent or the like. ^' Examples of fillers include, for example, coal tar, asbestos fiber, butterfly fiber, carbon fiber spring, polyethylene powder, polypropylene powder, quartz powder, mineral acid Salt, ~fen, cotton powder, slate powder, etc. 1 Examples of clothing mothers and stone pigments include, for example, high genus, oxidized trihydrate, aluminum, chalk powder, gypsum, calcium carbonate, penton, bismuth oxide (Siiica) , aerosol, stand-up powder, iithopone, barite, titanium dioxide, etc. Examples of conductive particles include carbon black, stone bismuth, and hard wood (carbon 〇nanotube) ), Changerene, iron oxide, gold, silver M and aluminum powder, iron powder, metal crystallization of rice, intermetallic compounds, etc. Examples of organic solvents can be listed as: toluene, - Tian # speak Gantian a Ganga One, one methyl ethyl ketone, methyl isobutyl hydrazine, acetic acid ethyl acetate, acetic acid butyl vinegar, etc. Examples of reactive diluents include, for example, Dingqi, diglycidyl ether, ν, ν, - , Glycidyl-o-toluidine, Phenyl glycidol, Oxidized phenylethylene glycol diglycidyl ether, Propylene glycol dihydrate, Redundant / Ether, 1,6-hexanediol diglycidyl ether, etc. Examples of non-reactive diluents can be exemplified by di-octyl benzoate, 321995 51 201100387 o-benzene: Examples include a monobutyl acrylate, a dioctyl adipate, a petroleum solvent, and the like. Examples of the oxime resin include a polyester resin, a polyurethane resin, a propionic acid system, a polynuclear resin, and a melamine resin. The amine s is intended to be modified with epoxy resin, eucalyptus rubber modified epoxy resin, alkyd modified epoxy resin, etc., modified epoxy tree sap, ', 〇曰曰 alcohol can be listed as: 1,2-cyclohexyl Glycol, 1, 3-cyclohexanediol, 1,4-3⁄4 hexanediol, sinotetraol, sorbitol, sucrose, trishydroxypropane. Any of these may It can be used effectively in accordance with the application. 匕1. "Medium" can be used as a paste composition containing the above curable composition or the above-mentioned curing agent, a film-like composition, an adhesive, a film for bonding α, a conductive material, Heterogeneous conductive material, insulating thermal conductivity, coating material, coating composition, prepreg, and agent, and: fd-connected r film can be used as a liquid-like manufacturing method and also viscous (1161 :) 011 (11 叩) material, etc. Film-like adhesive and Japanese special door half: For example, Japanese Patent Laid-Open No. 03 62-14(10) No. 3 The method described in the Gazette, etc., etc., all of the components of the liquid ring-shaped gas tree r and the three-mesh media are made of a solid epoxy resin, a === and a solid amine resin which is required to be used as a liquid. In the u towel, and dissolved, the second hardener is added and dispersed in 50, m ί;; rni^ on the thickness of the toluene after drying the toluene substrate -30# by drying the toluene, 321995 In 201100387, it is possible to obtain inertness in the knot/dish, and to perform the bonding action by the action of the latent agent by heating. The conductive material may be, for example, a conductive film, a conductive paste or the like. The two-way conductive material may be, for example, a hetero-conducting conductive film, an anisotropic film, or the like, and examples of the method for producing the same may be exemplified by the method described in Japanese Laid-Open Patent Publication No. More specifically, for example, in the preparation of the gland for bonding, in the case of preparing a lacquer, the conductive material and the anisotropic conductive material are mixed, dispersed, and coated on the substrate for peeling, and then dried. u made. 'Γ Conductive #子 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 And, for example, resin particles such as styrene oxide, amine vinegar resin, melamine resin, epoxy resin, acrylic resin, styrene resin, styrene-Tadiene resin, etc., gold, chain, = copper, solder, etc. The conductive film is coated with coated particles or the like. Conductive, 〇 often spherical particles of about 1 to 20. When the film is formed, for example, after coating on a substrate such as polyester, polyethylenic imide or polytetrafluoroethylene as a substrate, the method of drying the solvent may be exemplified by: The film is then infused with a paste. By l: the above-mentioned film for bonding 'is available as an insulating material"

膜。並且,除了使用密封材料之外,藉由調配上述充^ 中的絕緣性充填劑,亦可得到絕緣接著膏。核真J 密封材料可列舉如:_密封材、㈣輯材及膜狀 321995 53 201100387 後封材等。液狀密封材可有用於作為底部填充材 (underfill material)、灌封材(p〇tting material)、屏 障材(dam material),。密封材之製造方法,可使用曰本 特開平05-43661號公報及日本特開2002-226675號公報等 所記載之方法。由該製造方法即可作成電性.電子零件之密 封.含浸用成形材料。更具體而言,在添加雙酚4型環氧樹 脂、作為㈣硬蝴之甲基六氫鄰苯二?酸酐等硬化劑、membrane. Further, in addition to the use of the sealing material, an insulating paste can be obtained by blending the above-mentioned insulating filler. Nuclear Zhen J sealing materials can be listed as follows: _ sealing material, (four) and material and film 321995 53 201100387 after sealing materials. The liquid sealing material can be used as an underfill material, a potting material, and a dam material. For the method of producing the sealing material, the method described in JP-A-H05-43661, JP-A-2002-226675, and the like can be used. According to this production method, it is possible to form an electrical and electronic component seal. The impregnation molding material. More specifically, when a bisphenol type 4 epoxy resin is added, as a (four) hard butterfly methyl hexahydrophthalate? Hardener such as an acid anhydride,

❹ 以及球狀熔融氧切粉末並使之均自混合後,再添加本實 施型態的硬化性組絲或母料型硬化顯使之均勻混合, 藉此而可得到密封材料。 σ 塗佈用材料之例可列舉如:電子材料之塗佈材 電路板之遮蓋用之覆蓋材(Qven:Qai: _a丨丨、 ==、成物、電磁波吸收材等。塗佈用:料 =二 報曰:::平4,號公報、曰本 叫4W1旒公報、日本特開平〇8_6 日本特開_3-2侧8號公報等所記載之方遽么報、 而言:由充填射選出氧切等作為充填物,更=體 A型%氧樹脂與苯氧樹脂與_改質環㈣ \己又紛 調配本實施型態之硬化性組成物或母料型硬化$後,再 乙基_EK)調製50質量%之溶液。將此以5〇 ,以曱基 佈在聚醯亞賴上,使㈣疊合,在6()至=之厚度塗 積後,以180至200°C加熱硬化,藉此而n 〇下進行層 氧樹脂組成物 塗佈的積層板。 彳㈣層間經環 塗料組成物之製造方法可列舉例如:日本特開平士 321995 54 201100387 .323247號公報、日本特開號公報等所記載之 方法。更具體而言,在雙環氧樹脂中調配二氧化欽、 滑石等,再添加甲基異丁基酮(MIBK)/二甲苯之〗·· 1( 比)混合^劑,'經由授拌、混合而作成主劑。於其中,^ 添加本實施型態之硬化性、组成物或母料型硬化劑且使^均 勻分散,即可得到塗料組成物。 = 就預π物之製造方法而言,例如,如日本特開平〇9_ 71633號公報、國際公開第98/44〇17號等所記載之方法, 係使環氧樹脂組成物含浸於強化基材並經加熱即可獲得。 含浸之漆之溶劑可列舉如··甲基乙基酮、丙酮、乙纖 劑、甲醇、乙醇、異丙醇等,該等溶劑係以不殘留在預浸 物中為佳。另外,強化基材之種類並無特別限定,可列舉 如.紙、玻璃布、玻璃不織布、芳綸(aramid)布、液晶聚 合物等。樹脂組成物份與強化基材之比例亦無特別限定, 通常’預浸物中之樹脂份係以20至80質量%為佳。 〇 導熱性材料之製造方法可列舉例如:日本特開平〇6一 136244號公報、日本特開平10-237410號公報、日本特開 2000-3987號公報等所記载之方法。更具體而言,將作為 熱硬化性樹脂之環氧樹脂、作為硬化劑之酚酚醛清漆硬化 劑、以及作為導熱充填材之石墨粉末予以調配並進行均句 混練。於其中調配本實施型態之硬化性組成物或母料型硬 化劑,即可得到導熱性樹脂膏。 [實施例] 以下,依據實施例以詳加說明本發明,惟本發明並不 321995 55 201100387 ♦ 限定於下述之實施例。實施例及比較例中之「份」或「%」 如無特別記載’則為質量基準。依下述手法進行本實施例 與比較例之樹脂以及其硬化物的物性評估試驗。 (1) 粒度分佈測定 使用曰本雷射公司製造之雷射繞射式粒徑分佈分析儀 HEL0S/BF-M,並以乾式法測定。 (2) 融點測定 使用島津製作所公司製造之示差掃描量熱儀 0 (differential scanning calorimeter)DSC-60,以升溫速 度10°C/分鐘進行分析,將所得DSC圖表上的吸熱峰頂作 為融點。 (3) 低分子胺化合物之定量 高效液相層析儀(島津製作所公司製造,SCL-10AVP, 檢測器SPD-10AVP;以下稱為HPLC)中之管柱係使用GL Sciences公司製造之Inertsil C4。流動相係使用於曱醇/ ❹ 水=55/50中添加十二烷基硫酸鈉而成為20mM,並添加磷酸 使pH=3至4者。另外,檢測波長設為230nm。從HPLC分 析圖表上之低分子胺化合物的波峰面積,將含有微粉末狀 咪唑化合物的組成物中之低分子胺化合物之含量進行定 量。 (4) FT-IR 測定 使用曰本分光(股)公司製作之傅立葉轉換紅外線光譜 儀FT/IR-410測定吸光度。 (5) 從母料型硬化劑中,將含有咪唑化合物之微膠囊化組成 56 321995 201100387 • 物予以分離 將母料型硬化劑以二曱苯反覆 毫無環氧樹月旨為止。接著,以環己烧反覆隹過滤,直到 直到毫無二甲苯為止。另將環已烧濾除=。滌及過滤’ 度進行乾燥而將環己烷完全去除。 ' c以下之溫 ⑹從含有咪錢合狀彳轉纽組 分離 將膠囊膜予以 ο 將含㈣魏合物之_囊倾成〜 洗務及過渡直到毫無環氧樹月旨用硬 曱醇反覆進行 以下之溫度下進行乾燥而將甲醇完全去除止’然後在50°C (Ό硬化速度評估 ' t:默以及靴之熱盤上之凝膠時間(㈣ 就凝膠時間而言’係將實施例或 性環氧樹脂硬化性組成物〇.5g落加在 ^之早液 〇 =授拌’每隔數秒鐘就進行-次將竹籤從: = :::測定組成物變得不再對竹_-時間㈣為= (8) 貯藏安定性評估 將實施例或比較例所製造之單液性 成物保存在4(TC之悝溫槽中,經—定$于脂硬化性版 度變化者為「◎」;雖可觀察到黏度變化觀察不到黏 「〇/無錢性者為「X」。變紅具有流動性者為 (9) 溶劑安定性評估 321995 57 201100387 * 調製以4:1混合實施例或比較例所製造之單液性環氧 樹脂硬化性組成物與溶劑(甲苯及乙酸乙酯以及甲基乙基 酮)而成的組成物,在4〇°c之怪溫槽中保存8小時、1週、 2週,觀察不到黏度變化者為「◎」;雖可觀察到黏度變化 但具有流動性者為「〇」;無流動性者為「χ」。 [實施例1]After the spheroidal molten oxygen-cut powder is mixed and self-mixed, the curable composition of the present embodiment or the masterbatch type hardening is added to uniformly mix the mixture, whereby a sealing material can be obtained. Examples of the material for the σ coating include, for example, a covering material for covering a circuit board of an electronic material (Qven: Qai: _a 丨丨, ==, a product, an electromagnetic wave absorbing material, etc.. = 二报曰:::平四,号公告,曰本叫4W1旒公告, Japanese special Kaikai 8_6 Japanese special open _3-2 side No.8 bulletin, etc. Ejection of oxygen cut, etc. as a filling, more = body type A% oxygen resin and phenoxy resin and _ modified ring (four) \ have been formulated with this embodiment of the hardening composition or masterbatch type hardening $, then Ethyl-EK) was prepared in a 50% by mass solution. 5 〇, 曱 布 在 在 醯 醯 , , , , , , , , , , , , 在 在 在 在 在 在 在 在 在 在 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯 醯A laminate coated with a layer of oxy-resin composition. For example, the method of the present invention can be exemplified by the method described in Japanese Laid-Open Patent Publication No. Hei. No. Hei. More specifically, a di-epoxy resin is blended with chlorin, talc, etc., and then methyl isobutyl ketone (MIBK) / xylene is added. Mix to make a main agent. Among them, a coating composition can be obtained by adding the hardenability, composition or masterbatch type hardener of the present embodiment and uniformly dispersing it. For the method of producing the pre-π-material, for example, the epoxy resin composition is impregnated into the reinforcing substrate by the method described in Japanese Laid-Open Patent Publication No. Hei 9-71633, No. 98/44-17, and the like. It can be obtained by heating. The solvent of the impregnated varnish may, for example, be methyl ethyl ketone, acetone, ethyl ketone, methanol, ethanol, isopropanol or the like, and these solvents are preferably not left in the prepreg. Further, the type of the reinforcing substrate is not particularly limited, and examples thereof include paper, glass cloth, glass nonwoven fabric, aramid cloth, and liquid crystal polymer. The ratio of the resin component to the reinforcing substrate is also not particularly limited, and usually the resin portion in the prepreg is preferably 20 to 80% by mass.方法 The method of the method of producing a heat conductive material, for example, is described in JP-A-H06-136244, JP-A-10-237410, JP-A-2000-3987, and the like. More specifically, an epoxy resin as a thermosetting resin, a phenol novolac hardener as a curing agent, and a graphite powder as a heat conductive filler are blended and kneaded in a uniform manner. A thermally conductive resin paste can be obtained by blending the curable composition or the master batch type hardener of this embodiment. [Examples] Hereinafter, the present invention will be described in detail based on examples, but the present invention is not limited to the following examples. The "parts" or "%" in the examples and comparative examples are based on the quality unless otherwise stated. The physical property evaluation test of the resin of the present example and the comparative example and the cured product thereof was carried out in the following manner. (1) Particle size distribution measurement A laser diffraction type particle size distribution analyzer HEL0S/BF-M manufactured by Sakamoto Laser Co., Ltd. was used and measured by a dry method. (2) The melting point measurement was performed using a differential scanning calorimeter (DSC-60) manufactured by Shimadzu Corporation, and analyzed at a temperature rising rate of 10 ° C / min. The endothermic peak on the obtained DSC chart was used as a melting point. . (3) Quantification of low molecular weight amine compound The column in the high performance liquid chromatography (manufactured by Shimadzu Corporation, SCL-10AVP, detector SPD-10AVP; hereinafter referred to as HPLC) was Inertsil C4 manufactured by GL Sciences. The mobile phase was used in which decyl alcohol/hydrazine = 55/50 was added with sodium lauryl sulfate to become 20 mM, and phosphoric acid was added to make pH = 3 to 4. In addition, the detection wavelength was set to 230 nm. The peak area of the low molecular weight amine compound on the chart was analyzed by HPLC, and the content of the low molecular amine compound in the composition containing the fine powdery imidazole compound was quantified. (4) FT-IR measurement The absorbance was measured using a Fourier transform infrared spectrometer FT/IR-410 manufactured by Sakamoto Seiki Co., Ltd. (5) From the masterbatch type hardener, the microencapsulated composition containing the imidazole compound 56 321995 201100387 • Separation of the masterbatch type hardener is repeated with diphenylbenzene. Next, it is filtered through a loop of argon until it is free of xylene. In addition, the ring has been burned out =. The polyester and the filtration were dried to completely remove the cyclohexane. 'C below the temperature (6) Separate the capsule film from the group containing the Mickey 彳 ο ο 倾 含 含 含 含 含 含 将 将 将 将 将 将 将 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 〜 直到 直到 直到 直到 直到 直到 直到 直到Repeat the drying at the following temperature to completely remove the methanol' and then at 50 ° C (the evaluation of the hardening rate of the crucible: the gel time on the hot plate of the boot and (4) in terms of gel time Example or the epoxy resin hardenable composition 〇. 5g added to the early liquid 〇 = batching 'every few seconds to carry out - the bamboo stick from: = ::: the composition is no longer measured For bamboo _-time (four) = (8) Storage stability evaluation The single liquid product produced in the example or the comparative example is stored in 4 (TC 悝 悝 , , 经 于 于 于 于 于 于 于 于 于 于The changer is "◎"; although it can be observed that the viscosity change is not observed as "〇", "X" is used. The redness is fluid (9) Solvent stability evaluation 321995 57 201100387 * Modulation 4 :1 The single-component epoxy resin hardenable composition and solvent (toluene and ethyl acetate and methyl ethyl) produced by mixing the examples or the comparative examples The composition of the ketone was stored in a strange temperature tank of 4 ° ° C for 8 hours, 1 week, 2 weeks, and the change in viscosity was not observed as "◎"; although the viscosity change was observed but the fluidity was observed "〇"; no liquidity is "χ". [Example 1]

將1-胺基乙基-2-曱基咪唑30.0g(239. 67mm0l ;四國 化成公司製造)溶解於乙腈6〇〇mL中,一邊在室溫下攪拌’ 一邊以不使反應液溫度超出45°c之速度滴加丨,6_六亞甲 基二異氰酸酯17mL(l〇5.92mmol ;和光純藥工業公司製 造)°滴加時’開始生成白色固體,而成為漿液(slurry) 狀。滴加後,於室溫中攪拌3小時,將生成之白色固體過 濾分取並進行減壓乾燥,得到下述式(6)所示之咪唑化合物 41. 67g(收率94%)。所得咪唑化合物之鑑定係藉由質子核 磁共振光譜以及紅外線吸收光譜而進行。並且,與式(6) 所示之咪嗤化合物同時存在的低分子胺化合物係使用HPLC 並以上述(3)之方法定量。30.0 g of 1-aminoethyl-2-mercaptoimidazole (239.67 mm0; manufactured by Shikoku Chemicals Co., Ltd.) was dissolved in 6 〇〇mL of acetonitrile while stirring at room temperature to prevent the temperature of the reaction solution from exceeding At a rate of 45 ° C, ruthenium, 6-hexamethylene diisocyanate 17 mL (10 〇 5.92 mmol; manufactured by Wako Pure Chemical Industries, Ltd.) was added to form a white solid when it was added dropwise, and it became a slurry. After the dropwise addition, the mixture was stirred at room temperature for 3 hours, and the obtained white solid was filtered and dried under reduced pressure to give 41. 67 g (yield: 94%) of the imidazole compound of the formula (6). The identification of the obtained imidazole compound was carried out by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the oxime compound represented by the formula (6) is quantified by HPLC and by the method of the above (3).

H i \==J (6) 將所得白色固體以乳缽磨碎並使其通過網眼212//111 之篩而得到粗粉碎物。將所得粗粉碎物使用喷磨機 (nanojetmizer NJ-30 型;Aishin-nano technologies 公 司製造)進行粉碎’得到粒徑〇. 1/ZID以上50#m以下之比 例為100質量%且最大粒徑之微粉末狀的咪唑化合 58 321995 201100387 物。在200質量份之雙驗F型環氣樹脂 二醇末端雜質成分/基本構造成分吲.Ι3&έ氣當量175g/eq, 以下稱為「環氧樹脂(A)」)中加入微、’息氣量1900ppm: 100質量份、水1質量份、以及伸曱笨美狀之咪唑化合物 量份,在40°C下授拌並持續3小時之土〜異氰酸醋7質 °C下進行6小時之殼形成反應,得到母^其後,在50 使用二甲笨從該母料型硬化劑分 j化劑。 Ο 化合物之微膠囊化組成物,更進—3有微膠囊咪唑 FT-IR測定而確認其為具有鍵結基(χ)、刀囊膜,經由 更且,在1〇〇質量份之雙酚Α型環裊 總氣量以卿環氣== 硬化劑3°質量份時,此二液: 衣捕知硬化性組成物之硬化速度、貯藏安定性以及溶劑 安定性。將所得結果示於表i。 [實施例2] 〇 將1-胺基乙基-2-甲基咪唑30. 〇g(239. 67mmol ;四國 化成公司製造)溶解於乙腈g〇〇mL中,一邊在室溫下攪拌, 一邊以不使反應液溫度超出45¾之速度滴加異氰酸正十八 烷酯81mL(235. 74mmol;和光純藥工業公司製造)。滴加後, 於室溫中攪拌3小時,將生成之白色固體過濾分取並進行 減壓乾燥’仔到下述式(7)所示之味峻化合物93. 21g(收率 94%)。所得咪唑化合物之鑑定係藉由質子核磁共振光譜以 及紅外線吸收光譜而進行。並且,與式(?)所示之咪α坐化合 物同時存在的低分子胺化合物係使用ΗΡΐχ並以上述(3)之 59 321995 201100387 方法定量。 /=\H i \==J (6) The obtained white solid was ground in a mortar and passed through a sieve of mesh 212//111 to obtain a coarsely pulverized product. The obtained coarsely pulverized material was pulverized by a jet mill (nanojetmizer NJ-30 type; manufactured by Aishin-nano technologies Co., Ltd.) to obtain a particle diameter of 1. 1/ZID or more and 50#m or less was 100% by mass and the maximum particle diameter was Micronized imidazole compound 58 321995 201100387. In 200 parts by mass of the double-checked F-type cycloolefin resin diol terminal impurity component / basic structural component 吲. Ι 3 & έ gas equivalent 175 g / eq, hereinafter referred to as "epoxy resin (A)") 1900 ppm of gas: 100 parts by mass, 1 part by mass of water, and an imidazole compound in the form of a smattering, and the mixture is stirred at 40 ° C for 3 hours. The isocyanic acid vinegar is subjected to 6 hours at 6 ° C for 6 hours. The shell forms a reaction, and the mother is then used, and at 50, the masterbatch type hardener is used.微 The microencapsulated composition of the compound, further confirmed by micro-capsule imidazole FT-IR, which is confirmed to have a bonding group (χ), a capsular film, and further, in 1 part by mass of bisphenol When the total gas volume of the Α-type ring is 3° parts by mass of the ring gas == hardener, the two liquids: the hardening speed, the storage stability and the solvent stability of the hardening composition. The results obtained are shown in Table i. [Example 2] 1-1 1-aminoethyl-2-methylimidazole 30. 〇g (239.67 mmol; manufactured by Shikoku Chemicals Co., Ltd.) was dissolved in acetonitrile, 〇〇mL, and stirred at room temperature. 81 mL (235.74 mmol; manufactured by Wako Pure Chemical Industries, Ltd.) was added dropwise to n-octadecyl isocyanate at a rate not exceeding 453⁄4. After the dropwise addition, the mixture was stirred at room temperature for 3 hours, and the resulting white solid was collected by filtration and dried under reduced pressure to give the title compound 93. 21 g (yield 94%). The identification of the obtained imidazole compound was carried out by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the amide α-sit compound represented by the formula (?) is used and quantified by the method of the above (3) 59 321995 201100387. /=\

對所得之白色固體,以與實施例 7) 碎,得到粒徑〇.1_以上50/^以 5之操作進行粉 且最大粒徑13/zm之微粉末狀的味唾化^為100質里% 實施例1相同之作法而得到母_環ς =二以與 〇 :進亦:實r相同地確鳴具有鍵者對 7 /、實施例1相同地’在刚份之環氧樹脂⑻ 中f配所得之轉型環氧樹_硬_ 30料,評估此時 之單液性環氧樹脂硬化性組成物之硬化速度、貯藏安定性 以及溶劑安定性。將所得結果示於表1。 [實施例3] 將1-胺基乙基-2-甲基味〇坐30. 〇g(239. 67mmol ;四國 化成公司製造)溶解於乙腈600niL中,一邊在室溫下攪拌, Ο 一邊以不使反應液溫度超出45°C之速度滴加異氰酸環己酉旨 30mL(237. 28min〇l ;東京化成工業公司製造)。滴加後,於 室溫中攪拌3小時’將生成之白色固體過濾分取並進行減 壓乾燥,得到下述式(8)所示之咪唑化合物55. 24g(收率 93%)。所得咪唑化合物之鑑定係藉由質子核磁共振光譜以 及紅外線吸收光譜而進行。並且,與式(8)所示之咪唑化合 物同時存在的低分子胺化合物係使用HPLC並以上述(3)之 方法定量。 60 321995 (8 201100387 /=\ ΝνΝ^χ. 边之白色固體,以與實施例1相同之操作進行粉 碎,得到粒徑f] 1 7 . 以上50"m以下之比例為10〇質量% T = 4^111之微粉末狀的。米嗤化合物。進而,以與 Ο Ο 此方目同之作法而得到母料型環氧樹脂用硬化劑。對 n i例1相同地確認其為具有鍵結基⑴、(y)者。 尺進一步,歲會被 Φ /、包例1相同地,在100份之環氧樹脂(B) 二配传之母料型環氧樹月旨用硬化劑30份時,評估此時 之單液性%氧_旨硬化性組成物之硬化速度、貯藏安定性 以及溶劑安定性。將所得結果示於表卜 [實施例4] 將卜胺基丙基-2—甲基咪唑30.0g(215.52mmol ;四國 化成公司製造)溶解於乙腈βΟΟπ^中,一邊在室溫下攪拌, 一邊以不使反應液溫度超出45。(:之速度滴加異氰酸正十二 烷酯51mL(209. 95mmol;東京化成工業公司製造)。滴加後, 於室溫中攪拌3小時,將生成之白色固體過濾分取並進行 減壓乾燥,得到下述式(9)所示之咪唑化合物69. 18g(收率 94%)。所得咪唑化合物之鑑定係藉由質子核磁共振光譜以 及紅外線吸收光譜而進行。並且,與式(9)所示之咪唑化合 物同時存在的低分子胺化合物係使用HPLC並以上述(3)之 方法定量。The obtained white solid was pulverized in the same manner as in Example 7) to obtain a powder having a particle diameter of 11_ or more and 50/^, and the fine powder having a maximum particle diameter of 13/zm was 100-mass. In the same way as in the first embodiment, the mother _ ring ς = two is obtained in the same manner as the 〇: 亦: the same as the real r, the same as in the first embodiment, the epoxy resin in the same part (8) The transformation of the epoxy tree _ hard _ 30 material was used to evaluate the hardening speed, storage stability and solvent stability of the single-liquid epoxy resin hardening composition at this time. The results obtained are shown in Table 1. [Example 3] 1-Aminoethyl-2-methyl miso sitting 30. 〇g (239.67 mmol; manufactured by Shikoku Chemicals Co., Ltd.) was dissolved in 600 niL of acetonitrile, and stirred at room temperature, while Ο 30 mL (237.28 min〇l; manufactured by Tokyo Chemical Industry Co., Ltd.) was added dropwise to the temperature of the reaction liquid at a temperature exceeding 45 ° C. After the dropwise addition, the mixture was stirred at room temperature for 3 hours. The resulting white solid was separated by filtration and dried under reduced pressure to give an imidazole compound of the formula (8): 55. 24 g (yield: 93%). The identification of the obtained imidazole compound was carried out by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the imidazole compound represented by the formula (8) is quantified by HPLC and by the method of the above (3). 60 321995 (8 201100387 /=\ ΝνΝ^χ. The white solid of the side was pulverized in the same manner as in Example 1 to obtain a particle diameter f] 1 7 . The ratio of 50 or less than 50 m was 10 〇 mass % T = A fine powdery rice bran compound of 4^111. Further, a masterbatch type epoxy resin hardener was obtained in the same manner as in the above. This was confirmed to have a bonding group in the same manner as in the case of ni example 1. (1), (y). Further, the age will be Φ /, the same as in the case of the case 1, in 100 parts of the epoxy resin (B) two distribution of the masterbatch type epoxy resin monthly hardener 30 parts The single-liquid % oxygen at this time was evaluated as the curing rate, storage stability, and solvent stability of the curable composition. The results obtained are shown in the table [Example 4] The aminopropyl propyl-2 - 30.0 g (215.52 mmol; manufactured by Shikoku Chemicals Co., Ltd.) was dissolved in acetonitrile βΟΟπ^ and stirred at room temperature while not allowing the temperature of the reaction solution to exceed 45. 51 mL of an alkyl ester (209.95 mmol; manufactured by Tokyo Chemical Industry Co., Ltd.), and after stirring, it was stirred at room temperature for 3 hours to form The color solid was separated by filtration and dried under reduced pressure to give 69.18 g (yield: 94%) of the imidazole compound represented by the following formula (9). The obtained imidazole compound was identified by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the imidazole compound represented by the formula (9) is quantified by HPLC and by the method of the above (3).

321995 61 (9) 201100387 • 對所得之白色固體’以與實施例1相同之操作進行粉 碎,得到粒徑0. l/zm以上50# m以下之比例為1〇〇質量% 且最大粒徑13/zm之微粉末狀的咪唑化合物。進而,以與 實施例1相同之作法而得到母料型硬化劑。對此,亦與實 施例1相同地確認其為具有鍵結基(1)、(7)者。更進一步, 與實施例1相同地’在1〇〇質量份之環氧樹脂(β)中調配所 得之母料型硬化劑30質量份時,評估此時之單液性環氧樹 脂硬化性組成物之硬化速度、貯藏安定性以及溶劑安定 ^ 性。將所得結果示於表1。 [實施例5] 〇 將1-胺基丙基-2-甲基味嗤3〇.〇g(215. 52mmol ;和光 純藥工業公司製造)溶解於乙腈6〇〇mL中,一邊在室溫下攪 拌’ 一邊以不使反應液溫度超出45。(:之速度滴加基異氰酸 正十八烷酯73mL(212. 52咖〇1 ;和光純藥工業公司製造)。 滴加後,於室溫中攪拌3小時並進行減壓濃縮,將所得之 白色固體過濾分取並進行減壓乾燥,得到下述式(10)所示 之咪唑化合物86. 81g(收率94%).。所得咪唑化合物之鑑定 係藉由質子核磁共振光譜以及紅外線吸收光譜而進行。並 且’與式(10)所示之咪唑化合物同時存在的低分子胺化合 物係使用HPLC並以上述(3)之方法定量。 ν£ν321995 61 (9) 201100387 • The obtained white solid was pulverized in the same manner as in Example 1 to obtain a particle diameter of 0.1 l/zm or more and 50# m or less in a ratio of 1% by mass and a maximum particle diameter of 13 /zm of a finely powdered imidazole compound. Further, a master batch type hardener was obtained in the same manner as in Example 1. On the other hand, it was confirmed in the same manner as in Example 1 that it had the bonding groups (1) and (7). Further, in the same manner as in Example 1, when 30 parts by mass of the obtained master batch type hardener was blended in 1 part by mass of the epoxy resin (β), the hardening composition of the single-liquid epoxy resin at this time was evaluated. The hardening speed, storage stability and solvent stability of the material. The results obtained are shown in Table 1. [Example 5] 1-Aminopropyl-2-methyl miso 3 〇.〇g (215.52 mmol; manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in 6 〇〇mL of acetonitrile while being at room temperature. Stir underneath to prevent the temperature of the reaction solution from exceeding 45. (: a speed of dropwise addition of n-octadecyl isocyanate 73 mL (212. 52 Curry 1; manufactured by Wako Pure Chemical Industries, Ltd.). After dropwise addition, stirring at room temperature for 3 hours and concentration under reduced pressure, The obtained white solid was separated by filtration and dried under reduced pressure to give 86.81 g (yield: 94%) of the imidazole compound represented by the following formula (10). The obtained imidazole compound was identified by proton nuclear magnetic resonance spectroscopy and infrared ray. The absorption spectrum is carried out, and a low molecular amine compound which is present together with the imidazole compound represented by the formula (10) is quantified by HPLC and quantified by the above method (3).

Η (10) 對所得之白色固體,以與實施例1相同之操作進行粉 碎’得到粒徑0· 1 # m以上50 /z m以下之比例為100質量% 62 321995 201100387 •且最大粒徑之微粉末狀的咪唑化合物。進而,以與 實施例1相同之作法而得到母料型硬化劑。對此,亦與實 施例1相同地確認其為具有鍵結基(χ)、(y)者。更進一步, 與實施例1相同地’在100質量份之環氧樹脂(B)中調配所 得之母料型硬化劑30質量份時,評估此時之單液性環氧樹 脂硬化性組成物之硬化速度、貯藏安定性以及溶劑安定 性。將所得結果示於表1。 [實施例6] 將1-胺基丙基-2-甲基咪唑3〇.〇g(215. 52mmol ;和光 純藥工業公司製造)溶解於乙腈6〇〇mL中,一邊在室溫下攪 拌,一邊以不使反應液溫度超出45°C之速度滴加異氰酸環 己酯26mL(205. 64mmol;東京化成工業公司製造)。滴加後, 於室溫中攪拌3小時’將所得之白色固體過濾分取並進行 減壓乾燥,得到下述式(11)所示之咪唑化合物48. 38g(收 率89%)。所得咪唑化合物之鑑定係藉由質子核磁共振光譜 〇 以及紅外線吸收光譜而進行。並且,與式(11)所示之咪唑 化合物同時存在的低分子胺化合物係使用HPLC並以上述 (3)之方法定量。Η (10) The obtained white solid was pulverized in the same manner as in Example 1 to obtain a particle diameter of 0·1 # m or more and 50 / zm or less in a ratio of 100% by mass. 62 321995 201100387 • and the maximum particle diameter A powdered imidazole compound. Further, a master batch type hardener was obtained in the same manner as in Example 1. On the other hand, in the same manner as in Example 1, it was confirmed that it had a bonding group (χ) and (y). Further, in the same manner as in Example 1, when 30 parts by mass of the obtained master batch type hardener was blended in 100 parts by mass of the epoxy resin (B), the one-liquid epoxy resin curable composition at this time was evaluated. Hardening speed, storage stability, and solvent stability. The results obtained are shown in Table 1. [Example 6] 1-Aminopropyl-2-methylimidazole 3 〇.〇g (215.52 mmol; manufactured by Wako Pure Chemical Industries, Ltd.) was dissolved in 6 〇〇mL of acetonitrile while stirring at room temperature. Then, 26 mL (205.64 mmol; manufactured by Tokyo Chemical Industry Co., Ltd.) of cyclohexyl isocyanate was added dropwise at a rate such that the temperature of the reaction liquid did not exceed 45 °C. After the dropwise addition, the mixture was stirred at room temperature for 3 hours. The obtained white solid was collected by filtration and dried under reduced pressure to give the title compound (yield: 89%). The identification of the obtained imidazole compound was carried out by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the imidazole compound represented by the formula (11) is quantified by HPLC and by the method of the above (3).

對所得之白色固體,以與實施例1相同之操作進行粉 碎,得到粒徑0. 1 // m以上50 // m以下之比例為100質量% 且最大粒徑17/zm之微粉末狀的咪唑化合物。進而,以與 實施例1相同之作法而得到母料型硬化劑。對此,亦與實 63 321995 201100387 施例1相同地確認其為具有鍵結基(X)、(y)者。更進一步, 與實施例1相同地’在100質量份之環氧樹脂(B)中調配所 得之母料型硬化劑30質量份時,評估此時之單液性環氧樹 脂硬化性組成物之硬化速度、貯藏安定性以及溶劑安定 性。將所得結果示於表1。 [實施例7] 將1-胺基丙基-2-曱基咪唑30.0g(215. 52mmol ;和光The obtained white solid was pulverized in the same manner as in Example 1 to obtain a fine powder having a particle diameter of 0.1 g or more and 50 // m or less in a ratio of 100% by mass and a maximum particle diameter of 17/zm. Imidazole compound. Further, a master batch type hardener was obtained in the same manner as in Example 1. On the other hand, it was confirmed that it had the bonding groups (X) and (y) in the same manner as in Example 1 of the actual application. Further, in the same manner as in Example 1, when 30 parts by mass of the obtained master batch type hardener was blended in 100 parts by mass of the epoxy resin (B), the one-liquid epoxy resin curable composition at this time was evaluated. Hardening speed, storage stability, and solvent stability. The results obtained are shown in Table 1. [Example 7] 1-Aminopropyl-2-mercaptoimidazole 30.0 g (215.52 mmol; and light

純藥工業公司製造)溶解於乙腈600mL中,一邊在室溫了授 拌,一邊以不使反應液温度超出45°C之速度滴加丨,6—六亞 甲基一異氰酸醋17mL(105. 92丽〇1 ;和光純藥工業公司製 造)。滴加後,於室溫中攪拌3小時,將所生成之白色固體 過濾分取並進行減壓乾燥,得到下述式(12)所示之咪唑化 合物43· 99g(收率93%)。所得味嗤化合物之鑑定係藉由質 子核磁共振光譜以及紅外線吸收光譜而進行。並且,與式 (12)所示之咪唑化合物同時存在的低分子胺化合物係使用 HPLC並以上述(3)之方法定量。Dissolved in 600 mL of acetonitrile, while stirring at room temperature, while adding hydrazine, 6-hexamethylene-isocyanuric acid 17 mL at a rate that does not exceed the temperature of the reaction solution by 45 ° C ( 105. 92 Radisson 1; manufactured by Wako Pure Chemical Industries, Ltd.). After the dropwise addition, the mixture was stirred at room temperature for 3 hours, and the resulting white solid was filtered and dried under reduced pressure to give an imidazole compound (yield: 93%) of the formula (12). The identification of the resulting miso compound is carried out by proton nuclear magnetic resonance spectroscopy and infrared absorption spectroscopy. Further, a low molecular amine compound which is present together with the imidazole compound represented by the formula (12) is quantified by HPLC and by the method of the above (3).

ΟΟ

(12) 對所得之白色固體,以與實施例丨相同之操作進行粉 碎,得到粒徑〇· 1/zrn以上50/zm以下之比例為1〇〇質量% 且最大粒徑12//Π1之微粉末狀的咪唑化合物。進而,以與 實施例1相同之作法而得到母料型硬化劑。對此,亦與實 施例1相同地確認其為具有鍵結基(x)、(y)者。更進一步, 與實施例1相同地’在100質量份之環氧樹脂(幻中調配所 321995 64 201100387 得之母料型硬化劑30質量份時,評估此時之單液性環氧樹 脂硬化性組成物之硬化速度、貯藏安定性以及溶劑安定 性。將所得結果示於表1。 [實施例8] 將1-胺基丙基-2-曱基咪唑30. 0g(215. 52mmol ;四國 化成公司製造)溶解於乙腈60〇mL中,一邊在室溫下攪拌, 一邊以不使反應液溫度超出45。(:之速度滴加間-伸二甲苯 基一異氰酸酯16mL(102. 02mmol ;東京化成工業公司製 〇 造)。滴加後,於室溫中攪拌3小時,將所得之白色固體過 濾分取並進行減壓乾燥,得到下述式(13)所示之咪唑化人 物44. 27g(收率93%)。所得咪唑化合物之鑑定係藉由質; 核磁共振光譜以及紅外線吸收光譜而進行。並且,與式(^) 所示之咪唑化合物同時存在的低分子胺化合物係使用肋 並以上述(3)之方法定量。(12) The obtained white solid was pulverized in the same manner as in Example , to obtain a particle size of 〇·1/zrn or more and 50/zm or less in a ratio of 1% by mass and a maximum particle diameter of 12//Π1. A micro powdered imidazole compound. Further, a master batch type hardener was obtained in the same manner as in Example 1. On the other hand, in the same manner as in Example 1, it was confirmed that it had the bonding groups (x) and (y). Further, in the same manner as in Example 1, '100% by mass of epoxy resin (30 parts by mass of the master batch type hardener obtained by the illusion of 321995 64 201100387) was evaluated, and the single-liquid epoxy resin hardening property at this time was evaluated. The curing results of the composition, the storage stability, and the stability of the solvent. The results are shown in Table 1. [Example 8] 1-aminopropyl-2-mercaptoimidazole 30. 0 g (215.52 mmol; four countries Dissolved in 60 〇mL of acetonitrile, while stirring at room temperature, do not allow the temperature of the reaction solution to exceed 45. (:: dropwise addition of meta-xylylene monoisocyanate 16 mL (102.02 mmol; Tokyo Chemical After the dropwise addition, the mixture was stirred at room temperature for 3 hours, and the obtained white solid was separated by filtration and dried under reduced pressure to give the imidized character of the formula (13): 44. 27 g ( Yield 93%). The identification of the obtained imidazole compound was carried out by mass spectrometry; nuclear magnetic resonance spectrum and infrared absorption spectrum. Moreover, the low molecular amine compound coexisting with the imidazole compound represented by the formula (^) was The method of the above (3) is quantitative.

,所得之白色固體,以與實施例1相同之操作 碎:得到粒徑0.1P以上’㈣下之比例為 ^ 且隶大粒徑12/zm之微粉末狀的咪唑化合物。、里/〇 實施例1相同之作法而得到母料型硬化劑。對此,亦= 施例1相同地確認其為具有鍵結基(χ)、( /、實 。更進一步, 321995 65 201100387 與實施例1相同地,在1 〇 〇質量份之環氣匕 環氧樹 以及溶劑安定 得之母料型硬㈣30質量份時,評估此時^^⑻中調配所 早液性 脂硬化性組成物之硬化速度、貯藏安定性 性。將所得結果示於表1。 [實施例9] 在實施例5中,除了使用甘油2 5暂® ^ ^ 買蕙份以取代水1 質量份之外,其餘以相同做法進行殼形忐 〜珉反應,得到母料 Ο 型硬化劑。對此,亦與實施例1相同地,經ft_IR測定而 確認其為具有鍵結基(X)、(y)、(z)者。更進—步,與實施 例1相同地,在100質量份之環氧樹脂⑻中調=所得之母 料型硬化㈣0質量㈣’評估㈣之單贿環氧樹脂硬化 性組成物之硬化速度、貯藏安定性以及溶劑安定性。將所 得結果示於表1。 [實施例10] 將曱基丙烯腈67. 09g(5mol ;和光純藥工業公司製造) ❹ 以及乙醇鈉〇. 68g(0. Olmol ;和光純藥工業公司製造)溶解 於N,N-二甲基甲酿胺1500mL中,一邊在1〇〇。〇下撲拌,一 邊滴加2-甲基咪唾82. 10g(lmol;和光純藥工業公司製 造)。滴加後’攪拌4小時。將所得反應溶液進行減壓蒸餾 精製,得到下述式(14)所示之1-(2-氰基丙基)-2-甲基咪 唑。然後,在高壓釜中饋入1-(2-氰基丙基)-2-曱基咪唑 74. 60g(〇. 5mol)、作為溶媒之2-丙醇200g以及展開鈷觸 媒(川研精密化學公司製造;ODHT-60)15g。其次,將反應 器内之氫的壓力設為3. 92MPa,在100°C下反應3小時。反 66 321995 201100387 • 應後,經抽引過濾而濾除觸媒後,將反應溶液進行減壓蒸 餾精製,得到下述式(15)所示之1-(1-胺基-2-甲基丙基) -2-甲基咪唑。繼而,將1-(卜胺基-2-甲基丙基)一2一甲基 咪唑30. 0g(196mmol)溶解於乙腈600mL中,一邊於室溫下 攪拌,一邊以不使反應液溫度超出45°C之速度滴加異氰酸 正十八烷酯57. 3g(194mmoI ;和光純藥工業公司製造)。滴 加後,於室溫中攪拌3小時,將所生成之白色固體過濾分 取並進行減壓乾燥,得到下述式(16)所示之咪唑化合物 78. 30g(收率90%)。所得咪唑化合物之鑑定係藉由質子核 磁共振光譜以及紅外線吸收光譜而進行。The obtained white solid was crushed in the same manner as in Example 1 to obtain an imidazole compound having a particle diameter of 0.1 P or more and a ratio of (4) to a fine powder of 12/zm. In the same manner as in Example 1, a master batch type hardener was obtained. On the other hand, the same as in the case of Example 1, it was confirmed that it had a bonding group (χ), (/, and real. Further, 321995 65 201100387, in the same manner as in Example 1, the ring gas ring of 1 part by mass was used. When the oxygen tree and the solvent-prepared masterbatch type were hard (4) 30 parts by mass, the curing rate and storage stability of the early liquid fat-curing composition prepared in the above (8) were evaluated. The results obtained are shown in Table 1. [Example 9] In Example 5, except that glycerin 2 5 was used to buy hydrazine to replace 1 part by mass of water, the shell-like 忐-珉 reaction was carried out in the same manner to obtain a masterbatch type 硬化 type hardening. In the same manner as in Example 1, it was confirmed by ft_IR that it had the bonding groups (X), (y), and (z). Further, in the same manner as in Example 1, 100 parts by mass of epoxy resin (8) Middle adjustment = obtained masterbatch type hardening (4) 0 mass (4) 'Evaluation (4) Hardening speed, storage stability and solvent stability of the single brittle epoxy resin hardening composition. Table 1. [Example 10] Amidoxime acrylonitrile 67. 09g (5mol; manufactured by Wako Pure Chemical Industries, Ltd. ) ❹ and sodium ethoxide 〇. 68g (0. Olmol; manufactured by Wako Pure Chemical Industries, Ltd.) is dissolved in 1500 mL of N,N-dimethylamine, while stirring at 1 〇〇 - Methyl iodide 82. 10 g (1 mol; manufactured by Wako Pure Chemical Industries, Ltd.). After the dropwise addition, the mixture was stirred for 4 hours. The obtained reaction solution was subjected to distillation under reduced pressure to obtain 1-(1) represented by the following formula (14). 2-cyanopropyl)-2-methylimidazole. Then, 1-(2-cyanopropyl)-2-mercaptoimidazole 74. 60g (〇. 5mol) was fed into the autoclave as a solvent. 200 g of 2-propanol and 15 g of developed cobalt catalyst (manufactured by Kasei Precision Chemical Co., Ltd.; ODHT-60). Next, the pressure of hydrogen in the reactor was set to 3.92 MPa, and the reaction was carried out at 100 ° C for 3 hours. 66 321995 201100387 • After the catalyst is filtered off by suction filtration, the reaction solution is subjected to vacuum distillation to obtain 1-(1-amino-2-methylpropane represented by the following formula (15). 2-methylimidazole. Then, 1-(i-amino-2-methylpropyl)-2-methylimidazole 30. 0 g (196 mmol) was dissolved in 600 mL of acetonitrile and stirred at room temperature. One side does not make the reaction solution 5 g (194 mmoI; manufactured by Wako Pure Chemical Industries, Ltd.) was added dropwise at a rate of 45 ° C. After the dropwise addition, the resulting white solid was filtered by stirring at room temperature for 3 hours. The fractionated and dried under reduced pressure gave 78.30 g (yield: 90%) of the imidazole compound represented by the following formula (16). The identification of the obtained imidazole compound was carried out by proton nuclear magnetic resonance spectrum and infrared absorption spectrum.

對所得之白色固體,以與實施例1相同之操作進行粉 ) •丄Am以上50/zm以下之比例為1〇〇質量%The obtained white solid was subjected to the same operation as in Example 1) • The ratio of 丄Am to 50/zm or less was 1% by mass.

碎,得到粒徑〇.;[ 且最大粒徑15#m 實施例1相同之个 321995 67Broken to obtain particle size 〇.; [and maximum particle size 15#m the same as in Example 1 321995 67

201100387 * 硬化速度、貯藏安定性以及溶劑安定性。將所得結果示於 表1〇 [實施例11] 將 丁稀腈(allyl Cyanide)67. 09g(5mol ;和光純藥 工業公司製造)以及乙醇鈉〇. 68g(〇. 〇lm〇1 ;和光純藥工業 公司製造)溶解於N,N-二甲基甲醯胺i5〇〇mL中,一邊在100 C下擾拌’一邊滴加2_甲基咪唑82. 1〇g(lm〇1 ;和光純藥 工業公司製造)。滴加後’攪拌2小時。將所得反應溶液進 行減>1蒸館精製’得到下述式(17)所示之1_氰基丙基_2〜 曱基咪唑。然後,在高壓釜中饋入卜氰基丙基_2_甲基咪 唑74. 60g(0. 5mol)、作為溶媒之2-丙醇2〇〇g以及展開鈷 觸媒(川研精密化學公司製造;ODHT_6〇)15g。其次,將反 應器内之氫的壓力设為3. 92MPa,在l〇(Tc下反應3小時。 ,應後,經抽引過濾而據除觸媒後,將反應溶液進行減壓 療顧精製’得到下述式(18)所示《卜胺基丁基_2_甲基味 唑。繼而,將卜胺基丁基_2_甲基咪錢〇g⑽丽〇1)溶 解於乙腈_mL中,-邊於室溫下祕,—邊以不使反應 液溫度超出45T:之速料加異級正权㈣57 3g⑽ 和光純藥工業公司製造卜滴加後,於室 切,將射成之自色_聽分取朗㈣錄燥,得 至^下述式⑽所不之㈣化合物75為(收率_。 :唾化合物之就賴由質子核磁共振料以及紅外線吸 收光譜而進行。 321995 68 7 201100387201100387 * Hardening speed, storage stability and solvent stability. The results obtained are shown in Table 1 [Example 11] lyl Cyanide 67. 09 g (5 mol; manufactured by Wako Pure Chemical Industries, Ltd.) and sodium ethoxide oxime. 68 g (〇. 〇lm〇1; and pure light 〇 〇 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 82 Wako Pure Chemical Industries Co., Ltd.). After the dropwise addition, the mixture was stirred for 2 hours. The obtained reaction solution was reduced by > 1 steaming to obtain 1-cyanopropyl-2~nonylimidazole represented by the following formula (17). Then, 74.60 g (0.5 mol) of cyanopropyl-2-methylimidazole, 2 〇〇g of 2-propanol as a solvent, and cobalt catalyst were introduced into the autoclave (Kawasei Precision Chemical Co., Ltd.) Manufactured; ODHT_6〇) 15g. Next, the pressure of the hydrogen in the reactor was set to 3.92 MPa, and the reaction was carried out for 3 hours at 10 ° C. After the reaction, the reaction solution was subjected to decompression treatment after extraction and filtration. 'Aminoamine -2-methylisoxazole represented by the following formula (18) is obtained. Then, acetobutyl-2-methyl ketone g (10) 〇 1) is dissolved in acetonitrile _mL Medium, - at the room temperature secret, - do not let the temperature of the reaction liquid exceed 45T: the speed of the material plus the same level of positive power (four) 57 3g (10) and the pure pharmaceutical industry company made the drop, after the chamber cut, will shoot into Self-coloring _ listening to the lang (4) recording dryness, obtained by the following formula (10) (4) Compound 75 is (yield _. : The salic compound is carried out by proton NMR materials and infrared absorption spectrum. 321995 68 7 201100387

N 1 (18)N 1 (18)

V 19) o 對所得之白色固體,以與實施例丨相同之操作進行粉V 19) o The resulting white solid was subjected to the same operation as in Example 进行

G ❹ 碎,得到粒徑〇.丨以上50//Π!以下之比例為1〇〇質量0/ί 且最大粒徑W/zm之微粉末狀的咪唑化合物。進而,以與 實施例1相同之作法而得到母料型硬化劑。對此,亦與實 施例1相同地確認其為具有鍵結基(x)、(y)者。更進一步, 在100質量份之環氧樹脂(B)中調配所得之母料型硬化劑 30質1份時,評估此時之單液性環氧樹脂硬化性組成物之 硬化速度、貯藏安定性以及溶定性。將所得結果示於 表1。 [比較例1 ] 所得之式⑺表示的微粉末狀之_ 量份份之環氧_(A)與1_質 性組成物之硬化^、Μ — w夜叫氧樹脂硬化 得結果示於表1 X騎劑安定性。將戶月 [比較例2] 將又酚A型環氧樹脂(旭化成化學製造.脔σ々y 「AER-2603」)19 以月m , k,商品名稱 〇g以及2—乙基_4'甲基味唾(四國化成工 321995 69 201100387 •業公司製造;商品名稱「_2」川⑽容解於甲基乙基 酮20mL之後’進行加熱反應’得到抓下為固體狀之胺 加成體。將該胺加成體100質量份進行熔融,於其中將2.5 質量份之2-乙基-4-甲基味詞句混合,冷卻至室溫後, 與實施例1相同進行粉碎,得到母料型硬化劑。對此,亦 與實施例1相同地確認其為具有鍵結基⑴、(y)、(z)者。 更進-步,與實施例1相同地,在1〇〇質量份之環氧樹月旨 (B)中調配所得之母料型硬化劑3〇質量份時,評估此時之 單液性環氧樹脂硬化性組成物之硬化速度、貯藏安定性以 及溶劑安定性。將所得結果示於表1。 [表1] 實施例 1 實施例 2 實施例 3 實施例 4 實施例 5 實施例 6 實施例 7 實施例 8 實施例 Θ 實施例 10 實施例 11 咪唑化合物之融點 140至 89 JL 171至 70至 76至 90至 110至 95至 76至 70至 70至 147t 98eC 174t 76t 89〇C 95eC 125t 120*C 89*C 90Χ: 90t 低分子胺化合物之含量 500ppm lOOOppot lOOOppiD ΙΟΟΟρρβ ΙΟΟΟρρη 2000ppn 500ρρη 500{φ〇 ΙΟΟΟρρη ΙΟΟΟρρη ΙΟΟΟρρη 硬化速度(140·〇 21秒 24秒 19秒 18秒 18秒 16秒 19秒 22秒 18秒 17秒 17秒 硬化速度(loot:) 600秒社 417秒 503秒 225秒 240秒 138秒 249秒 245秒 235秒 230秒 233秒 貯藏安定性(4010、8小時) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ 貯藏安定性(4tnc、1遇) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ 貯藏安定性(40*0、2週) ◎ ◎ 0 0 ◎ 〇 ◎ ◎ ◎ ◎ ◎ 溶劑安定性(甲笨) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ 溶剤安定性(乙酸乙酯) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ 溶劑安定k(甲基乙基酮) ◎ ◎ 〇 〇 ◎ 〇 ◎ ◎ ◎ ◎ ◎G ❹ , , , , , , , , , , , , , , , 丨 丨 丨 丨 丨 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下 以下. Further, a master batch type hardener was obtained in the same manner as in Example 1. On the other hand, in the same manner as in Example 1, it was confirmed that it had the bonding groups (x) and (y). Further, when 100 parts by mass of the obtained master batch type hardener is blended in 100 parts by mass of the epoxy resin (B), the hardening speed and storage stability of the single-component epoxy resin curable composition at this time are evaluated. And solubility. The results obtained are shown in Table 1. [Comparative Example 1] The results of the micro-powder-formed epoxy_(A) represented by the formula (7) and the hardening of the 1_mass composition, Μ-w night called oxygen resin, are shown in the table. 1 X riding stability. Households [Comparative Example 2] A phenol A type epoxy resin (made by Asahi Kasei Chemicals Co., Ltd. 脔σ々y "AER-2603") 19 in months m, k, trade name 〇g and 2-ethyl _4' Methyl-flavored saliva (Four countries into 32936 69 201100387 • manufactured by the company; trade name “_2” Chuan (10) is dissolved in methyl ethyl ketone 20mL and then 'heated reaction' to obtain a solid amine adduct 100 parts by mass of the amine addition product was melted, and 2.5 parts by mass of 2-ethyl-4-methyl taste was mixed therein, and after cooling to room temperature, it was pulverized in the same manner as in Example 1 to obtain a master batch. In the same manner as in Example 1, it was confirmed that it had the bonding groups (1), (y), and (z). Further, in the same manner as in Example 1, it was 1 part by mass. In the case of the masterbatch type hardener obtained by blending the epoxy resin in (B), the curing rate, storage stability, and solvent stability of the single-component epoxy resin curable composition at this time were evaluated. The results obtained are shown in Table 1. [Table 1] Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Example 7 Example 8 Example 实施 Example 10 Example 11 Melting point of imidazole compound 140 to 89 JL 171 to 70 to 76 to 90 to 110 to 95 to 76 to 70 to 70 to 147 t 98eC 174t 76t 89 〇C 95eC 125t 120* C 89*C 90Χ: 90t low molecular amine compound content 500ppm lOOOOppot lOOOOppiD ΙΟΟΟρρβ ΙΟΟΟρρη 2000ppn 500ρρη 500{φ〇ΙΟΟΟρρη ΙΟΟΟρρη ΙΟΟΟρρη hardening speed (140·〇21 seconds 24 seconds 19 seconds 18 seconds 18 seconds 16 seconds 19 seconds 22 seconds 18 Second 17 seconds 17 seconds hardening speed (loot:) 600 seconds 417 seconds 503 seconds 225 seconds 240 seconds 138 seconds 249 seconds 245 seconds 235 seconds 230 seconds 233 seconds storage stability (4010, 8 hours) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Storage stability (4tnc, 1 case) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Storage stability (40*0, 2 weeks) ◎ ◎ 0 0 ◎ 〇 ◎ ◎ ◎ ◎ ◎ Solvent stability ( ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ 剤 剤 stability (ethyl acetate) ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ ◎ Solvent stability k (methyl ethyl ketone) ◎ ◎ 〇〇 ◎ 〇 ◎◎ ◎ ◎

70 321995 201100387 -[表 2]70 321995 201100387 -[Table 2]

比較例1 比較例2 咪唑化合物之融點 89 至 98°C 58 至 72t 低分子胺化合物之含量 lOOOppm 30000ρρπι 硬化速度(140°C) 23秒 25秒 硬化速度(100°C) 435秒 600秒以上 貯藏安定性(40°C、8小時) 〇 ◎ 貯藏安定性(40°C、1週) X ◎ 貯藏安定性(40°C、2週) X ◎ 溶劑安定性(甲苯) 〇 ◎ 溶劑安定性(乙酸6酯) 〇 〇 溶劑安定性(甲基乙基鲷) 〇 -1---. XComparative Example 1 Comparative Example 2 Imidazole compound melting point 89 to 98 ° C 58 to 72 t Low molecular amine compound content 1000 ppm 30000ρρπι Hardening speed (140 ° C) 23 seconds 25 seconds Hardening speed (100 ° C) 435 seconds 600 seconds or more Storage stability (40 ° C, 8 hours) 〇 ◎ Storage stability (40 ° C, 1 week) X ◎ Storage stability (40 ° C, 2 weeks) X ◎ Solvent stability (toluene) 〇 ◎ Solvent stability (6 acetate acetate) 〇〇 Solvent stability (methyl ethyl hydrazine) 〇-1---. X

[導電性膜之製作] 將雙酚A型環氧樹脂(旭化成化學製造;商品名稱 「AER-2603」)15質量份、酚酚醛清漆樹脂(昭和高分子八 司製造;商品名稱「BRG-558」)6質量份以及合成橡膠(二 本Zeon公司製造;商品名稱「NIP0L 1072」、重量平均八 〇 子量3〇萬)4質量份溶解於質量比為1 : 1之甲基乙美 丁基溶纖素乙酸酯的混合溶劑20質量份中。在該溶液中二 合銀粉末74質量份,進一步以三軸輥進行混練。於其中 添加實施例7所得之母料型硬化劑3〇質量份,再使之均= 混合而得到導電性接著劑。使用所得之導電性接著劑 厚度40之聚丙烯膜上進行澆鑄,在8(TC以60分鐘使 之乾燥半硬化,得到具有厚度35# m之導電性接著劑層的 導電性膜。使用該導電性膜,在8(TC之乾熱板(heat block) 上’使石夕晶圓(silicon wafer)之背面的導電性接著劑層轉 71 321995 201100387 • 印在導電性膜上。再將矽晶圓進行全切割,在乾熱板上使 附有導電性接著劑之半導體晶片(Chip)與導線2〇〇 °C、2分鐘之條件進行接著硬化後’並無晶片之導電性的 問題。 [導電性膏之製作] 在100質量份之環氧樹脂(環氧當量189g/eq,總氣量 1200Ppm:以下稱為「環氧樹脂(C)」)中,添加實施例7所 得之母料型硬化劑30質量份、平均粒徑u (aspect ratio)為11之鱗片狀銀粉(德力化學研究所(股) 製造)150g、以及平均粒徑ΙΟ/zra且長寬比為9之鱗片狀錄 粉(高純度化學(股)製造;商品名稱「NIli〇1〇4」)6〇g,’' 拌至均勻後以三軸輥均勻分散,得到導電膏。將所得§導電 膏在厚度1.4mm之聚醯亞胺膜基板上進行網版印刷後,在 200°C下以1小時加熱硬化。測定所得配線板之導電性的妗 果’為可適合使用之導電性膏。 % 〇 [異方導電性膜之製作] 將雙酚A型環氧樹脂(旭化成化學製造;商品名稱「A跺 _」’環氧當量425GGg/eq)4G質量份、苯氧樹脂(東都化 成製造;商品名稱「YP-50」)30質量份溶解於乙酸乙酉旨3〇 伤中,於其中,添加實施例1所得母料型硬化劑質量广 以及粒徑之導電粒子(經施行鍍金之交聯聚笨乙烯& 質量份並均勻混合,得到單液性環氧樹脂組成物。將其塗 佈在聚_上並在70t:下將乙酸乙6旨乾燥去除,得到異 導電性膜。 、 321995 72 201100387 ' 將所得異方導電性膜夾在1C晶片與電極間,在200t: 之熱板上以30kg/cm2進行20秒鐘之熱壓合,其結果係使電 極間接合、導通而適合作為異方導電性材料使用。 [異方導電性膏之製作] 將雙酚A型環氧樹脂(旭化成化學製造;商品名稱「AER 6091」,環氧當量480g/eq)50質量份、雙酚A型環氧樹脂(旭 化成化學製造;商品名稱「AER 2603」)50質量份與作為 導電粒子之「micropearl Au-205」(積水化學製造;比重 η 2. 67)5質量份混合後,添加實施例7所得之母料型硬化劑 30質量份’再加以均勻混合,得到異方導電性膏。將所得 異方導電性膏塗佈在具有ΙΤ0電極之低鹼性玻璃上。使用 230°C之陶瓷工具(ceramic tool),在30秒中以2MPa之壓 力與試驗用TAB(Tape Automated Bonding,帶式自動接合) 膜壓合,而進行貼合。測定鄰接之IT0電極間的電阻值, 係適合作為異方導電性膏者。 Q [絕緣性膏之製作] 將雙酚F型環氧樹脂(Yuka-Shell Epoxy(股)製造;商 品名稱「YL983U」)100質量份、雙氰胺4質量份、氧化矽 粉末100質量份、作為稀釋劑之苯基縮水甘油醚10質量 份、以及有機磷酸酯(曰本化藥公司製造;商品名稱「PM-2」) 1質量份充分混合後,再以三軸輥進行混練。更進一步, 於其中添加實施例7所得之母料型硬化劑30質量份,再使 之均勻混合,進行減壓脫泡以及離心脫泡處理而製得絕緣 性膏。使用所得絕緣性膏,在2〇(TC下加熱硬化1小時而 321995 73 201100387 將半導體Βθ片接著至樹脂基板,係適合作為絕緣性膏者。 [絕緣性膜之製作.] 將苯氧樹脂(東都化成(股)製造;商品名稱「γρ_5〇」) 18〇質量份、甲酚酚醛清漆型環氧樹脂(環氧當量2〇〇g/ eq,日本化藥(股)製造;商品名稱「EOCN-1020-80」)40 =量份、球狀氧化矽(平均粒徑·· 2/zm,Admatechs(股)製 這,商品名稱「SE-5101」)300質量份、甲基乙基酮2〇〇 〇 質量份予以調合並均勻分散後,於其中添加實施例7所得 之母料型硬化劑250質量份,再進行授拌、混合後,得到 含有環氧樹脂組成物之溶液。將所得溶液塗佈在經施行脫 模處理之聚對苯二甲酸乙二醋上並使乾燥後之厚度成為5〇 _’然後在熱風循環式乾賴中進行加燥,得到半導 體接著用之絕緣性膜。將所得半導體接著用之絕緣性膜, 以包含其支樓基材之形式-域切成大於5叶晶圓之大 J在附有凸塊(bumP)電極之晶圓的電極部侧調整樹脂 〇膜。其次,於上方夹著附有脫模處理之支撐基材,並於70 °C、IMPa下、加壓時間10秒鐘在真空中進行加熱壓合, 得到附有接著樹脂之晶圓。然後,使用切刻鋸(dicing沾幻 (DISCO 製造;DAD-2H6M),以轉軸(spindle)轉數 3〇,〇〇〇 rpm、切割速度2〇mm/秒切割分離成個片,觀察到附有接著 膜之半導體元件的樹脂不會從該個片上剎離。所得之膜 適合作為絕緣性膜者。 、' [密封材之製作] 將雙酚A型環氧樹脂(旭化成化學製造;商品名稱「八肫 321995 74 201100387 _ι」’環氧當量侧g/eq)5〇f量份、雙齡 化成化學製诰.侖σ々β「 衣乳樹月日(旭 ^ 、,商σ口名稱ΑΕΚ 2603」)50質量份、作為 ”之以鄰笨二甲酸酐為主成分的「 化 成工業(股)製造)4。質量份、以及平均 」(= 熔融氧化矽8〇皙旦於& — a 私ω之球狀 施例7所得之母^刀廊/丁句勻分散、調配。於其中添加實 物。將所r ^ 劑5質量份,得到環氧樹月旨組成 ο 、t %氧樹月旨組成物在印刷電路基板上 =正方狀並使其厚度成為_,於靴=長 熱^分鐘使其半硬化。然後,將厚度37—、邊^ 之 狀之矽晶片置於半硬化之環卜 m 重量而使凸塊鱼曰片… 樹曰成物上,施加 d、样、隹〜"日片電極接觸並予以保持,在22『C以1 全硬化處理。ώ得狀縣賴㈣物所構# 「的二封/係外觀及晶片之導通毫無問題的有用之物。構成 [塗佈材之製作][Production of Conductive Film] 15 parts by mass of bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name "AER-2603"), phenol novolac resin (made by Showa Polymer Co., Ltd.; trade name "BRG-558" ") 6 parts by mass and synthetic rubber (manufactured by two Zeon companies; trade name "NIP0L 1072", weight average scorpion amount 30,000) 4 parts by mass dissolved in a mass ratio of 1:1 methyl methacrylate The mixed solvent of the cellulose acetate is 20 parts by mass. In this solution, 74 parts by mass of silver silver powder was further kneaded by a triaxial roll. To the mixture, 3 parts by mass of the master batch type hardener obtained in Example 7 was added, and the mixture was uniformly mixed to obtain a conductive adhesive. Casting was carried out using a polypropylene film having a thickness of 40 of the obtained conductive adhesive, and dried by semi-curing at 8 (TC for 60 minutes to obtain a conductive film having a conductive adhesive layer having a thickness of 35 # m. The film, on the 8 (TC dry block), makes the conductive adhesive layer on the back side of the silicon wafer turn 71 321995 201100387 • Printed on the conductive film. The circle was fully cut, and the semiconductor wafer with the conductive adhesive was placed on the dry hot plate with the wire 2 ° C for 2 minutes, followed by hardening, and there was no problem of the conductivity of the wafer. Preparation of Conductive Paste] In 100 parts by mass of epoxy resin (epoxy equivalent: 189 g/eq, total gas volume: 1200 Ppm: hereinafter referred to as "epoxy resin (C)"), the master batch type hardening obtained in Example 7 was added. 30 parts by mass of a scaly silver powder having an average particle diameter u (aspect ratio) of 11 (manufactured by Deli Chemical Research Co., Ltd.) 150 g, and a scale-like recording powder having an average particle diameter ΙΟ/zra and an aspect ratio of 9. (Manufacture of high purity chemistry (stock); trade name "NIli〇1〇4") 6 g,'' After mixing evenly, it is uniformly dispersed by a triaxial roll to obtain a conductive paste. The obtained § conductive paste is screen-printed on a 1.4 mm thick polyimine film substrate, and then at 200 ° C for 1 hour. Heat-hardening. The result of measuring the conductivity of the obtained wiring board is a conductive paste which can be suitably used. % 〇 [Production of an anisotropic conductive film] A bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemical Co., Ltd.; A跺_"'epoxy equivalent 425GGg/eq) 4G parts by mass, phenoxy resin (manufactured by Tohto Kasei Co., Ltd.; trade name "YP-50"), 30 parts by mass, dissolved in acetic acid, acetaminophen The master batch-type hardener obtained in Example 1 has a wide mass and a conductive particle of a particle size (cross-linked polystyrene & mass parts by gold plating and uniformly mixed to obtain a one-component epoxy resin composition. The upper conductive film was dried and removed at 70t: to obtain a heteroconductive film. 321995 72 201100387 'The obtained heteroconductive film was sandwiched between the 1C wafer and the electrode, and 30 kg on a 200t: hot plate. /cm2 for 20 seconds of hot pressing, the result is It is suitable for use as an anisotropic conductive material for inter-electrode bonding and conduction. [Production of Heterogeneous Conductive Paste] Bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name "AER 6091", epoxy equivalent 480g/eq 50 parts by mass of bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name "AER 2603") 50 parts by mass and "micropearl Au-205" (made by Sekisui Chemical Co., Ltd.; specific gravity η 2. 67) as conductive particles After the mass parts were mixed, 30 parts by mass of the master batch type hardener obtained in Example 7 was added and uniformly mixed to obtain an isotropic conductive paste. The resulting heteroconductive paste was applied to a low alkali glass having a ΙΤ0 electrode. The film was bonded by pressurization with a test TAB (Tape Automated Bonding) film at a pressure of 2 MPa for 30 seconds using a ceramic tool at 230 °C. The resistance value between the adjacent IT0 electrodes is measured, and it is suitable as an anisotropic conductive paste. Q [Production of Insulating Paste] 100 parts by mass of bisphenol F type epoxy resin (manufactured by Yuka-Shell Epoxy Co., Ltd.; trade name "YL983U"), 4 parts by mass of dicyandiamide, 100 parts by mass of cerium oxide powder, 10 parts by mass of phenyl glycidyl ether as a diluent, and 1 part by mass of an organic phosphate (manufactured by Sakamoto Chemical Co., Ltd.; trade name "PM-2") were sufficiently mixed, and then kneaded by a triaxial roll. Further, 30 parts by mass of the master batch type hardener obtained in Example 7 was added thereto, and the mixture was uniformly mixed, and subjected to vacuum degassing and centrifugal defoaming treatment to obtain an insulating paste. Using the obtained insulating paste, it is suitable for use as an insulating paste by heat-hardening for 2 hours at TC and 321995 73 201100387. The film is suitable as an insulating paste. [Production of Insulating Film.] Phenoxy Resin ( Dongdu Chemical Co., Ltd.; trade name “γρ_5〇”) 18〇 parts by mass, cresol novolac type epoxy resin (epoxy equivalent 2〇〇g/eq, manufactured by Nippon Kayaku Co., Ltd.; trade name “EOCN -1020-80") 40 = Quantitative, spherical cerium oxide (average particle size · 2 / zm, manufactured by Admatechs Co., Ltd., trade name "SE-5101") 300 parts by mass, methyl ethyl ketone 2 After the mass fraction was adjusted and uniformly dispersed, 250 parts by mass of the master batch type hardener obtained in Example 7 was added thereto, and the mixture was mixed and mixed to obtain a solution containing the epoxy resin composition. It is coated on the polyethylene terephthalate subjected to the release treatment and the thickness after drying is 5 〇 ′′, and then dried in a hot air circulation type to obtain an insulating film for semiconductor use. The resulting semiconductor is followed by an insulating film, The form including the base material of the branch is cut into a larger than 5 leaf wafers. The resin film is adjusted on the side of the electrode portion of the wafer with the bump (bumP) electrode. The support substrate is molded and heated and pressed in a vacuum at 70 ° C, IMPa, and pressurization time for 10 seconds to obtain a wafer with a resin attached thereto. Then, using a dicing saw (dicing Made by DISCO; DAD-2H6M), cut into a piece with a spindle rotation of 3 〇, 〇〇〇 rpm, cutting speed of 2 〇 mm / sec, and observed that the resin with the semiconductor element attached to the film does not The film is suitable for use as an insulating film. '[Production of sealing material] A bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name "八肫321995 74 201100387 _ι"' epoxy Equivalent side g/eq) 5〇f parts, two-year-old chemical system 诰. 々σ々β "Women's tree month (Xu ^, 、, σ mouth name ΑΕΚ 2603)) 50 parts by weight, as Manufactured by Huacheng Industrial Co., Ltd., which is mainly composed of phthalic anhydride, 4. parts by mass, and average (= fused矽 〇皙 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 The composition of the tree ○, t% oxygen tree composition on the printed circuit board = square shape and its thickness becomes _, semi-hardened in the shoe = long heat ^ minutes. Then, the thickness 37 -, side ^ The shape of the wafer is placed in the semi-hardened ring, and the weight of the ring is made to make the bumps of the fish. On the tree, the d, the sample, the 隹~" the contact of the electrode is held and held at 22"C 1 Full hardening treatment. ώ 状 赖 赖 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四 四

G 氧樹脂(C)30質量份、苯氧樹脂30質量份(東都 ^股)製造心名y份、以及 工業(股)m樹脂的甲基乙基_液(荒,"化學 菜UO錢,商w口名稱「c〇聊ce刪」) 中,添加實施例1所得夕β 重伤 . 斤仲之母料型硬化劑30質量份,再以甲 混合而調製成5嶋之溶液。將所調: 之命液讀塗機塗佈在♦ (PAMCC股)製造;商品名γ對本一甲^乙一酉曰)媒 分鐘使之錢、硬化,^^1」)上,在職下以15 半硬化樹脂(乾膜)。將離膜之膜厚10—的 竹邊專乾膜在之前的覆銅積層扳上在 321995 75 201100387 .12代下以6MPa進行1G分鐘之熱壓合後,使其回復到室、、田 並去除剝離膜,在200。〇下使其硬化2小時後,得到 作為層間絕緣膜用塗佈材者。 、 [塗料組成物之製作] 在雙酚A型環氧樹脂(旭化成化學製造;商品名稱「处尺 =91」,環氧當量480g/eq)50質量份中調配二氧化鈦3〇質 1份與滑石70質量份,並添加作為混合溶劑之曱基異丁美 0酮(ΜΙβΚ)/二甲苯為1 : K質量比)的混合溶劑140質量份, 加以攪拌、混合而作為主劑。於其中添加實施例7所得之 母料型硬化劑30質量份,經由使之均勻分散,而得到適合 作為環氧樹脂組成物者。 [預浸物之製作] 在130C之油浴中的燒瓶内,將酚醛清漆型環氧樹脂 (大日本印墨化學工業製造;商品名稱 貝量份、雙酚F型環氧樹脂(JER製造;商品名稱「EPIK0TE ❹ 4005」M0質量份、雙酚A型液狀環氧樹脂(旭化成化學製 ,商品名稱「AER 2603」)30質量份進行溶解、混合並 冷部至80°C。再添加實施例7所得之母料型硬化劑15質 量份並充分攪拌、混合。將冷卻至室溫之上述樹脂組成物 使用刮刀在脫模紙上以樹脂密度162g/m2進行塗佈而作成 樹脂膜。其次,在該樹脂膜上疊上將彈性率24噸/mm2之碳 纖維以12.5條/吋進行平織而成的三菱嫘縈製造的CF布 (型號:TR3110,密度20(^/1112),並使樹脂組成物含浸於碳 纖維布後,疊上聚丙稀膜並通過表面溫度90 °C之對輥之 76 321995 201100387 • 間,而製作成布質預浸物。樹脂之含有率為45質量%。使 所得預浸物與纖維方向一致後再加以層積,以硬化條件15〇 °C、1小時進行成形,可得到以碳纖維作為強化纖維之FRP 成形體,所製作之預浸物為有用者。 [導熱性環氧樹脂組成物之製作] 將雙紛A型環氧樹脂(旭化成化學製造;商品名稱rAER 2603」)100質量份、作為環氧樹脂用硬化劑之酚酚醛清漆 〇 樹脂(荒川化學工業(股)製造;商品名稱「Tamanol」)之甲 基乙基酮50%溶液40質量份、鱗月狀石墨粉末(Uni〇nG Oxygen resin (C) 30 parts by mass, phenoxy resin 30 parts by mass (East), manufacturing name y, and industrial (strand) m resin methyl ethyl _ liquid (wild, " chemical dish UO money In the name of the quotient of the quotient of the quotient of the quotient, the addition of 30 parts by mass of the masterbatch type hardener obtained in Example 1 was carried out, and then mixed with a solution to prepare a solution of 5 Torr. The adjustment: The life liquid reading applicator is coated on ♦ (PAMCC stock); the product name γ is on the one-to-one ^ 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 分钟 使 分钟 使 、 ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ Semi-hardened resin (dry film). The bamboo edge special film of the film thickness of the film is placed on the previous copper-clad laminate on the 321995 75 201100387 .12 generation and heat-pressed at 6 MPa for 1G minutes, and then returned to the chamber, the field and removed. Strip the film at 200. After hardening for 2 hours under the crucible, a coating material for an interlayer insulating film was obtained. [Production of Coating Composition] In a 50 parts by mass of bisphenol A type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name "dimensions = 91", epoxy equivalent 480 g/eq), 1 part of titanium dioxide 3 enamel and talc are blended. 70 parts by mass of a mixed solvent of decyl isobutyl ketone (ΜΙβΚ) / xylene (1 : K mass ratio) as a mixed solvent was added, and the mixture was stirred and mixed to obtain a main component. 30 parts by mass of the master batch type hardener obtained in Example 7 was added thereto, and uniformly dispersed to obtain an epoxy resin composition. [Preparation of prepreg] In a flask in an oil bath of 130 C, a novolac type epoxy resin (manufactured by Dainippon Ink Chemical Industry Co., Ltd.; trade name: shell-sized portion, bisphenol F-type epoxy resin (manufactured by JER; Product name "EPIK0TE ❹ 4005" M0 parts by mass, bisphenol A type liquid epoxy resin (manufactured by Asahi Kasei Chemicals, trade name "AER 2603") 30 parts by mass, dissolved, mixed and cooled to 80 ° C. 15 parts by mass of the master batch type hardener obtained in Example 7 was sufficiently stirred and mixed. The resin composition cooled to room temperature was applied to a release paper at a resin density of 162 g/m 2 to form a resin film. A CF cloth (model: TR3110, density 20 (^/1112)) made of Mitsubishi 将 obtained by flat-weaving a carbon fiber having an elastic modulus of 24 ton/mm 2 at a rate of 1 ton/inch was laminated on the resin film, and the resin was composed of a resin. After impregnating the carbon fiber cloth, the polypropylene film was laminated and passed through a surface temperature of 90 ° C to a roll of 76 321995 201100387 • to prepare a cloth prepreg. The resin content was 45 mass%. The dip is aligned with the fiber direction and then added The laminate is molded at a curing temperature of 15 ° C for 1 hour to obtain an FRP molded body using carbon fibers as reinforcing fibers, and the prepared prepreg is useful. [Production of thermally conductive epoxy resin composition] 100 parts by mass of phenol novolac enamel resin (manufactured by Arakawa Chemical Industry Co., Ltd.; trade name "Tamanol") as a curing agent for epoxy resin, 100 parts by mass of A-type epoxy resin (manufactured by Asahi Kasei Chemicals; trade name: rAER 2603) Methyl ethyl ketone 50% solution 40 parts by mass, squamous graphite powder (Uni〇n

Carbide Corporation製造;商品名稱「HOPG」)15質量份 予以攪拌至均勻後,以三軸輥使之均勻分散。於其中添加 實施例7所得之母料型硬化劑15質量份並充分攪拌、混 合。使用所得之導電膏在Cu導線架上安裝半導體晶片(邊 長1. 5mm之正方形,厚度〇. gmm)且在i5(Tc下加熱30分鐘 使之硬化’得到評估用試樣。對於所得試樣之導熱性係以 〇 雷射閃光法(Laser Flash Method)測定。亦即,從測定之 熱擴散率α、比熱Cp、密度σ,由下述式:K=axCpxc7求 取導熱率K時,β 5xl(T3Cal/Cm· sec· t以上,而為適 合作為導熱性膏。 確認到實施例1至Η之母料型硬化劑均為低溫硬化性 優異、且貯藏安定性與溶劑安定性優異者。更且,Q為碳 原子數3以上之煙基時,相較為碳原子數2之烴基者, 可確認到其融點較低且10(TC之硬化速度較快。另一方面, 比幸又例1及2在低溫硬化性、貯藏安定性以及溶劑安定性 321995 77 201100387 ‘ 中之至少一者為不良者。 更且,確認到藉由使用實施例之母料型硬化劑,可得 到適合作為導電性膜、導電性膏、異方導電性膜、異方導 電性膏、絕緣性膏、絕緣性膜、密封材、塗佈材、塗料組 成物、預浸物以及導熱性環氧樹脂組成物者。 本申請案係根據2009年4月24日向日本國專利廳申 請之日本專利申請案(日本特願2009-106289號公報)之内 容,參照其内容並納入其中。 D [產業上之可利用性] 本發明之含有咪唑化合物的微膠囊化組成物可適合作 為硬化性組成物、母料型硬化劑、以及以膏狀組成物、膜 狀組成物、接著劑、接合用膏、接合用膜、導電性材料、 異方導電性材料、絕緣性材料、密封材料、塗佈用材料、 塗料組成物、預浸物、導熱性材料等為首之各種材料。 【圖式簡單說明】 3 無。 【主要元件符號說明】 益〇 ”》、 78 32199515 parts by mass manufactured by Carbide Corporation; trade name "HOPG". After being stirred until uniform, it was uniformly dispersed by a triaxial roll. 15 parts by mass of the master batch type hardener obtained in Example 7 was added thereto, and the mixture was thoroughly stirred and mixed. Using the obtained conductive paste, a semiconductor wafer (a square having a side length of 1.5 mm, a thickness of 〇.gmm) was mounted on a Cu lead frame and heated at i5 (heated for 30 minutes under Tc) to obtain a sample for evaluation. The thermal conductivity is measured by the Laser Flash Method, that is, from the measured thermal diffusivity α, the specific heat Cp, and the density σ, when the thermal conductivity K is obtained by the following formula: K=axCpxc7, β 5x1 (T3Cal/Cm·sec·t or more) is suitable as a thermal conductive paste. It is confirmed that the master batch type hardeners of Examples 1 to 2 are excellent in low-temperature curability, and excellent in storage stability and solvent stability. Further, when Q is a ketone group having 3 or more carbon atoms, it can be confirmed that the melting point is lower and 10 (the hardening rate of TC is faster) than that of a hydrocarbon group having 2 carbon atoms. On the other hand, Examples 1 and 2 were at least one of low temperature hardenability, storage stability, and solvent stability 321995 77 201100387'. Further, it was confirmed that by using the master batch type hardener of the examples, it is possible to obtain suitable Conductive film, conductive paste, heteroconductive film, and anisotropic A conductive paste, an insulating paste, an insulating film, a sealing material, a coating material, a coating composition, a prepreg, and a thermally conductive epoxy resin composition. The present application is based on a Japanese patent dated April 24, 2009. The content of the Japanese Patent Application (Japanese Patent Application No. 2009-106289), which is incorporated by reference, is incorporated herein by reference. D [Industrial Applicability] The microencapsulated composition containing the imidazole compound of the present invention can be suitably used. As a curable composition, a masterbatch type hardener, a paste composition, a film-form composition, an adhesive, a bonding paste, a bonding film, a conductive material, an anisotropic conductive material, an insulating material, and a seal Various materials such as materials, coating materials, coating compositions, prepregs, and thermal conductive materials. [Simple description of the diagram] 3 No. [Explanation of main components] YIYI", 78 321995

Claims (1)

201100387 七、申請專利範圍: 1. 一種含有13米β坐化合物之微膠囊化組成物,係包含: 含有下述式(1)所示ρ米β坐化合物之芯,與 含有有機高分子、無機化合物或該兩者且包覆上述 芯的表面之殼; R1 人 Ν Ν-Q Υ- •Ζ ⑴ 〇 R2 (式中,R1、R2、R3各自獨立地表示氫原子、鹵基、可含 取代基之碳原子數1至20之烷基、可含取代基之芳香 族基、可含取代基之碳原子數1至20之烷氧基、或可 含取代基之苯氧基;Q表示可含取代基之碳原子數1至 20之2價烴基;m表示1至100之整數;Ζ表示具有價 數m之有機基;Y表示下述式(G)所示之脲鍵、硫脲鍵、 醯胺鍵或硫醯胺鍵)201100387 VII. Patent application scope: 1. A microencapsulated composition containing a 13-m β-seat compound, comprising: a core containing a p-m β-supplement compound represented by the following formula (1), and an organic polymer and an inorganic substance; a shell of the compound or both and covering the surface of the core; R1 human Ν Q-Q Υ- • Ζ (1) 〇 R2 (wherein R1, R2, and R3 each independently represent a hydrogen atom, a halogen group, and may contain a substituent An alkyl group having 1 to 20 carbon atoms, an aromatic group which may have a substituent, an alkoxy group having 1 to 20 carbon atoms which may have a substituent, or a phenoxy group which may have a substituent; Q means a divalent hydrocarbon group having 1 to 20 carbon atoms; the m represents an integer of 1 to 100; Ζ represents an organic group having a valence of m; and Y represents a urea bond or a thiourea bond represented by the following formula (G) , amidoxime bond or thiolamine bond) NIH I CMS I NIH G) /|\ -c=s n-ih r 2.如申請專利範圍第1項之含有咪唑化合物之微膠囊化 組成物,其中,R1、R2、R3係各自獨立地為氫原子、碳 原子數1至10之烷基、或碳原子數1至10之烷氧基; Q係碳原子數1至20之2價烴基;m係1至3之整數。 79 321995 201100387 3. 如申請專利範圍第1項之含有咪唑化合物之微膠囊化 組成物,其中,R1、R2、R3係各自獨立地為氳原子、碳 原子數1至10之烷基、或碳原子數1至10之烷氧基; Q係碳原子數3至20之2價烴基;m係1至3之整數。 4. 如申請專利範圍第3項之含有咪唑化合物之微膠囊化 組成物,其中,Y係脲鍵。 5. 如申請專利範圍第1至4項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,上述咪唑化合物係在10°C 以上時為固體,且為結晶性或非結晶性者。 6. 如申請專利範圍第1至5項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,咪唑化合物係在25°C以上 時為固體,且為在250°C以下具有融點的結晶性固體。 7. 如申請專利範圍第1至6項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,上述_σ坐化合物之最大粒徑 係100/zm以下,並且粒徑在以上100/zm以下 之粒子係在上述咪唑化合物中之含量為90質量%以上。 8. 如申請專利範圍第1至7項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,上述芯含有上述咪唑化合物 與低分子胺化合物。 9. 如申請專利範圍第1至8項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,上述殼含有由異氰酸酯化合 物所衍生之有機高分子作為主成分,且於表面至少具有 吸收1630至1680CHT1之紅外線的鍵結基與吸收1680至 1725CHT1之紅外線的鍵結基。 80 321995 201100387 10. 如申請專利範圍第1至9項中任一項之含有咪唑化合物 之微膠囊化組成物,其中,上述殼含有由異氖酸酯化合 物所衍生之有機高分子作為主成分,且至少具有吸收 1730至1755cm-1之紅外線的鍵結基。 11. 如申請專利範圍第1至1〇項中任一項之含有咪唑化合 物之微膠囊化組成物,其中,相對於上述芯1〇〇質^ 份,上述殼為0.01至1〇〇質量份。 ΟNIH I CMS I NIH G) /|\ -c=s n-ih r 2. The microencapsulated composition containing an imidazole compound according to claim 1, wherein R1, R2 and R3 are each independently a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, or an alkoxy group having 1 to 10 carbon atoms; a Q-based divalent hydrocarbon group having 1 to 20 carbon atoms; and m is an integer of 1 to 3. 79 321995 201100387 3. The microencapsulated composition containing an imidazole compound according to claim 1, wherein R1, R2 and R3 are each independently a halogen atom, an alkyl group having 1 to 10 carbon atoms, or carbon. An alkoxy group having an atomic number of 1 to 10; a Q-based divalent hydrocarbon group having 3 to 20 carbon atoms; m being an integer of 1 to 3. 4. The microencapsulated composition containing an imidazole compound according to the third aspect of the patent application, wherein the Y-based urea bond. 5. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 4, wherein the imidazole compound is solid at 10 ° C or higher and is crystalline or amorphous. . 6. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 5, wherein the imidazole compound is a solid at 25 ° C or higher and has a melting point below 250 ° C. Crystalline solid. 7. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 6, wherein the maximum particle diameter of the above-mentioned _σ sitting compound is 100/zm or less, and the particle diameter is 100/100/ The content of the particles of zm or less is 90% by mass or more in the above imidazole compound. 8. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 7, wherein the core contains the above imidazole compound and a low molecular amine compound. 9. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 8, wherein the shell contains an organic polymer derived from an isocyanate compound as a main component and has at least absorption on the surface. The bonding group of the infrared rays of 1630 to 1680 CHT1 and the bonding group of the infrared rays of 1680 to 1725 CHT1 are absorbed. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 9, wherein the shell contains an organic polymer derived from an isophthalate compound as a main component. And at least having a bonding group that absorbs infrared rays of 1730 to 1755 cm-1. 11. The microencapsulated composition containing an imidazole compound according to any one of claims 1 to 1 wherein the shell is 0.01 to 1 part by mass relative to the core 1 core. . Ο 12· —種硬化性組成物,其中,相對於如申請專利範圍第^ 至11項中任一項之含有咪唑化合物之微膠囊化組成物 100質量份’含有環氧樹脂10至50, 000質量份者。 13· —種母料型硬化劑,其係含有如申請專利範圍第a項 之硬化性組成物作為主成分者。 、 14· 一種膏狀組成物,其係含有如申請專利範圍第a 硬化性組成物或如申請專利範圍第13項之母料型硬^ 劑者。 15.A curable composition comprising 100 parts by mass of the epoxy resin containing 10 to 50,000 parts of the microencapsulated composition containing the imidazole compound according to any one of claims 1 to 11 Share. A masterbatch type hardener comprising a curable composition as a main component of the item a of the patent application. And a paste composition comprising a hardening composition of the a-th aspect of the patent application or a masterbatch type hardener according to claim 13 of the patent application. 15. 一種膜狀組成物,其係含有如申請專利範圍第a項之 硬化性組成物或如巾請專鄉㈣13叙母料型硬化 查|丨去。 範圍第12項之硬化 項之母料型硬化劑 一種接著劑,其係含有如申請專利 性組成物或如申請專利範圍第13 者0 321995 81 201100387 ρ 18. -種接合用膜,其係含有如申請專利範圍第ΐ2項之硬 化性組成物或如申請專利範圍第13項之母料型硬化劑 者。 19. -種導電性材料,其係含有如中請專利範圍第12項之 硬化性組成物或如中請專利範圍第13項之母料型硬化 劑者。 ο 20. -種異方導電性材料,其係含有如申請專利範圍第a 項之硬化性組成物或如_請專利範圍第13項 硬化劑者。 2L -種異方導電性膜,其係含有如中請專利範圍第㈣ 之硬化性組成物或如申請專利範圍第13項之母料型硬 化劑者。 22. -種絕緣性材料,其係含有如申請專職圍第u 硬化性組成物或如申請專利範圍第13項之母料型硬^ ο 23. —種密封材料,其係含有如申請專利範圍第 化性組成物或如申請專利範圍第13項之母料型項之硬 24. —種塗佈用材料,其係含有如申請專利範圍第 硬化性組成物或如申請專利範圍第13 丨2項之 劑者。 、文母料型硬化 25. —種塗料組成物,其係含有如申請專利範園 硬化性組成物或如申請專利範圍第13項 12 劑者。 、史母料型, 321995 82 201100387 ,26. —種預浸物,其係含有如申請專利範圍第12項之硬化 性組成物或如申請專利範圍第13項之母料型硬化劑 者。 27. —種導熱性材料,其係含有如申請專利範圍第12項之 硬化性組成物或如申請專利範圍第13項之母料型硬化 劑者。 〇 〇 83 321995 201100387 V 四、指定代表圖:本案無圖式。 (一) 本案指定代表圖為:第( )圖。 (二) 本代表圖之元件符號簡單說明:A film-like composition comprising a sclerosing composition as in item a of the patent application scope or a refractory material such as a towel. A masterbatch type hardener of the hardening term of the item 12, which is an adhesive containing a patent-like composition or a film for bonding according to claim 13 of the patent application No. 13 321995 81 201100387 ρ 18. For example, the sclerosing composition of claim 2 or the masterbatch type hardener of claim 13 of the patent application. 19. A conductive material comprising a hardenable composition according to item 12 of the scope of the patent application or a masterbatch type hardener according to item 13 of the scope of the patent application. ο 20. An isotropic conductive material containing a hardenable composition as in item a of the patent application or a hardener according to item 13 of the patent scope. 2L - an isotropic conductive film containing a hardenable composition as in the fourth aspect of the patent application or a masterbatch type hardener as in claim 13 of the patent application. 22. An insulating material comprising a masterbatch type u hardenable composition as claimed in the application or a masterbatch type according to claim 13 of the patent scope, a sealing material, such as a patent application scope A chemical composition or a hard coating material of the master batch type according to claim 13 of the patent application, which contains a hardening composition as claimed in the patent application or as claimed in claim 13 The agent of the item. , Masterbatch type hardening 25. A coating composition, which contains a hardening composition such as a patent application or a drug according to claim 13 of the patent application. , Masterbatch type, 321995 82 201100387, 26. A prepreg containing a hardenable composition as claimed in claim 12 or a masterbatch type hardener as in claim 13 of the patent application. 27. A thermally conductive material comprising a hardenable composition as in claim 12 or a masterbatch type hardener according to claim 13 of the patent application. 〇 〇 83 321995 201100387 V IV. Designated representative map: There is no schema in this case. (1) The representative representative of the case is: ( ). (2) A brief description of the symbol of the representative figure: 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式:5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: (1) 4 321995(1) 4 321995
TW099112659A 2009-04-24 2010-04-22 Microcapsule composition containing imidazole compound, curable composition and master batch curing agent using the same TW201100387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009106289 2009-04-24

Publications (1)

Publication Number Publication Date
TW201100387A true TW201100387A (en) 2011-01-01

Family

ID=43011112

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099112659A TW201100387A (en) 2009-04-24 2010-04-22 Microcapsule composition containing imidazole compound, curable composition and master batch curing agent using the same

Country Status (5)

Country Link
JP (1) JP5763527B2 (en)
KR (1) KR20110100235A (en)
CN (1) CN102414241A (en)
TW (1) TW201100387A (en)
WO (1) WO2010122995A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103958560A (en) * 2011-11-29 2014-07-30 三菱丽阳株式会社 Epoxy resin composition, prepreg, fiber-reinforced composite material, and method for producing same
CN103958560B (en) * 2011-11-29 2016-11-30 三菱丽阳株式会社 Composition epoxy resin, prepreg, fiber reinforced composite material and manufacture method thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011208098A (en) * 2010-03-30 2011-10-20 Asahi Kasei E-Materials Corp Imidazole compound-containing micro-encapsulated composition, curable composition using the same, and master batch curing agent
WO2011126702A2 (en) * 2010-03-30 2011-10-13 Henkel Corporation Encapsulated curing agents
JP2013001875A (en) * 2011-06-20 2013-01-07 Asahi Kasei E-Materials Corp Masterbatch type hardener composition, one-part epoxy resin composition and molded article using the same, and method for producing the masterbatch type hardener composition
JP5772450B2 (en) * 2011-09-28 2015-09-02 住友ベークライト株式会社 One-part epoxy resin composition and cured product
JP6347534B2 (en) * 2013-04-26 2018-06-27 クラリアント・ファイナンス・(ビーブイアイ)・リミテッド Pigment composition and pigment resin mixture
US20170233569A1 (en) * 2014-08-12 2017-08-17 Ocv Intellectual Capital, Llc Electrically conductive sheet molding compound
JP6505428B2 (en) * 2014-12-05 2019-04-24 旭化成株式会社 Microcapsule type amine curing agent, curable resin composition, fine chemicals and composition
GB201509525D0 (en) 2015-06-02 2015-07-15 Cytec Ind Inc Fast cure epoxy resin compositions
EP3135709B1 (en) * 2015-08-31 2018-01-10 ATOTECH Deutschland GmbH Imidazoyl urea polymers and their use in metal or metal alloy plating bath compositions
DE102017201498A1 (en) * 2017-01-31 2018-08-02 Siemens Aktiengesellschaft Winding tape insulation system for electrical machines, use thereof as well as electrical machine
JP2019189834A (en) * 2018-04-27 2019-10-31 旭化成株式会社 Curing agent for epoxy resin, curing agent composition for master batch type epoxy resin, one-component epoxy resin composition, and processed article
CN111117611B (en) * 2020-01-20 2022-05-13 太原理工大学 Concentration-dependent fluorescence adjustable solid red light carbon quantum dot and preparation method thereof
CN111171285B (en) * 2020-02-15 2022-04-26 常州大学 Epoxy resin curing agent microcapsule taking polyurethane as shell material and preparation method thereof
CN112992404B (en) * 2021-05-06 2021-09-03 西安宏星电子浆料科技股份有限公司 High-conductivity conductive slurry
CN113813890B (en) * 2021-08-31 2024-01-23 无锡拜纳高分子材料科技有限公司 Preparation process method of microencapsulated liquid latent single-component epoxy curing agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797455A (en) * 1987-08-06 1989-01-10 W. R. Grace & Co.-Conn. Isocyanates blocked with 1-amino-alkyl imidazoles as epoxy curing agents
DE4136573A1 (en) * 1991-11-07 1993-07-08 Witco Gmbh N-AMINOALKYLIMIDAZOLE COMPOUNDS CONTAINING AMID AND CARBOXYL GROUPS AND THE USE THEREOF AS A CURING AGENT FOR EPOXY RESINS
JPH06184274A (en) * 1992-12-16 1994-07-05 Fuji Kasei Kogyo Kk One component system thermoset epoxide composition
JP2000290260A (en) * 1999-04-01 2000-10-17 Shikoku Chem Corp New imidazole compound and epoxy resin curing agent comprising imidazole compound as active ingredient
US20060128835A1 (en) * 2002-10-25 2006-06-15 Taketoshi Usui Capsule type hardener and composition
WO2007088889A1 (en) * 2006-02-03 2007-08-09 Asahi Kasei Chemicals Corporation Microcapsule type hardener for epoxy resin, masterbatch type hardener composition for epoxy resin, one-pack type epoxy resin composition, and processed article
WO2009005135A1 (en) * 2007-07-05 2009-01-08 Asahi Kasei E-Materials Corporation Curing agent for epoxy resin and curing agent composition for epoxy resin

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103958560A (en) * 2011-11-29 2014-07-30 三菱丽阳株式会社 Epoxy resin composition, prepreg, fiber-reinforced composite material, and method for producing same
TWI488913B (en) * 2011-11-29 2015-06-21 Mitsubishi Rayon Co Epoxy resin composition, prepreg, fiber reinforced composite material and method for manufacturing the same
CN103958560B (en) * 2011-11-29 2016-11-30 三菱丽阳株式会社 Composition epoxy resin, prepreg, fiber reinforced composite material and manufacture method thereof

Also Published As

Publication number Publication date
JP5763527B2 (en) 2015-08-12
KR20110100235A (en) 2011-09-09
CN102414241A (en) 2012-04-11
WO2010122995A1 (en) 2010-10-28
JPWO2010122995A1 (en) 2012-10-25

Similar Documents

Publication Publication Date Title
TW201100387A (en) Microcapsule composition containing imidazole compound, curable composition and master batch curing agent using the same
TWI344473B (en)
TWI316947B (en) Highly stable microcapsule-type hardener for epoxy resin and epoxy resin composition
TWI291969B (en) Curing agent for epoxy resins and epoxy resin composition
TWI247764B (en) Capsulated curing agent and composition
JP4753934B2 (en) Latent curing agent for epoxy resin and epoxy resin composition
JP5558118B2 (en) Microcapsule type epoxy resin curing agent and masterbatch type epoxy resin curing agent composition containing the same
TW201035158A (en) Composition, and processed article
JP2007204669A (en) Curing agent for epoxy resin, having specific small particle diameter particle size distribution and epoxy resin composition
JP5158088B2 (en) Microcapsule type latent curing agent for epoxy resin and method for producing the same, and one-part epoxy resin composition and cured product thereof
JP4877717B2 (en) Curing agent for slow-reactive epoxy resin and epoxy resin composition
JP2007204670A (en) Highly water- and solvent-containing curing agent for epoxy resin, and epoxy resin composition
JP4463208B2 (en) Latent curing agent and composition
JP2010053353A (en) Microcapsule type latent curing agent for epoxy resin and method for producing the same, one-part epoxy resin composition, cured product of epoxy resin, adhesive, film for bonding, conductive material, and anisotropically conductive material
JP2007091900A (en) Curing agent for rapidly curable epoxy resin and epoxy resin composition
JP5138685B2 (en) Curing agent for epoxy resin and curing agent composition for epoxy resin
JP5228644B2 (en) Microcapsule type latent curing agent for epoxy resin and method for producing the same, one-pack epoxy resin composition and cured epoxy resin
JP2011208098A (en) Imidazole compound-containing micro-encapsulated composition, curable composition using the same, and master batch curing agent
JP6063304B2 (en) Microcapsule type curing agent for epoxy resin
JP2023137042A (en) Masterbatch type curing agent for one-pack epoxy resin composition, and epoxy resin composition
JP2019189834A (en) Curing agent for epoxy resin, curing agent composition for master batch type epoxy resin, one-component epoxy resin composition, and processed article